HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 9.1 WIN_PRO 21JAN08:13:33:5921JAN08:13:33:59 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS ADAE SASDATA 9.1 WIN_PRO 21JAN08:13:33:5921JAN08:13:33:59 HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000005500000000000000000000  USUBJID Unique Subject Identifier AESEQ Sequence Number  STUDYID Study Identifier DOMAIN Domain Abbreviation SITEID Study Site Identifier 'SUBJID Subject Identifier for the Study * AETERM Reported Term for the Adverse Event ..AEDECOD Dictionary-Derived Term ;C AEBODSYSBody System or Organ Class i AESEV Severity / Intensity  AESER Serious Event  AESERN Serious Event, Numeric  AEREL Causality DSREASAEDiscontinued due to AE? ONTRTFL On or Off Study Treatment Flag TRTEMFL Treament Emergent Flag AEFN 1st AE Occurrence (1=Yes) BODFN 1st Occurrence of SOC (1=Yes) DECODFN 1st Occurrence of preferred term (1=Yes) SAEFN 1st Serious Occurrence (1=Yes) SDECODFN1st Serious Ocurrence of Term (1=Yes) SBODFN 1st Serious Ocurrence of SOC (1=Yes) AEDERMFNSpecial Dermatologic-Related Event (1=Y) AESTDT Start Date/Time of Adverse Event DATE AESTDTF Imputed Date Flag AESTDY Study Day of Start of Adverse Event  ANLSTDY Analysis Start Day AEENDT End Date/Time of Adverse Event DATE AEENDY Study Day of End of Adverse Event !TRTP ADaM Description of Planned Arm )TRTPCD ADaM Planned Arm Code = TRTPN ADaM Planned Arm Code, Numeric E!AGE Age in AGEU at RFSTDTC M"AGEGRP Age Group U#AGEGRPN Age Group, Numeric ZN$RACE Race b%RACEN Race, Numeric &SEX Sex 'SAFETY Safety Population Flag (ITT Intent to Treat Population Flag )EFFICACYEfficacy Population Flag *COMPLT24Completers of Week 24 Population Flag 8+AEDICT Coding Dictionary Information ,AESCAN Involves Cancer -AESCONG Congenital Anomaly or Birth Defect .AESDISABPersist or Signif Disability/Incapacity /AESDTH Results in Death 0AESHOSP Requires or Prolongs Hospitalization 1AESLIFE Is Life Threatening x2HLGTERM High Level Group Term x3HLTERM High Level Term sx4LLTERM Lower Level Term 5LSTDOSDTDate of Last Dose DATE c6TRTDUR Duration of treatment (days) k7TRTSTDT Start Date of Treatment DATE s HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 01-701-1015ACDISCPILOT01ADAE 7011015VERBATIM_0995APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADM A A ..Placebo Pbo B?<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DMBDM 01-701-1015A CDISCPILOT01ADAE 7011015VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADM A A ..Placebo Pbo B?<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMBDM 01-701-1015A0CDISCPILOT01ADAE 7011015VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MILD NREMOTE YY.AA....DM AADMAPlacebo Pbo B?<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DMBDM 01-701-1023ACDISCPILOT01ADAE 7011023VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYYAAA...ADK A0A0DK#BPlacebo Pbo B@<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DK%BDK 01-701-1023A CDISCPILOT01ADAE 7011023VERBATIM_1549ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADK A0A0..Placebo Pbo B@<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 LOCALIZED ERYTHEMA DK%BDK 01-701-1023A0CDISCPILOT01ADAE 7011023VERBATIM_1650ATRIOVENTRICULAR BLOCK SECOND DEGREE CARDIAC DISORDERS MILD NPOSSIBLEYYY.AA....DK BB..Placebo Pbo B@<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0086 HLT_0415 AV BLOCK SECOND DEGREE DK%BDK 01-701-1023A@CDISCPILOT01ADAE 7011023VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY......ADK A0A0DK#BPlacebo Pbo B@<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DK%BDK 01-701-1028ACDISCPILOT01ADAE 7011028VERBATIM_1157APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YYAAA...ADLh A0A0..Xanomeline High DoseXan_Hi A BG65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE ERYTHEMA DMBDLf01-701-1028A CDISCPILOT01ADAE 7011028VERBATIM_0578APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADLz BB..Xanomeline High DoseXan_Hi A BG65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMBDLf01-701-1034ACDISCPILOT01ADAE 7011034VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADM B:B:..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DNwBDM01-701-1034A CDISCPILOT01ADAE 7011034VERBATIM_0555FATIGUE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY..A....DN= B}B}..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0181 HLT_0043 FATIGUE DNwBDM01-701-1047ACDISCPILOT01ADAE 7011047VERBATIM_0130HIATUS HERNIA GASTROINTESTINAL DISORDERS MODERATENNONE YYYAAA....DK AADKAPlacebo Pbo BU>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0109 HLT_0159 HERNIA HIATAL DKBDK01-701-1047A CDISCPILOT01ADAE 7011047VERBATIM_0130HIATUS HERNIA GASTROINTESTINAL DISORDERS MODERATENNONE YYY.......DK AADKAPlacebo Pbo BU>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0109 HLT_0159 HERNIA HIATAL DKBDK01-701-1047A0CDISCPILOT01ADAE 7011047VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YYY.AA....DK BB..Placebo Pbo BU>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DKBDK01-701-1047A@CDISCPILOT01ADAE 7011047VERBATIM_0197BUNDLE BRANCH BLOCK LEFT CARDIAC DISORDERS MILD NNONE YNY.AA....DK BB..Placebo Pbo BU>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0721 HLT_0281 LEFT BUNDLE BRANCH BLOCK DKBDK01-701-1097ACDISCPILOT01ADAE 7011097VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YYAAA...ADM A0A0..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DMBDM 01-701-1097A CDISCPILOT01ADAE 7011097VERBATIM_0990PRURITUS GENERALISED SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLE YY..A...ADM> B3B3DM>B3Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0689 HLT_0123 GENERALIZED PRURITUS DMBDM 01-701-1097A0CDISCPILOT01ADAE 7011097VERBATIM_1522APPLICATION SITE VESICLES GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADM> B3B3DM@B5Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0576 HLT_0180 APPLICATION SITE BLISTER DMBDM 01-701-1097A@CDISCPILOT01ADAE 7011097VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY..A...ADM? B4B4..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMBDM 01-701-1097APCDISCPILOT01ADAE 7011097VERBATIM_0758PRURITUS GENERALISED SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLE YY......ADM[ BPBPDM[BPXanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0689 HLT_0123 GENERALIZED PRURITUS DMBDM 01-701-1097A`CDISCPILOT01ADAE 7011097VERBATIM_0990PRURITUS GENERALISED SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLE YY......ADMe BZBZDMeBZXanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0689 HLT_0123 GENERALIZED PRURITUS DMBDM 01-701-1097ApCDISCPILOT01ADAE 7011097VERBATIM_0758PRURITUS GENERALISED SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLE YY......ADMx BmBmDMyBnXanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0689 HLT_0123 GENERALIZED PRURITUS DMBDM 01-701-1097ACDISCPILOT01ADAE 7011097VERBATIM_1230PHARYNGOLARYNGEAL PAIN RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.AA....DMx BmBmDM{BpXanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0402 HLT_0130 SORE THROAT DMBDM 01-701-1097ACDISCPILOT01ADAE 7011097VERBATIM_1612NASAL CONGESTION RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY..A....DMx BmBmDM{BpXanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0549 HLT_0118 NASAL CONGESTION DMBDM 01-701-1097ACDISCPILOT01ADAE 7011097VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPOSSIBLE YY......ADM? B4B4..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMBDM 01-701-1111ACDISCPILOT01ADAE 7011111VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NNONE YNN......ADK& P@DK+AXanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DK4ADK+01-701-1111A CDISCPILOT01ADAE 7011111VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NNONE YNN......ADK& P@DK+AXanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DK4ADK+01-701-1111A0CDISCPILOT01ADAE 7011111VERBATIM_1224LOCALISED INFECTION INFECTIONS AND INFESTATIONS MODERATENNONE YNN.......DJ =<..Xanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0557 HLT_0435 LOCALIZED INFECTION DK4ADK+01-701-1111A@CDISCPILOT01ADAE 7011111VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NNONE YNN......ADK& P@DK+AXanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DK4ADK+01-701-1111APCDISCPILOT01ADAE 7011111VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NNONE YNN......ADK& P@DK+AXanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DK4ADK+01-701-1111A`CDISCPILOT01ADAE 7011111VERBATIM_1179MICTURITION URGENCY RENAL AND URINARY DISORDERS MILD NNONE YYYAAA....DK+ AA..Xanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0483 HLT_0294 URINARY URGENCY DK4ADK+01-701-1111ApCDISCPILOT01ADAE 7011111VERBATIM_1614ARTHRALGIA MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MODERATENNONE YYY.AA....DK1 ApAp..Xanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0610 HLT_0375 GENERALIZED JOINT PAIN DK4ADK+01-701-1111ACDISCPILOT01ADAE 7011111VERBATIM_0034CELLULITIS INFECTIONS AND INFESTATIONS MODERATENNONE YYY.AA....DK1 ApAp..Xanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0066 HLT_0613 CELLULITIS OF LEG DK4ADK+01-701-1115ACDISCPILOT01ADAE 7011115VERBATIM_0716APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYYAAA...ADK A0A0..Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DKB7DK01-701-1115A CDISCPILOT01ADAE 7011115VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY..A...ADK A0A0..Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DKB7DK01-701-1115A0CDISCPILOT01ADAE 7011115VERBATIM_0212APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYY..A...ADK BBDKBXanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DKB7DK01-701-1115A@CDISCPILOT01ADAE 7011115VERBATIM_0212APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYY......ADK BBDKBXanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DKB7DK01-701-1115APCDISCPILOT01ADAE 7011115VERBATIM_0716APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADK A0A0..Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DKB7DK01-701-1115A`CDISCPILOT01ADAE 7011115VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADK A0A0..Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DKB7DK01-701-1115ApCDISCPILOT01ADAE 7011115VERBATIM_1777FATIGUE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENREMOTE YYY..A....DK B.B...Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0181 HLT_0043 FATIGUE DKB7DK01-701-1115ACDISCPILOT01ADAE 7011115VERBATIM_0434APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADK B3B3..Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DKB7DK01-701-1115ACDISCPILOT01ADAE 7011115VERBATIM_0316APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY..A...ADK B3B3..Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DKB7DK01-701-1118ACDISCPILOT01ADAE 7011118VERBATIM_1139COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE NN........ ....Placebo Pbo B4<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DNBDMR01-701-1130ACDISCPILOT01ADAE 7011130VERBATIM_1682URINARY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YYAAA....DMO BBDMVBPlacebo Pbo BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0093 HLT_0161 URINARY TRACT INFECTION DMBDM901-701-1130A CDISCPILOT01ADAE 7011130VERBATIM_1401PYREXIA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NNONE YY.AA....DMO BBDMOBPlacebo Pbo BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0652 HLT_0310 FEVER DMBDM901-701-1130A0CDISCPILOT01ADAE 7011130VERBATIM_1682URINARY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YY.......DMO BBDMVBPlacebo Pbo BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0093 HLT_0161 URINARY TRACT INFECTION DMBDM901-701-1130A@CDISCPILOT01ADAE 7011130VERBATIM_0805EYE SWELLING EYE DISORDERS MILD NNONE YY.AA....DM BTBTDMBTPlacebo Pbo BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0466 HLT_0008 EYES SWOLLEN DMBDM901-701-1130APCDISCPILOT01ADAE 7011130VERBATIM_0299EYE ALLERGY EYE DISORDERS MILD NNONE YY..A....DM BTBTDMBTPlacebo Pbo BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0071 HLT_0256 EYE ALLERGY DMBDM901-701-1130A`CDISCPILOT01ADAE 7011130VERBATIM_1731EYE PRURITUS EYE DISORDERS MILD NREMOTE YY..A....DM BaBa..Placebo Pbo BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0240 HLT_0523 EYE ITCHING DMBDM901-701-1130ApCDISCPILOT01ADAE 7011130VERBATIM_0826PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NREMOTE YY.AA...ADM BaBa..Placebo Pbo BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING BOTH HANDS DMBDM901-701-1130ACDISCPILOT01ADAE 7011130VERBATIM_0615NASAL CONGESTION RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NREMOTE YY.AA....DM BaBa..Placebo Pbo BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0549 HLT_0118 NASAL CONGESTION DMBDM901-701-1133ACDISCPILOT01ADAE 7011133VERBATIM_0995APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADK B=B=..Xanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DLBDK^01-701-1133A CDISCPILOT01ADAE 7011133VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADK B=B=..Xanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLBDK^01-701-1133A0CDISCPILOT01ADAE 7011133VERBATIM_0995APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY......ADK B=B=..Xanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DLBDK^01-701-1133A@CDISCPILOT01ADAE 7011133VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY......ADK B=B=..Xanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLBDK^01-701-1146ACDISCPILOT01ADAE 7011146VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NNONE YNN......ADL& @0DL7AXanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLOB&DL*01-701-1146A CDISCPILOT01ADAE 7011146VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NNONE YNN......ADL& @0DL7AXanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLOB&DL*01-701-1146A0CDISCPILOT01ADAE 7011146VERBATIM_0583APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYYAAA...ADL6 AADL7AXanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DLOB&DL*01-701-1146A@CDISCPILOT01ADAE 7011146VERBATIM_0555FATIGUE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYY..A....DL8 AA..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0181 HLT_0043 FATIGUE DLOB&DL*01-701-1146APCDISCPILOT01ADAE 7011146VERBATIM_0349APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY..A...ADL? BB..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE ERYTHEMA DLOB&DL*01-701-1146A`CDISCPILOT01ADAE 7011146VERBATIM_0578APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY..A...ADL? BB..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLOB&DL*01-701-1146ApCDISCPILOT01ADAE 7011146VERBATIM_0349APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADL? BB..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE ERYTHEMA DLOB&DL*01-701-1146ACDISCPILOT01ADAE 7011146VERBATIM_0578APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADL? BB..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLOB&DL*01-701-1146ACDISCPILOT01ADAE 7011146VERBATIM_0516APPLICATION SITE PAIN GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY..A...ADLK B"B"..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0085 HLT_0342 APPLICATION SITE PAIN DLOB&DL*01-701-1146ACDISCPILOT01ADAE 7011146VERBATIM_0347APPLICATION SITE VESICLES GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY..A...ADLO B&B&..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0576 HLT_0180 APPLICATION SITE VESICLES DLOB&DL*01-701-1146ACDISCPILOT01ADAE 7011146VERBATIM_0244APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADLO B&B&..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DLOB&DL*01-701-1148ACDISCPILOT01ADAE 7011148VERBATIM_0922APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADL A0A0..Xanomeline High DoseXan_Hi A B9<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DM>BDL01-701-1148A CDISCPILOT01ADAE 7011148VERBATIM_0445APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADL A0A0..Xanomeline High DoseXan_Hi A B9<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DM>BDL01-701-1148A0CDISCPILOT01ADAE 7011148VERBATIM_1765LOWER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MODERATENNONE YY.AA....DL B3B3DLBPXanomeline High DoseXan_Hi A B9<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0217 HLT_0052 CHEST COLD DM>BDL01-701-1148A@CDISCPILOT01ADAE 7011148VERBATIM_1765LOWER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MODERATENNONE YY.......DL B3B3DLBPXanomeline High DoseXan_Hi A B9<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0217 HLT_0052 CHEST COLD DM>BDL01-701-1148APCDISCPILOT01ADAE 7011148VERBATIM_0630FLANK PAIN MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MODERATENNONE YY.AA....DL BsBsDLBuXanomeline High DoseXan_Hi A B9<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0543 HLT_0484 FLANK PAIN DM>BDL01-701-1148A`CDISCPILOT01ADAE 7011148VERBATIM_1748CALCULUS URETHRAL RENAL AND URINARY DISORDERS MODERATENNONE YY.AA....DL BuBuDLBuXanomeline High DoseXan_Hi A B9<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0414 HLT_0550 URETHRAL CALCULUS DM>BDL01-701-1148ApCDISCPILOT01ADAE 7011148VERBATIM_0847EPISTAXIS RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.AA....DM BBDMBXanomeline High DoseXan_Hi A B9<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0577 HLT_0386 NOSE BLEED DM>BDL01-701-1148ACDISCPILOT01ADAE 7011148VERBATIM_0800DYSPEPSIA GASTROINTESTINAL DISORDERS MODERATENNONE NN.......DJPD##..Xanomeline High DoseXan_Hi A B9<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0716 HLT_0244 INDIGESTION DM>BDL01-701-1148ACDISCPILOT01ADAE 7011148VERBATIM_0591DEPRESSED MOOD PSYCHIATRIC DISORDERS MODERATENNONE NN.......DLp ..Xanomeline High DoseXan_Hi A B9<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0122 HLT_0784 DEPRESSED MOOD DM>BDL01-701-1148ACDISCPILOT01ADAE 7011148VERBATIM_0022ACTINIC KERATOSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NNONE YY.AA...ADM6 BB..Xanomeline High DoseXan_Hi A B9<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0490 HLT_0609 ACTINIC KERATOSIS DM>BDL01-701-1153ACDISCPILOT01ADAE 7011153VERBATIM_0156INCREASED APPETITE METABOLISM AND NUTRITION DISORDERS MILD NPOSSIBLE YYAAA....DL BBDLB-Placebo Pbo BO65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0769 HLT_0566 INCREASED APPETITE DMVBDL01-701-1153A CDISCPILOT01ADAE 7011153VERBATIM_0156INCREASED APPETITE METABOLISM AND NUTRITION DISORDERS MILD NPOSSIBLE YY.......DL BBDLB-Placebo Pbo BO65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0769 HLT_0566 INCREASED APPETITE DMVBDL01-701-1180ACDISCPILOT01ADAE 7011180VERBATIM_1453VOMITING GASTROINTESTINAL DISORDERS MILD NNONE YYYAAA....DK AADKAXanomeline High DoseXan_Hi A B8<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 VOMITING DKB#DK01-701-1180A CDISCPILOT01ADAE 7011180VERBATIM_1453VOMITING GASTROINTESTINAL DISORDERS MILD NNONE YYY.......DK AADKAXanomeline High DoseXan_Hi A B8<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 VOMITING DKB#DK01-701-1180A0CDISCPILOT01ADAE 7011180VERBATIM_1179MICTURITION URGENCY RENAL AND URINARY DISORDERS MILD NPOSSIBLEYYY.AA....DK A@A@DKB$Xanomeline High DoseXan_Hi A B8<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0483 HLT_0294 URINARY URGENCY DKB#DK01-701-1180A@CDISCPILOT01ADAE 7011180VERBATIM_0929HEADACHE NERVOUS SYSTEM DISORDERS MODERATENNONE YNN........ ....Xanomeline High DoseXan_Hi A B8<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DKB#DK01-701-1180APCDISCPILOT01ADAE 7011180VERBATIM_1698NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YYY.AA....DK BBDKBXanomeline High DoseXan_Hi A B8<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD DKB#DK01-701-1180A`CDISCPILOT01ADAE 7011180VERBATIM_1179MICTURITION URGENCY RENAL AND URINARY DISORDERS MILD NPOSSIBLEYYY.......DK A@A@DKB$Xanomeline High DoseXan_Hi A B8<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0483 HLT_0294 URINARY URGENCY DKB#DK01-701-1180ApCDISCPILOT01ADAE 7011180VERBATIM_1474APPLICATION SITE VESICLES GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPOSSIBLEYNY.AA...ADK B$B$..Xanomeline High DoseXan_Hi A B8<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0576 HLT_0180 APPLICATION SITE BLISTER DKB#DK01-701-1180ACDISCPILOT01ADAE 7011180VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPOSSIBLEYNY..A...ADK B$B$..Xanomeline High DoseXan_Hi A B8<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DKB#DK01-701-1180ACDISCPILOT01ADAE 7011180VERBATIM_0709APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPOSSIBLEYNY..A...ADK B$B$..Xanomeline High DoseXan_Hi A B8<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE ERYTHEMA DKB#DK01-701-1181ACDISCPILOT01ADAE 7011181VERBATIM_0499AGITATION PSYCHIATRIC DISORDERS MODERATENNONE YYYAAA....DL APAPDLAPXanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0170 HLT_0140 AGITATION DLAPDL01-701-1188ACDISCPILOT01ADAE 7011188VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYYAAA...ADK A A ..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DKB&DK01-701-1188A CDISCPILOT01ADAE 7011188VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY..A...ADK A A ..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DKB&DK01-701-1188A0CDISCPILOT01ADAE 7011188VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADK A A ..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DKB&DK01-701-1188A@CDISCPILOT01ADAE 7011188VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADK A A ..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DKB&DK01-701-1188APCDISCPILOT01ADAE 7011188VERBATIM_0252URTICARIA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY..A...ADK BB..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0705 HLT_0420 WELTS DKB&DK01-701-1188A`CDISCPILOT01ADAE 7011188VERBATIM_0252URTICARIA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADK BB..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0705 HLT_0420 WELTS DKB&DK01-701-1188ApCDISCPILOT01ADAE 7011188VERBATIM_0761APPLICATION SITE URTICARIA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY.AA...ADK B#B#..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0233 HLT_0196 APPLICATION SITE URTICARIA DKB&DK01-701-1188ACDISCPILOT01ADAE 7011188VERBATIM_1569URTICARIA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY......ADK B#B#..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0705 HLT_0420 WELTS DKB&DK01-701-1192ACDISCPILOT01ADAE 7011192VERBATIM_0819NASAL MUCOSA BIOPSY INVESTIGATIONS MILD NNONE YYAAA....DK AADKAXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0396 HLT_0680 NASAL MUCOSA BIOPSY DKBDJ01-701-1192A CDISCPILOT01ADAE 7011192VERBATIM_0589SECRETION DISCHARGE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NNONE YY.AA....DK BBDK2B7Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0575 HLT_0683 SECRETION DISCHARGE DKBDJ01-701-1192A0CDISCPILOT01ADAE 7011192VERBATIM_1470ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NNONE YY.AA...ADK BBDK2B7Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA FACIAL DKBDJ01-701-1192A@CDISCPILOT01ADAE 7011192VERBATIM_1421COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MODERATENNONE NN.......DGD00..Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DKBDJ01-701-1192APCDISCPILOT01ADAE 7011192VERBATIM_0589SECRETION DISCHARGE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NNONE YY.......DK BBDK2B7Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0575 HLT_0683 SECRETION DISCHARGE DKBDJ01-701-1192A`CDISCPILOT01ADAE 7011192VERBATIM_1470ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NNONE YY......ADK BBDK2B7Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA FACIAL DKBDJ01-701-1192ApCDISCPILOT01ADAE 7011192VERBATIM_0919PNEUMONIA INFECTIONS AND INFESTATIONS MODERATENNONE YY.AA....DK+ B0B0DKHBMXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0671 HLT_0251 PNEUMONIA DKBDJ01-701-1192ACDISCPILOT01ADAE 7011192VERBATIM_1050MUSCULAR WEAKNESS MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MODERATENNONE YY.AA....DK+ B0B0DKBBGXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0211 HLT_0444 MUSCULAR WEAKNESS DKBDJ01-701-1192ACDISCPILOT01ADAE 7011192VERBATIM_1421COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE NN.......DGD00..Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DKBDJ01-701-1192ACDISCPILOT01ADAE 7011192VERBATIM_0919PNEUMONIA INFECTIONS AND INFESTATIONS MODERATENNONE YY.......DK+ B0B0DKHBMXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0671 HLT_0251 PNEUMONIA DKBDJ01-701-1192ACDISCPILOT01ADAE 7011192VERBATIM_1050MUSCULAR WEAKNESS MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MODERATENNONE YY.......DK+ B0B0DKBBGXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0211 HLT_0444 MUSCULAR WEAKNESS DKBDJ01-701-1192ACDISCPILOT01ADAE 7011192VERBATIM_1067APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADK BBDKBXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DKBDJ01-701-1192ACDISCPILOT01ADAE 7011192VERBATIM_1444APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADK BB..Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DKBDJ01-701-1192ACDISCPILOT01ADAE 7011192VERBATIM_0578APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADK BB..Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DKBDJ01-701-1192ACDISCPILOT01ADAE 7011192VERBATIM_1067APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADK BBDKBXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DKBDJ01-701-1203ACDISCPILOT01ADAE 7011203VERBATIM_1020EYE LASER SURGERY SURGICAL AND MEDICAL PROCEDURES MILD NNONE YYAAA....DK B0B0DKB0Placebo Pbo BQ>80 A0AFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0189 HLT_0355 EYE LASER SURGERY DLuBDK01-701-1211ACDISCPILOT01ADAE 7011211VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YYAAA...ADKq A A ..Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DKB;DKp01-701-1211A CDISCPILOT01ADAE 7011211VERBATIM_0394JOINT DISLOCATION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MODERATENNONE YY.AA....DKv ApApDKvApXanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0227 HLT_0035 SHOULDER DISLOCATION DKB;DKp01-701-1211A0CDISCPILOT01ADAE 7011211VERBATIM_1643SHOULDER PAIN MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MILD NNONE YY.AA....DKv ApAp..Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0288 HLT_0527 SHOULDER PAIN DKB;DKp01-701-1211A@CDISCPILOT01ADAE 7011211VERBATIM_0312INCONTINENCE RENAL AND URINARY DISORDERS MILD NNONE YY.AA....DKw AA..Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0503 HLT_0560 INCONTINENCE DKB;DKp01-701-1211APCDISCPILOT01ADAE 7011211VERBATIM_0995APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY..A...ADK~ AA..Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DKB;DKp01-701-1211A`CDISCPILOT01ADAE 7011211VERBATIM_0548SKIN LACERATION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NNONE YY..A....DK BB..Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0118 HLT_0075 LACERATION OF FACE DKB;DKp01-701-1211ApCDISCPILOT01ADAE 7011211VERBATIM_1524CONFUSIONAL STATE PSYCHIATRIC DISORDERS MODERATENNONE YY.AA....DK B:B:..Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0329 HLT_0642 CONFUSION DKB;DKp01-701-1211ACDISCPILOT01ADAE 7011211VERBATIM_1509DYSPNOEA RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MODERATENNONE YY.AA....DK B:B:..Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0255 HLT_0296 SHORTNESS OF BREATH DKB;DKp01-701-1211ACDISCPILOT01ADAE 7011211VERBATIM_0484SUDDEN DEATH GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS SEVERE NNONE NY..A....DK B=B=DKB=Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNYNYHLGT_0272 HLT_0142 SUDDEN DEATH DKB;DKp01-701-1239ACDISCPILOT01ADAE 7011239VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YYAAA...ADM A A ..Xanomeline High DoseXan_Hi A B8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DMBDM01-701-1239A CDISCPILOT01ADAE 7011239VERBATIM_0385SKIN ODOUR ABNORMAL SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NREMOTE YY..A...ADM A A ..Xanomeline High DoseXan_Hi A B8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0184 HLT_0510 SKIN ODOR ABNORMAL DMBDM01-701-1239A0CDISCPILOT01ADAE 7011239VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY..A...ADM A0A0..Xanomeline High DoseXan_Hi A B8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DMBDM01-701-1239A@CDISCPILOT01ADAE 7011239VERBATIM_1231APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADM AADM2BXanomeline High DoseXan_Hi A B8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DMBDM01-701-1239APCDISCPILOT01ADAE 7011239VERBATIM_1231APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADM AADM2BXanomeline High DoseXan_Hi A B8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DMBDM01-701-1239A`CDISCPILOT01ADAE 7011239VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLE YY......ADM A A ..Xanomeline High DoseXan_Hi A B8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DMBDM01-701-1239ApCDISCPILOT01ADAE 7011239VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YY.AA....DM> B)B)DMRB=Xanomeline High DoseXan_Hi A B8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DMBDM01-701-1239ACDISCPILOT01ADAE 7011239VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YY.......DM> B)B)DMRB=Xanomeline High DoseXan_Hi A B8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DMBDM01-701-1239ACDISCPILOT01ADAE 7011239VERBATIM_0555FATIGUE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NREMOTE YY..A....DMGDB2B2..Xanomeline High DoseXan_Hi A B8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0181 HLT_0043 FATIGUE DMBDM01-701-1239ACDISCPILOT01ADAE 7011239VERBATIM_1306HORDEOLUM INFECTIONS AND INFESTATIONS MILD NNONE YY..A....DMfDBQBQ..Xanomeline High DoseXan_Hi A B8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0290 HLT_0604 STYE DMBDM01-701-1275ACDISCPILOT01ADAE 7011275VERBATIM_0775NAUSEA GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YYAAA....DM7 ApApDMBuXanomeline High DoseXan_Hi A B=<65 AOTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO) A`MYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0326 HLT_0742 NAUSEA DMBrDM101-701-1275A CDISCPILOT01ADAE 7011275VERBATIM_0897VOMITING GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YY..A....DMA BBDMABXanomeline High DoseXan_Hi A B=<65 AOTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO) A`MYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 VOMITING DMBrDM101-701-1275A0CDISCPILOT01ADAE 7011275VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY.AA...ADMB BBDMB~Xanomeline High DoseXan_Hi A B=<65 AOTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO) A`MYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DMBrDM101-701-1275A@CDISCPILOT01ADAE 7011275VERBATIM_1572SALIVARY HYPERSECRETION GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YY..A....DMB BBDMBuXanomeline High DoseXan_Hi A B=<65 AOTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO) A`MYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0488 HLT_0374 HYPERSALIVATION DMBrDM101-701-1275APCDISCPILOT01ADAE 7011275VERBATIM_0923PAROSMIA NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YY.AA....DMB BBDMBuXanomeline High DoseXan_Hi A B=<65 AOTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO) A`MYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0471 HLT_0258 STRANGE SMELL SENSATION DMBrDM101-701-1275A`CDISCPILOT01ADAE 7011275VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY..A...ADMB BBDMB~Xanomeline High DoseXan_Hi A B=<65 AOTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO) A`MYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DMBrDM101-701-1275ApCDISCPILOT01ADAE 7011275VERBATIM_0910COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.AA....DMR B"B"DMaB1Xanomeline High DoseXan_Hi A B=<65 AOTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO) A`MYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DMBrDM101-701-1275ACDISCPILOT01ADAE 7011275VERBATIM_1612NASAL CONGESTION RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY..A....DMR B"B"DMaB1Xanomeline High DoseXan_Hi A B=<65 AOTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO) A`MYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0549 HLT_0118 NASAL CONGESTION DMBrDM101-701-1275ACDISCPILOT01ADAE 7011275VERBATIM_0910COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.......DMR B"B"DMaB1Xanomeline High DoseXan_Hi A B=<65 AOTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO) A`MYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DMBrDM101-701-1275ACDISCPILOT01ADAE 7011275VERBATIM_1612NASAL CONGESTION RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.......DMR B"B"DMaB1Xanomeline High DoseXan_Hi A B=<65 AOTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO) A`MYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0549 HLT_0118 NASAL CONGESTION DMBrDM101-701-1275ACDISCPILOT01ADAE 7011275VERBATIM_0775NAUSEA GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YY.......DM7 ApApDMBuXanomeline High DoseXan_Hi A B=<65 AOTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO) A`MYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0326 HLT_0742 NAUSEA DMBrDM101-701-1275ACDISCPILOT01ADAE 7011275VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY......ADMB BBDMB~Xanomeline High DoseXan_Hi A B=<65 AOTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO) A`MYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DMBrDM101-701-1275ACDISCPILOT01ADAE 7011275VERBATIM_1572SALIVARY HYPERSECRETION GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YY.......DMB BBDMBuXanomeline High DoseXan_Hi A B=<65 AOTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO) A`MYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0488 HLT_0374 HYPERSALIVATION DMBrDM101-701-1275ACDISCPILOT01ADAE 7011275VERBATIM_0923PAROSMIA NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YY.......DMB BBDMBuXanomeline High DoseXan_Hi A B=<65 AOTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO) A`MYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0471 HLT_0258 STRANGE SMELL SENSATION DMBrDM101-701-1275ACDISCPILOT01ADAE 7011275VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY......ADMB BBDMB~Xanomeline High DoseXan_Hi A B=<65 AOTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO) A`MYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DMBrDM101-701-1287ACDISCPILOT01ADAE 7011287VERBATIM_1433SALIVARY HYPERSECRETION GASTROINTESTINAL DISORDERS MILD NNONE YYAAA....DM% A A ..Xanomeline High DoseXan_Hi A B8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0488 HLT_0374 INCREASED SALIVATION DMBDM$01-701-1287A CDISCPILOT01ADAE 7011287VERBATIM_0445APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY.AA...ADM@ BB..Xanomeline High DoseXan_Hi A B8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMBDM$01-701-1287A0CDISCPILOT01ADAE 7011287VERBATIM_0716APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADMO B,B,..Xanomeline High DoseXan_Hi A B8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DMBDM$01-701-1287A@CDISCPILOT01ADAE 7011287VERBATIM_1075RHINORRHOEA RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.AA....DM BBDMBXanomeline High DoseXan_Hi A B8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0460 HLT_0635 RUNNY NOSE DMBDM$01-701-1287APCDISCPILOT01ADAE 7011287VERBATIM_1075RHINORRHOEA RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.......DM BBDMBXanomeline High DoseXan_Hi A B8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0460 HLT_0635 RUNNY NOSE DMBDM$01-701-1294ACDISCPILOT01ADAE 7011294VERBATIM_0578APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENNONE YNN......ADK DKXanomeline Low Dose Xan_Lo ABC65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLCBSDK01-701-1294A CDISCPILOT01ADAE 7011294VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYYAAA...ADL) B9B9..Xanomeline Low Dose Xan_Lo ABC65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLCBSDK01-701-1294A0CDISCPILOT01ADAE 7011294VERBATIM_0716APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY..A...ADL) B9B9..Xanomeline Low Dose Xan_Lo ABC65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DLCBSDK01-701-1294A@CDISCPILOT01ADAE 7011294VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPOSSIBLEYYY......ADL) B9B9..Xanomeline Low Dose Xan_Lo ABC65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLCBSDK01-701-1294APCDISCPILOT01ADAE 7011294VERBATIM_0716APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADL) B9B9..Xanomeline Low Dose Xan_Lo ABC65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DLCBSDK01-701-1294A`CDISCPILOT01ADAE 7011294VERBATIM_1620RASH ERYTHEMATOUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY.AA...ADL? BOBO..Xanomeline Low Dose Xan_Lo ABC65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0701 HLT_0336 ERYTHEMATOUS RASH DLCBSDK01-701-1302ACDISCPILOT01ADAE 7011302VERBATIM_0038APPLICATION SITE PERSPIRATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYYAAA...ADL A A ..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0403 HLT_0283 APPLICATION SITE PERSPIRATION DLBEDL01-701-1302A CDISCPILOT01ADAE 7011302VERBATIM_0551HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY.AA....DL A A ..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 PERSPIRATION EXCESSIVE DLBEDL01-701-1302A0CDISCPILOT01ADAE 7011302VERBATIM_0350STOMACH DISCOMFORT GASTROINTESTINAL DISORDERS MILD NPOSSIBLEYYY.AA....DL A A ..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0183 HLT_0065 STOMACH UPSET DLBEDL01-701-1302A@CDISCPILOT01ADAE 7011302VERBATIM_1314PAIN GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYY..A....DL A0A0..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0478 HLT_0314 STINGING DLBEDL01-701-1302APCDISCPILOT01ADAE 7011302VERBATIM_1612NASAL CONGESTION RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YYY.AA....DL A@A@..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0549 HLT_0118 NASAL CONGESTION DLBEDL01-701-1302A`CDISCPILOT01ADAE 7011302VERBATIM_1230PHARYNGOLARYNGEAL PAIN RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YYY..A....DL APAP..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0402 HLT_0130 SORE THROAT DLBEDL01-701-1302ApCDISCPILOT01ADAE 7011302VERBATIM_0298PRODUCTIVE COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YYY..A....DL APAP..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0681 HLT_0545 PRODUCTIVE COUGH DLBEDL01-701-1302ACDISCPILOT01ADAE 7011302VERBATIM_0734MALAISE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NREMOTE YYY..A....DL APAP..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0178 HLT_0456 MALAISE DLBEDL01-701-1302ACDISCPILOT01ADAE 7011302VERBATIM_0327DIZZINESS NERVOUS SYSTEM DISORDERS MODERATENREMOTE YYY.AA....DL APAPDLA`Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZY DLBEDL01-701-1302ACDISCPILOT01ADAE 7011302VERBATIM_0183MYALGIA MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MILD NPOSSIBLEYYY.AA....DL APAP..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0121 HLT_0700 MYALGIA DLBEDL01-701-1302ACDISCPILOT01ADAE 7011302VERBATIM_1049DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLEYYY.......DL ApAp..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 LIGHTHEADEDNESS DLBEDL01-701-1302ACDISCPILOT01ADAE 7011302VERBATIM_1465CONTUSION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NREMOTE YYY.AA....DL AADLB)Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0381 HLT_0713 BRUISE DLBEDL01-701-1302ACDISCPILOT01ADAE 7011302VERBATIM_0735HEADACHE NERVOUS SYSTEM DISORDERS MILD NNONE YYY..A....DL BB..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DLBEDL01-701-1302ACDISCPILOT01ADAE 7011302VERBATIM_1199EPISTAXIS RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NREMOTE YYY..A....DL B!B!..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0577 HLT_0386 NOSE BLEED DLBEDL01-701-1302ACDISCPILOT01ADAE 7011302VERBATIM_1465CONTUSION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NREMOTE YYY.......DL AADLB)Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0381 HLT_0713 BRUISE DLBEDL01-701-1302BCDISCPILOT01ADAE 7011302VERBATIM_1005APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY..A...ADL B0B0..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DLBEDL01-701-1302BCDISCPILOT01ADAE 7011302VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY..A...ADL B0B0..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLBEDL01-701-1302BCDISCPILOT01ADAE 7011302VERBATIM_0734MALAISE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENREMOTE YYY.......DL APAP..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0178 HLT_0456 MALAISE DLBEDL01-701-1302BCDISCPILOT01ADAE 7011302VERBATIM_1148RESPIRATORY TRACT CONGESTION RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YYY..A....DL B8B8..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0424 HLT_0330 RESPIRATORY TRACT CONGESTION DLBEDL01-701-1302BCDISCPILOT01ADAE 7011302VERBATIM_0358RHINITIS INFECTIONS AND INFESTATIONS MILD NNONE YYY.AA....DL B8B8..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0322 HLT_0239 CORYZA DLBEDL01-701-1302BCDISCPILOT01ADAE 7011302VERBATIM_0374FEELING ABNORMAL GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYY..A....DL B9B9..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0749 HLT_0524 FOGGY FEELING IN HEAD DLBEDL01-701-1302BCDISCPILOT01ADAE 7011302VERBATIM_0482LISTLESS PSYCHIATRIC DISORDERS MILD NPOSSIBLEYYY.AA....DL B9B9..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0124 HLT_0657 LISTLESSNESS DLBEDL01-701-1302BCDISCPILOT01ADAE 7011302VERBATIM_1773LIBIDO DECREASED PSYCHIATRIC DISORDERS MILD NPOSSIBLEYYY..A....DL B9B9..Xanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0496 HLT_0338 LIBIDO DECREASED DLBEDL01-701-1317ACDISCPILOT01ADAE 7011317VERBATIM_0468ONYCHOMYCOSIS INFECTIONS AND INFESTATIONS MILD NNONE NN.......DM ..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0243 HLT_0275 ONYCHOMYCOSIS DNOBDM01-701-1317A CDISCPILOT01ADAE 7011317VERBATIM_1010CYST GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NNONE NN.......DM ..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0341 HLT_0763 CYST DNOBDM01-701-1317A0CDISCPILOT01ADAE 7011317VERBATIM_0716APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YYAAA...ADM B!B!..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DNOBDM01-701-1317A@CDISCPILOT01ADAE 7011317VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY..A...ADM B!B!..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DNOBDM01-701-1317APCDISCPILOT01ADAE 7011317VERBATIM_1456APPLICATION SITE URTICARIA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY..A...ADM B!B!..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0233 HLT_0196 APPLICATION SITE URTICARIA DNOBDM01-701-1317A`CDISCPILOT01ADAE 7011317VERBATIM_0326DEPRESSED MOOD PSYCHIATRIC DISORDERS MILD NPOSSIBLE YY.AA....DM B,B,..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0122 HLT_0784 DEPRESSED MOOD DNOBDM01-701-1317ApCDISCPILOT01ADAE 7011317VERBATIM_0326DEPRESSED MOOD PSYCHIATRIC DISORDERS MODERATENPOSSIBLE YY.......DM B,B,..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0122 HLT_0784 DEPRESSED MOOD DNOBDM01-701-1317ACDISCPILOT01ADAE 7011317VERBATIM_1301FATIGUE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NREMOTE YY..A....DN BrBr..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0181 HLT_0043 TIREDNESS DNOBDM01-701-1317ACDISCPILOT01ADAE 7011317VERBATIM_0933DYSPHONIA RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NREMOTE YY.AA....DN> BB..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0274 HLT_0073 HOARSENESS DNOBDM01-701-1324ACDISCPILOT01ADAE 7011324VERBATIM_0013APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADKX BB..Xanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE ERYTHEMA DKBDKD01-701-1324A CDISCPILOT01ADAE 7011324VERBATIM_1035APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADK B>B>..Xanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DKBDKD01-701-1324A0CDISCPILOT01ADAE 7011324VERBATIM_0996APPLICATION SITE VESICLES GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADK BUBUDKBkXanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0576 HLT_0180 APPLICATION SITE BLISTER DKBDKD01-701-1324A@CDISCPILOT01ADAE 7011324VERBATIM_0996APPLICATION SITE VESICLES GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADK BUBUDKBkXanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0576 HLT_0180 APPLICATION SITE BLISTER DKBDKD01-701-1341ACDISCPILOT01ADAE 7011341VERBATIM_1271APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYYAAA...ADK AA..Xanomeline Low Dose Xan_Lo AB3<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DKBDK01-701-1341A CDISCPILOT01ADAE 7011341VERBATIM_0437APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY..A...ADK AA..Xanomeline Low Dose Xan_Lo AB3<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DKBDK01-701-1341A0CDISCPILOT01ADAE 7011341VERBATIM_1318APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADK BBDKBXanomeline Low Dose Xan_Lo AB3<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DKBDK01-701-1341A@CDISCPILOT01ADAE 7011341VERBATIM_1791APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADK BB..Xanomeline Low Dose Xan_Lo AB3<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DKBDK01-701-1341APCDISCPILOT01ADAE 7011341VERBATIM_0810APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY..A...ADK BBDKBXanomeline Low Dose Xan_Lo AB3<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DKBDK01-701-1360ACDISCPILOT01ADAE 7011360VERBATIM_0709APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YYAAA...ADLt A0A0..Xanomeline High DoseXan_Hi A BC65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE ERYTHEMA DLwA`DLr01-701-1360A CDISCPILOT01ADAE 7011360VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY..A...ADLt A0A0..Xanomeline High DoseXan_Hi A BC65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLwA`DLr01-701-1360A0CDISCPILOT01ADAE 7011360VERBATIM_0996APPLICATION SITE VESICLES GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY..A...ADLw A`A`..Xanomeline High DoseXan_Hi A BC65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0576 HLT_0180 APPLICATION SITE BLISTER DLwA`DLr01-701-1363ACDISCPILOT01ADAE 7011363VERBATIM_0775NAUSEA GASTROINTESTINAL DISORDERS MILD NREMOTE YYAAA....DLC BBDLDBPlacebo Pbo BQ>80 A0AFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0326 HLT_0742 NAUSEA DLBDL401-701-1363A CDISCPILOT01ADAE 7011363VERBATIM_0301HEADACHE NERVOUS SYSTEM DISORDERS MODERATENPOSSIBLE NN........ ....Placebo Pbo BQ>80 A0AFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DLBDL401-701-1363A0CDISCPILOT01ADAE 7011363VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADLc B0B0..Placebo Pbo BQ>80 A0AFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLBDL401-701-1363A@CDISCPILOT01ADAE 7011363VERBATIM_0301HEADACHE NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE NN........ ....Placebo Pbo BQ>80 A0AFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DLBDL401-701-1363APCDISCPILOT01ADAE 7011363VERBATIM_1742BACK PAIN MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MILD NNONE YY.AA....DL BBDLBPlacebo Pbo BQ>80 A0AFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0508 HLT_0115 BACKACHE DLBDL401-701-1363A`CDISCPILOT01ADAE 7011363VERBATIM_1742BACK PAIN MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MILD NNONE YY.......DL BBDLBPlacebo Pbo BQ>80 A0AFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0508 HLT_0115 BACKACHE DLBDL401-701-1383ACDISCPILOT01ADAE 7011383VERBATIM_1035APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADK A@A@DKA@Xanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLxBDK01-701-1383A CDISCPILOT01ADAE 7011383VERBATIM_0725APPLICATION SITE PAIN GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADK A@A@DKA@Xanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0085 HLT_0342 APPLICATION SITE PAIN DLxBDK01-701-1383A0CDISCPILOT01ADAE 7011383VERBATIM_1157APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY..A...ADK B0B0DKB3Xanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE ERYTHEMA DLxBDK01-701-1383A@CDISCPILOT01ADAE 7011383VERBATIM_1035APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY......ADK B0B0..Xanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLxBDK01-701-1383APCDISCPILOT01ADAE 7011383VERBATIM_0349APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY......ADL BDBD..Xanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE ERYTHEMA DLxBDK01-701-1383A`CDISCPILOT01ADAE 7011383VERBATIM_1067APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY..A...ADL BDBD..Xanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DLxBDK01-701-1383ApCDISCPILOT01ADAE 7011383VERBATIM_1035APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPOSSIBLE YY......ADK B0B0..Xanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLxBDK01-701-1383ACDISCPILOT01ADAE 7011383VERBATIM_1067APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPOSSIBLE YY......ADL BDBD..Xanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DLxBDK01-701-1383ACDISCPILOT01ADAE 7011383VERBATIM_0880APPLICATION SITE VESICLES GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY..A...ADL B]B]DL.BnXanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0576 HLT_0180 APPLICATION SITE BLISTER DLxBDK01-701-1383ACDISCPILOT01ADAE 7011383VERBATIM_0653CHEST DISCOMFORT GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NNONE YY..A....DLM BBDLMBXanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0441 HLT_0593 CHEST PRESSURE DLxBDK01-701-1383ACDISCPILOT01ADAE 7011383VERBATIM_1739HEADACHE NERVOUS SYSTEM DISORDERS MILD NNONE YY.AA....DLM BBDLMBXanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 FULLNESS HEAD DLxBDK01-701-1383ACDISCPILOT01ADAE 7011383VERBATIM_0910COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MODERATENNONE YY.AA....DLd BBDLmBXanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DLxBDK01-701-1387ACDISCPILOT01ADAE 7011387VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MILD NREMOTE YYAAA....DMX ApApDMXApPlacebo Pbo BW>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DM_ADMR01-701-1387A CDISCPILOT01ADAE 7011387VERBATIM_1343HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NREMOTE YY.AA....DMX ApApDMXApPlacebo Pbo BW>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 SWEATING DM_ADMR01-701-1392ACDISCPILOT01ADAE 7011392VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NREMOTE YYAAA....DK BBDKBPlacebo Pbo BN65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DLBDK^01-701-1392A CDISCPILOT01ADAE 7011392VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NREMOTE YY.......DK BBDKBPlacebo Pbo BN65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DLBDK^01-701-1415ACDISCPILOT01ADAE 7011415VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YYAAA....DL BBDLB+Placebo Pbo BU>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DM^BDL01-701-1415A CDISCPILOT01ADAE 7011415VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YY.......DL BBDLB+Placebo Pbo BU>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DM^BDL01-701-1415A0CDISCPILOT01ADAE 7011415VERBATIM_1179MICTURITION URGENCY RENAL AND URINARY DISORDERS MILD NNONE YY.AA....DL BGBG..Placebo Pbo BU>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0483 HLT_0294 URINARY URGENCY DM^BDL01-701-1415A@CDISCPILOT01ADAE 7011415VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NREMOTE YY.......DM ByByDM4BPlacebo Pbo BU>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DM^BDL01-701-1415APCDISCPILOT01ADAE 7011415VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NREMOTE YY.......DM ByByDM4BPlacebo Pbo BU>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DM^BDL01-701-1415A`CDISCPILOT01ADAE 7011415VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MILD NNONE YY.AA....DMO BBDMOBPlacebo Pbo BU>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DM^BDL01-701-1442ACDISCPILOT01ADAE 7011442VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADM BMBM..Xanomeline Low Dose Xan_Lo AB9<65 AAFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMBDL01-701-1444ACDISCPILOT01ADAE 7011444VERBATIM_0349APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYYAAA...ADK AA..Xanomeline High DoseXan_Hi A B?<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE ERYTHEMA DKB'DK01-701-1444A CDISCPILOT01ADAE 7011444VERBATIM_0578APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY..A...ADK AA..Xanomeline High DoseXan_Hi A B?<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DKB'DK01-701-1444A0CDISCPILOT01ADAE 7011444VERBATIM_1572SALIVARY HYPERSECRETION GASTROINTESTINAL DISORDERS MILD NPOSSIBLEYYY.AA....DK AA..Xanomeline High DoseXan_Hi A B?<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0488 HLT_0374 HYPERSALIVATION DKB'DK01-701-1444A@CDISCPILOT01ADAE 7011444VERBATIM_0349APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPOSSIBLEYYY......ADK AA..Xanomeline High DoseXan_Hi A B?<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE ERYTHEMA DKB'DK01-701-1444APCDISCPILOT01ADAE 7011444VERBATIM_0578APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADK AA..Xanomeline High DoseXan_Hi A B?<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DKB'DK01-701-1444A`CDISCPILOT01ADAE 7011444VERBATIM_1067APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY..A...ADK BB..Xanomeline High DoseXan_Hi A B?<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DKB'DK01-701-1444ApCDISCPILOT01ADAE 7011444VERBATIM_0880APPLICATION SITE VESICLES GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY..A...ADK BB..Xanomeline High DoseXan_Hi A B?<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0576 HLT_0180 APPLICATION SITE BLISTER DKB'DK01-701-1444ACDISCPILOT01ADAE 7011444VERBATIM_0365PARAESTHESIA NERVOUS SYSTEM DISORDERS MILD NNONE YYY.AA....DK B#B#DKB#Xanomeline High DoseXan_Hi A B?<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0534 HLT_0481 TINGLING DKB'DK01-702-1082ACDISCPILOT01ADAE 7021082VERBATIM_0795WHITE BLOOD CELL COUNT INCREASED INVESTIGATIONS MILD NNONE NN.......DLZ DLmAXanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0465 HLT_0417 WBC INCREASED DLBPDLm01-702-1082A CDISCPILOT01ADAE 7021082VERBATIM_0831NEUTROPHIL COUNT INCREASED INVESTIGATIONS MILD NNONE NN.......DLZ DLmAXanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0625 HLT_0326 NEUTROPHIL COUNT INCREASED DLBPDLm01-702-1082A0CDISCPILOT01ADAE 7021082VERBATIM_0459URINE ANALYSIS ABNORMAL INVESTIGATIONS MILD NNONE NN.......DLZ DLk Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0295 HLT_0783 URINE ANALYSIS ABNORMAL DLBPDLm01-702-1082A@CDISCPILOT01ADAE 7021082VERBATIM_0459URINE ANALYSIS ABNORMAL INVESTIGATIONS MILD NNONE NN.......DLZ DLk Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0295 HLT_0783 URINE ANALYSIS ABNORMAL DLBPDLm01-702-1082APCDISCPILOT01ADAE 7021082VERBATIM_0795WHITE BLOOD CELL COUNT INCREASED INVESTIGATIONS MILD NNONE NN.......DLZ DLmAXanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0465 HLT_0417 WBC INCREASED DLBPDLm01-702-1082A`CDISCPILOT01ADAE 7021082VERBATIM_0831NEUTROPHIL COUNT INCREASED INVESTIGATIONS MILD NNONE NN.......DLZ DLmAXanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0625 HLT_0326 NEUTROPHIL COUNT INCREASED DLBPDLm01-702-1082ApCDISCPILOT01ADAE 7021082VERBATIM_0250RECTAL HAEMORRHAGE GASTROINTESTINAL DISORDERS MILD NNONE YYAAA....DL B'B'DLB+Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0755 HLT_0353 RECTAL BLEEDING DLBPDLm01-702-1082ACDISCPILOT01ADAE 7021082VERBATIM_0250RECTAL HAEMORRHAGE GASTROINTESTINAL DISORDERS MILD NNONE YY.......DL B'B'DLB+Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0755 HLT_0353 RECTAL BLEEDING DLBPDLm01-702-1082ACDISCPILOT01ADAE 7021082VERBATIM_1336APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADL B.B.DLB=Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DLBPDLm01-702-1082ACDISCPILOT01ADAE 7021082VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLE YY.AA...ADL BOBODLBbXanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DLBPDLm01-703-1042ACDISCPILOT01ADAE 7031042VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YYAAA....DK A0A0DKA@Placebo Pbo B@<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DLBDK01-703-1042A CDISCPILOT01ADAE 7031042VERBATIM_0377INSOMNIA PSYCHIATRIC DISORDERS MILD NREMOTE YY.AA....DK A@A@DKAPPlacebo Pbo B@<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0469 HLT_0297 INSOMNIA DLBDK01-703-1076ACDISCPILOT01ADAE 7031076VERBATIM_1681BIOPSY PROSTATE INVESTIGATIONS MODERATENNONE YYYAAA....DL BBDLBXanomeline High DoseXan_Hi A BE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0725 HLT_0553 BIOPSY OF PROSTATE DMB=DL01-703-1076A CDISCPILOT01ADAE 7031076VERBATIM_0138BENIGN PROSTATIC HYPERPLASIA REPRODUCTIVE SYSTEM AND BREAST DISORDERS MODERATENNONE YYY.AA....DL BB..Xanomeline High DoseXan_Hi A BE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0568 HLT_0215 BENIGN PROSTATIC HYPERTROPHY DMB=DL01-703-1076A0CDISCPILOT01ADAE 7031076VERBATIM_0164HYPERCHOLESTEROLAEMIA METABOLISM AND NUTRITION DISORDERS MODERATENNONE YNN........ ....Xanomeline High DoseXan_Hi A BE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0703 HLT_0025 HYPERCHOLESTEROLEMIA DMB=DL01-703-1076A@CDISCPILOT01ADAE 7031076VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY.AA...ADL BB..Xanomeline High DoseXan_Hi A BE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMB=DL01-703-1076APCDISCPILOT01ADAE 7031076VERBATIM_1298APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY..A...ADL BB..Xanomeline High DoseXan_Hi A BE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DMB=DL01-703-1076A`CDISCPILOT01ADAE 7031076VERBATIM_1343HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY.AA....DL B B ..Xanomeline High DoseXan_Hi A BE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 SWEATING DMB=DL01-703-1076ApCDISCPILOT01ADAE 7031076VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADL BB..Xanomeline High DoseXan_Hi A BE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMB=DL01-703-1086ACDISCPILOT01ADAE 7031086VERBATIM_1336APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYYAAA...ADK1 AADKB{Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DKB^DK&01-703-1086A CDISCPILOT01ADAE 7031086VERBATIM_1336APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADK1 AADKB{Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DKB^DK&01-703-1086A0CDISCPILOT01ADAE 7031086VERBATIM_1336APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS SEVERE NPROBABLEYYY......ADK1 AADKB{Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DKB^DK&01-703-1086A@CDISCPILOT01ADAE 7031086VERBATIM_1398CHILLS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYY..A....DKK B&B&DKQB,Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0161 HLT_0586 CHILLS DKB^DK&01-703-1086APCDISCPILOT01ADAE 7031086VERBATIM_1398CHILLS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYY.......DKK B&B&DKQB,Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0161 HLT_0586 CHILLS DKB^DK&01-703-1086A`CDISCPILOT01ADAE 7031086VERBATIM_1336APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY......ADK1 AADKB{Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DKB^DK&01-703-1100ACDISCPILOT01ADAE 7031100VERBATIM_0583APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YYAAA...ADK BBDLB#Placebo Pbo BT>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DLBDK01-703-1100A CDISCPILOT01ADAE 7031100VERBATIM_0583APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADK BBDLB#Placebo Pbo BT>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DLBDK01-703-1100A0CDISCPILOT01ADAE 7031100VERBATIM_0583APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADK BBDLB#Placebo Pbo BT>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DLBDK01-703-1100A@CDISCPILOT01ADAE 7031100VERBATIM_1581CATARACT OPERATION SURGICAL AND MEDICAL PROCEDURES MODERATENNONE YY.AA....DL B,B,DLB,Placebo Pbo BT>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0058 HLT_0432 CATARACT EXTRACTION DLBDK01-703-1100APCDISCPILOT01ADAE 7031100VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MODERATENREMOTE YY.AA....DL1 BLBLDL8BSPlacebo Pbo BT>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DLBDK01-703-1100A`CDISCPILOT01ADAE 7031100VERBATIM_1652OEDEMA PERIPHERAL GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENREMOTE NN.......DK DLBPlacebo Pbo BT>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0137 HLT_0661 LEG EDEMA DLBDK01-703-1100ApCDISCPILOT01ADAE 7031100VERBATIM_0098OEDEMA PERIPHERAL GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NREMOTE YY..A....DLd BBDLBPlacebo Pbo BT>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0137 HLT_0661 LEG EDEMA DLBDK01-703-1100ACDISCPILOT01ADAE 7031100VERBATIM_1652OEDEMA PERIPHERAL GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENREMOTE NN.......DK DLBPlacebo Pbo BT>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0137 HLT_0661 LEG EDEMA DLBDK01-703-1100ACDISCPILOT01ADAE 7031100VERBATIM_0098OEDEMA PERIPHERAL GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NREMOTE YY.......DLd BBDLBPlacebo Pbo BT>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0137 HLT_0661 LEG EDEMA DLBDK01-703-1119ACDISCPILOT01ADAE 7031119VERBATIM_1336APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYYAAA...ADK BB..Xanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DLBBrDK01-703-1119A CDISCPILOT01ADAE 7031119VERBATIM_1336APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS SEVERE NPROBABLEYYY......ADK BB..Xanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DLBBrDK01-703-1119A0CDISCPILOT01ADAE 7031119VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY.AA...ADL BJBJ..Xanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLBBrDK01-703-1119A@CDISCPILOT01ADAE 7031119VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS SEVERE NPROBABLEYYY......ADL BJBJ..Xanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLBBrDK01-703-1175ACDISCPILOT01ADAE 7031175VERBATIM_0077ATRIOVENTRICULAR BLOCK SECOND DEGREE CARDIAC DISORDERS SEVERE NNONE NN.......DL ..Placebo Pbo BK65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0086 HLT_0415 HEART BLOCK SECOND DEGREE DMApDM01-703-1182ACDISCPILOT01ADAE 7031182VERBATIM_1489APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYYAAA...ADL AA..Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DLB8DL01-703-1182A CDISCPILOT01ADAE 7031182VERBATIM_1489APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPOSSIBLEYYY......ADL AA..Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DLB8DL01-703-1182A0CDISCPILOT01ADAE 7031182VERBATIM_0485SOMNOLENCE NERVOUS SYSTEM DISORDERS MILD NREMOTE YYY.AA....DL B%B%..Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0254 HLT_0160 DROWSINESS DLB8DL01-703-1182A@CDISCPILOT01ADAE 7031182VERBATIM_0485SOMNOLENCE NERVOUS SYSTEM DISORDERS MODERATENREMOTE YYY.......DL B%B%..Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0254 HLT_0160 DROWSINESS DLB8DL01-703-1210ACDISCPILOT01ADAE 7031210VERBATIM_0787DISORIENTATION PSYCHIATRIC DISORDERS MILD NREMOTE YYAAA....DK BB..Placebo Pbo BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0307 HLT_0299 DISORIENTATION DLBDK01-703-1210A CDISCPILOT01ADAE 7031210VERBATIM_0965DECREASED APPETITE METABOLISM AND NUTRITION DISORDERS MILD NPOSSIBLE YY.AA....DL B2B2..Placebo Pbo BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0231 HLT_0574 DECREASED APPETITE DLBDK01-703-1210A0CDISCPILOT01ADAE 7031210VERBATIM_0965DECREASED APPETITE METABOLISM AND NUTRITION DISORDERS MODERATENPOSSIBLE YY.......DL B2B2..Placebo Pbo BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0231 HLT_0574 DECREASED APPETITE DLBDK01-703-1258ACDISCPILOT01ADAE 7031258VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YYYAAA....DK BBDKBXanomeline High DoseXan_Hi A BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DKBDJ01-703-1258A CDISCPILOT01ADAE 7031258VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MODERATENNONE YNN........ ....Xanomeline High DoseXan_Hi A BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DKBDJ01-703-1258A0CDISCPILOT01ADAE 7031258VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YYY.......DK BBDKBXanomeline High DoseXan_Hi A BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DKBDJ01-703-1258A@CDISCPILOT01ADAE 7031258VERBATIM_1298APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY.AA...ADK( B/B/DKBXanomeline High DoseXan_Hi A BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DKBDJ01-703-1258APCDISCPILOT01ADAE 7031258VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MILD NNONE YNN........ ....Xanomeline High DoseXan_Hi A BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DKBDJ01-703-1258A`CDISCPILOT01ADAE 7031258VERBATIM_1298APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADK( B/B/DKBXanomeline High DoseXan_Hi A BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DKBDJ01-703-1258ApCDISCPILOT01ADAE 7031258VERBATIM_1298APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY......ADK( B/B/DKBXanomeline High DoseXan_Hi A BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DKBDJ01-703-1295ACDISCPILOT01ADAE 7031295VERBATIM_0065ARTHRITIS MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MODERATENNONE YYAAA....DM B&B&..Xanomeline High DoseXan_Hi A BX>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0587 HLT_0019 ARTHRITIS DMxBDL01-703-1299ACDISCPILOT01ADAE 7031299VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YYAAA....DK? BBDKHBPlacebo Pbo BQ>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DKBDK001-703-1299A CDISCPILOT01ADAE 7031299VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YY.......DK? BBDKHBPlacebo Pbo BQ>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DKBDK001-703-1299A0CDISCPILOT01ADAE 7031299VERBATIM_0308GLAUCOMA EYE DISORDERS MODERATENNONE NN........ ....Placebo Pbo BQ>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0734 HLT_0556 GLAUCOMA DKBDK001-703-1299A@CDISCPILOT01ADAE 7031299VERBATIM_0677HYPOTENSION VASCULAR DISORDERS MILD NREMOTE YY.AA....DK BB..Placebo Pbo BQ>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0412 HLT_0761 HYPOTENSION DKBDK001-703-1299APCDISCPILOT01ADAE 7031299VERBATIM_0231TACHYCARDIA CARDIAC DISORDERS MILD NREMOTE YY.AA....DK BB..Placebo Pbo BQ>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0574 HLT_0082 TACHYCARDIA DKBDK001-703-1299A`CDISCPILOT01ADAE 7031299VERBATIM_0677HYPOTENSION VASCULAR DISORDERS MODERATENREMOTE YY.......DK BB..Placebo Pbo BQ>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0412 HLT_0761 HYPOTENSION DKBDK001-703-1299ApCDISCPILOT01ADAE 7031299VERBATIM_0231TACHYCARDIA CARDIAC DISORDERS MODERATENREMOTE YY.......DK BB..Placebo Pbo BQ>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0574 HLT_0082 TACHYCARDIA DKBDK001-703-1299ACDISCPILOT01ADAE 7031299VERBATIM_1262MYOCARDIAL INFARCTION CARDIAC DISORDERS MODERATENREMOTE YY..A....DK BB..Placebo Pbo BQ>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0688 HLT_0649 MYOCARDIAL INFARCTION DKBDK001-703-1335ACDISCPILOT01ADAE 7031335VERBATIM_1650ATRIOVENTRICULAR BLOCK SECOND DEGREE CARDIAC DISORDERS MILD NNONE NN.......DMU DMdAXanomeline High DoseXan_Hi A BC65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0086 HLT_0415 AV BLOCK SECOND DEGREE DMB4DMW01-703-1335A CDISCPILOT01ADAE 7031335VERBATIM_1650ATRIOVENTRICULAR BLOCK SECOND DEGREE CARDIAC DISORDERS MILD NNONE NN.......DMU DMdAXanomeline High DoseXan_Hi A BC65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0086 HLT_0415 AV BLOCK SECOND DEGREE DMB4DMW01-703-1403ACDISCPILOT01ADAE 7031403VERBATIM_0293WEIGHT DECREASED INVESTIGATIONS MODERATENNONE YYYAAA....DK AADKAXanomeline High DoseXan_Hi A BC65-80A CAUCASIAN AMYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0778 HLT_0158 WEIGHT LOSS DKA DK01-703-1403A CDISCPILOT01ADAE 7031403VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MODERATENPROBABLEYYY.AA....DK A A DKA0Xanomeline High DoseXan_Hi A BC65-80A CAUCASIAN AMYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DKA DK01-703-1403A0CDISCPILOT01ADAE 7031403VERBATIM_0897VOMITING GASTROINTESTINAL DISORDERS MODERATENPROBABLEYYY..A....DK A A DKA0Xanomeline High DoseXan_Hi A BC65-80A CAUCASIAN AMYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 VOMITING DKA DK01-703-1403A@CDISCPILOT01ADAE 7031403VERBATIM_1293CHEST DISCOMFORT GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYNY.AA....DK A@A@DKAPXanomeline High DoseXan_Hi A BC65-80A CAUCASIAN AMYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0441 HLT_0593 CHEST TIGHTNESS DKA DK01-703-1403APCDISCPILOT01ADAE 7031403VERBATIM_0293WEIGHT DECREASED INVESTIGATIONS MODERATENNONE YYY.......DK AADKAXanomeline High DoseXan_Hi A BC65-80A CAUCASIAN AMYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0778 HLT_0158 WEIGHT LOSS DKA DK01-703-1439ACDISCPILOT01ADAE 7031439VERBATIM_0583APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADM} B,B,..Xanomeline High DoseXan_Hi A BL65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DN BDMR01-703-1439A CDISCPILOT01ADAE 7031439VERBATIM_0583APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY......ADM} B,B,..Xanomeline High DoseXan_Hi A BL65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DN BDMR01-704-1008ACDISCPILOT01ADAE 7041008VERBATIM_0895HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYYAAA....DK BB..Xanomeline High DoseXan_Hi A BL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 SWEATING INCREASED DKB(DK01-704-1008A CDISCPILOT01ADAE 7041008VERBATIM_1299TRANSIENT ISCHAEMIC ATTACK NERVOUS SYSTEM DISORDERS SEVERE NNONE YYY.AA....DK B(B(DKB(Xanomeline High DoseXan_Hi A BL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0433 HLT_0041 TRANSIENT ISCHEMIC ATTACKS DKB(DK01-704-1008A0CDISCPILOT01ADAE 7041008VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MODERATENNONE YNY.AA....DK B,B,..Xanomeline High DoseXan_Hi A BL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DKB(DK01-704-1009ACDISCPILOT01ADAE 7041009VERBATIM_0555FATIGUE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NREMOTE YYAAA....DL AA..Xanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0181 HLT_0043 FATIGUE DLBDL01-704-1009A CDISCPILOT01ADAE 7041009VERBATIM_1562MALAISE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY..A....DL AADLB Xanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0178 HLT_0456 MALAISE DLBDL01-704-1009A0CDISCPILOT01ADAE 7041009VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY.AA...ADL BB..Xanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLBDL01-704-1009A@CDISCPILOT01ADAE 7041009VERBATIM_1562MALAISE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY.......DL AADLB Xanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0178 HLT_0456 MALAISE DLBDL01-704-1009APCDISCPILOT01ADAE 7041009VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MILD NREMOTE YY.AA....DL BB..Xanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DLBDL01-704-1009A`CDISCPILOT01ADAE 7041009VERBATIM_0775NAUSEA GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YY.AA....DL BBDLBXanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0326 HLT_0742 NAUSEA DLBDL01-704-1010ACDISCPILOT01ADAE 7041010VERBATIM_0822CYSTITIS INFECTIONS AND INFESTATIONS MILD NNONE YYAAA....DME ApApDMLAPlacebo Pbo BP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0129 HLT_0739 BLADDER INFECTION DMBDM?01-704-1010A CDISCPILOT01ADAE 7041010VERBATIM_0897VOMITING GASTROINTESTINAL DISORDERS MILD NNONE YY.AA....DM BBDMBPlacebo Pbo BP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 VOMITING DMBDM?01-704-1010A0CDISCPILOT01ADAE 7041010VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MILD NNONE YY..A....DM BBDMBPlacebo Pbo BP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DMBDM?01-704-1010A@CDISCPILOT01ADAE 7041010VERBATIM_0274EXCORIATION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NNONE YY.AA....DM BB..Placebo Pbo BP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0511 HLT_0738 ABRASION NOS DMBDM?01-704-1010APCDISCPILOT01ADAE 7041010VERBATIM_1710SKIN LACERATION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NNONE YY..A....DM BB..Placebo Pbo BP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0118 HLT_0075 SKIN TEAR DMBDM?01-704-1010A`CDISCPILOT01ADAE 7041010VERBATIM_1396ARTHRALGIA MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MILD NNONE YY.AA....DM BB..Placebo Pbo BP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0610 HLT_0375 KNEE PAIN DMBDM?01-704-1010ApCDISCPILOT01ADAE 7041010VERBATIM_0689CONTUSION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NNONE YY..A....DM BB..Placebo Pbo BP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0381 HLT_0713 BRUISE OF HEAD DMBDM?01-704-1017ACDISCPILOT01ADAE 7041017VERBATIM_1635MYOCARDIAL INFARCTION CARDIAC DISORDERS MILD NNONE YYYAAA....DL AA..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0688 HLT_0649 MYOCARDIAL INFARCTION DLB,DL01-704-1017A CDISCPILOT01ADAE 7041017VERBATIM_0888VENTRICULAR SEPTAL DEFECT CONGENITAL, FAMILIAL AND GENETIC DISORDERS MILD NNONE YYY.AA....DL AA..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0747 HLT_0589 VENTRICULAR SEPTAL DEFECT DLB,DL01-704-1017A0CDISCPILOT01ADAE 7041017VERBATIM_1543INFLUENZA INFECTIONS AND INFESTATIONS MILD NNONE YYY.AA....DL BBDLB"Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0081 HLT_0125 FLU DLB,DL01-704-1017A@CDISCPILOT01ADAE 7041017VERBATIM_1744CARDIAC DISORDER CARDIAC DISORDERS MILD NNONE YYY..A....DL BB..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0126 HLT_0507 CARDIAC DISORDER DLB,DL01-704-1017APCDISCPILOT01ADAE 7041017VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY.AA...ADL BBDLB0Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLB,DL01-704-1017A`CDISCPILOT01ADAE 7041017VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY..A...ADL BBDLB0Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLB,DL01-704-1017ApCDISCPILOT01ADAE 7041017VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY......ADL BBDLB0Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLB,DL01-704-1017ACDISCPILOT01ADAE 7041017VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY......ADL BBDLB0Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLB,DL01-704-1025ACDISCPILOT01ADAE 7041025VERBATIM_1703VERTIGO EAR AND LABYRINTH DISORDERS MODERATENPOSSIBLEYYYAAA....DL A A DLA@Xanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0147 HLT_0255 VERTIGO DLBDL01-704-1025A CDISCPILOT01ADAE 7041025VERBATIM_0266PALPITATIONS CARDIAC DISORDERS MODERATENREMOTE YYY.AA....DL A A DLA@Xanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0593 HLT_0493 PALPITATIONS DLBDL01-704-1025A0CDISCPILOT01ADAE 7041025VERBATIM_1153ELECTROCARDIOGRAM ST SEGMENT DEPRESSION INVESTIGATIONS MILD NPOSSIBLEYYY.AA....DL AADLBXanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0220 HLT_0610 ST SEGMENT DEPRESSED DLBDL01-704-1025A@CDISCPILOT01ADAE 7041025VERBATIM_1601WOLFF-PARKINSON-WHITE SYNDROME CARDIAC DISORDERS MILD NPOSSIBLEYNY..A....DL BBDLB@Xanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0218 HLT_0612 WOLFF-PARKINSON-WHITE SYNDROME DLBDL01-704-1025APCDISCPILOT01ADAE 7041025VERBATIM_1153ELECTROCARDIOGRAM ST SEGMENT DEPRESSION INVESTIGATIONS MILD NPOSSIBLEYYY.......DL AADLBXanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0220 HLT_0610 ST SEGMENT DEPRESSED DLBDL01-704-1025A`CDISCPILOT01ADAE 7041025VERBATIM_1601WOLFF-PARKINSON-WHITE SYNDROME CARDIAC DISORDERS MILD NPOSSIBLEYNY.......DL BBDLB@Xanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0218 HLT_0612 WOLFF-PARKINSON-WHITE SYNDROME DLBDL01-704-1065ACDISCPILOT01ADAE 7041065VERBATIM_1040ABDOMINAL DISCOMFORT GASTROINTESTINAL DISORDERS MILD NREMOTE YYYAAA....DL A0A0..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0332 HLT_0012 ABDOMINAL DISCOMFORT DMB<DL01-704-1065A CDISCPILOT01ADAE 7041065VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY.AA...ADL A@A@..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DMB<DL01-704-1065A0CDISCPILOT01ADAE 7041065VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY.AA...ADL A@A@..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMB<DL01-704-1065A@CDISCPILOT01ADAE 7041065VERBATIM_1335APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY..A...ADL BB..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DMB<DL01-704-1065APCDISCPILOT01ADAE 7041065VERBATIM_1562MALAISE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYY..A....DL BB..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0178 HLT_0456 MALAISE DMB<DL01-704-1065A`CDISCPILOT01ADAE 7041065VERBATIM_1115HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY..A....DL BB..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 PERSPIRATION EXCESSIVE DMB<DL01-704-1065ApCDISCPILOT01ADAE 7041065VERBATIM_1398CHILLS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NREMOTE YYY..A....DL BBDLBXanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0161 HLT_0586 CHILLS DMB<DL01-704-1065ACDISCPILOT01ADAE 7041065VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MILD NREMOTE YYY.AA....DL BBDLBXanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DMB<DL01-704-1065ACDISCPILOT01ADAE 7041065VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MILD NREMOTE YYY..A....DL B5B5DLB5Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DMB<DL01-704-1065ACDISCPILOT01ADAE 7041065VERBATIM_1422SINUS BRADYCARDIA CARDIAC DISORDERS MILD NNONE YNY.AA....DM B>B>..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 BRADYCARDIA SINUS DMB<DL01-704-1074ACDISCPILOT01ADAE 7041074VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYYAAA...ADM! AA..Xanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DMZB:DM!01-704-1074A CDISCPILOT01ADAE 7041074VERBATIM_0027ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY..A...ADM3 BB..Xanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 SKIN RED DMZB:DM!01-704-1093ACDISCPILOT01ADAE 7041093VERBATIM_0814BLOOD GLUCOSE INCREASED INVESTIGATIONS MILD NNONE YYYAAA....DK BBDLBXanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0188 HLT_0450 GLUCOSE INCREASED DLFB_DK01-704-1093A CDISCPILOT01ADAE 7041093VERBATIM_0814BLOOD GLUCOSE INCREASED INVESTIGATIONS MILD NNONE YYY.......DK BBDLBXanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0188 HLT_0450 GLUCOSE INCREASED DLFB_DK01-704-1093A0CDISCPILOT01ADAE 7041093VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY.AA...ADL B3B3..Xanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLFB_DK01-704-1093A@CDISCPILOT01ADAE 7041093VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY..A...ADL B3B3..Xanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLFB_DK01-704-1114ACDISCPILOT01ADAE 7041114VERBATIM_1639ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YYAAA...ADK BBDKB Xanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 REDNESS DLZBDK01-704-1114A CDISCPILOT01ADAE 7041114VERBATIM_1138OEDEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA....DK B B ..Xanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0036 HLT_0656 EDEMA DLZBDK01-704-1114A0CDISCPILOT01ADAE 7041114VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY..A...ADK B<B<..Xanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLZBDK01-704-1114A@CDISCPILOT01ADAE 7041114VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY..A...ADK B<B<..Xanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLZBDK01-704-1114APCDISCPILOT01ADAE 7041114VERBATIM_1543INFLUENZA INFECTIONS AND INFESTATIONS MILD NNONE YY.AA....DL< BBDLBBXanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0081 HLT_0125 FLU DLZBDK01-704-1120ACDISCPILOT01ADAE 7041120VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYYAAA...ADM BB..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DM+B>DL01-704-1120A CDISCPILOT01ADAE 7041120VERBATIM_1698NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YYY.AA....DM BBDM-B@Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD DM+B>DL01-704-1120A0CDISCPILOT01ADAE 7041120VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADM BB..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DM+B>DL01-704-1120A@CDISCPILOT01ADAE 7041120VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY..A...ADM& B9B9..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DM+B>DL01-704-1120APCDISCPILOT01ADAE 7041120VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADM& B9B9..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DM+B>DL01-704-1120A`CDISCPILOT01ADAE 7041120VERBATIM_1698NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YYY.......DM BBDM-B@Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD DM+B>DL01-704-1135ACDISCPILOT01ADAE 7041135VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD N YYAAA...ADL B'B'..Xanomeline Low Dose Xan_Lo ABJ65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DMBDL01-704-1135A CDISCPILOT01ADAE 7041135VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS SEVERE N YY......ADL B'B'..Xanomeline Low Dose Xan_Lo ABJ65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DMBDL01-704-1164ACDISCPILOT01ADAE 7041164VERBATIM_1543INFLUENZA INFECTIONS AND INFESTATIONS MILD NNONE YYAAA....DK? AADKIBPlacebo Pbo BC65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0081 HLT_0125 FLU DKBDK701-704-1164A CDISCPILOT01ADAE 7041164VERBATIM_1543INFLUENZA INFECTIONS AND INFESTATIONS MILD NNONE YY.......DK? AADKIBPlacebo Pbo BC65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0081 HLT_0125 FLU DKBDK701-704-1164A0CDISCPILOT01ADAE 7041164VERBATIM_0304OEDEMA PERIPHERAL GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NNONE YY.AA....DK BBDKBPlacebo Pbo BC65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0137 HLT_0661 SWELLING OF FEET DKBDK701-704-1218ACDISCPILOT01ADAE 7041218VERBATIM_0814BLOOD GLUCOSE INCREASED INVESTIGATIONS MILD NNONE YYAAA....DK B*B*..Xanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0188 HLT_0450 GLUCOSE INCREASED DL1BDKt01-704-1241ACDISCPILOT01ADAE 7041241VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENNONE YNN......ADL ..Xanomeline High DoseXan_Hi A BV>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLB.DL01-704-1241A CDISCPILOT01ADAE 7041241VERBATIM_0785DYSPNOEA RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YYYAAA....DL B#B#..Xanomeline High DoseXan_Hi A BV>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0255 HLT_0296 RESPIRATION LABORED DLB.DL01-704-1266ACDISCPILOT01ADAE 7041266VERBATIM_0396SEASONAL ALLERGY IMMUNE SYSTEM DISORDERS MILD NNONE YNN.......DL p`..Xanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0782 HLT_0714 HAY FEVER DLB7DL01-704-1266A CDISCPILOT01ADAE 7041266VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYYAAA...ADL APAPDMBHXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLB7DL01-704-1266A0CDISCPILOT01ADAE 7041266VERBATIM_0096ATRIAL FLUTTER CARDIAC DISORDERS MILD NNONE YYY.AA....DL AADLBXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0627 HLT_0477 ATRIAL FLUTTER DLB7DL01-704-1266A@CDISCPILOT01ADAE 7041266VERBATIM_0402ATRIAL FIBRILLATION CARDIAC DISORDERS MILD NNONE YYY..A....DL BBDLB7Xanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0012 HLT_0365 ATRIAL FIBRILLATION DLB7DL01-704-1266APCDISCPILOT01ADAE 7041266VERBATIM_0096ATRIAL FLUTTER CARDIAC DISORDERS MILD NNONE YYY.......DL AADLBXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0627 HLT_0477 ATRIAL FLUTTER DLB7DL01-704-1266A`CDISCPILOT01ADAE 7041266VERBATIM_1115HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY..A....DL BBDLB5Xanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 PERSPIRATION EXCESSIVE DLB7DL01-704-1266ApCDISCPILOT01ADAE 7041266VERBATIM_0408BLISTER SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY..A...ADL B"B"DLB?Xanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0267 HLT_0752 BLISTERING DLB7DL01-704-1266ACDISCPILOT01ADAE 7041266VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY..A...ADL B"B"DMBHXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLB7DL01-704-1266ACDISCPILOT01ADAE 7041266VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADL APAPDMBHXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLB7DL01-704-1266ACDISCPILOT01ADAE 7041266VERBATIM_1115HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY.......DL BBDLB5Xanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 PERSPIRATION EXCESSIVE DLB7DL01-704-1266ACDISCPILOT01ADAE 7041266VERBATIM_1287ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY......ADL B7B7DMBHXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 REDNESS DLB7DL01-704-1266ACDISCPILOT01ADAE 7041266VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADL APAPDMBHXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLB7DL01-704-1266ACDISCPILOT01ADAE 7041266VERBATIM_0402ATRIAL FIBRILLATION CARDIAC DISORDERS MILD NNONE YYY.......DL BBDLB7Xanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0012 HLT_0365 ATRIAL FIBRILLATION DLB7DL01-704-1266ACDISCPILOT01ADAE 7041266VERBATIM_0408BLISTER SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY......ADL B"B"DLB?Xanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0267 HLT_0752 BLISTERING DLB7DL01-704-1266ACDISCPILOT01ADAE 7041266VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY......ADL B"B"DMBHXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLB7DL01-704-1266BCDISCPILOT01ADAE 7041266VERBATIM_1287ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY......ADL B7B7DMBHXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 REDNESS DLB7DL01-704-1323ACDISCPILOT01ADAE 7041323VERBATIM_0002VIRAL INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YYYAAA....DLq BBDLuBXanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0408 HLT_0733 VIRAL INFECTION DLwBDL[01-704-1323A CDISCPILOT01ADAE 7041323VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY.AA...ADLv BB..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLwBDL[01-704-1323A0CDISCPILOT01ADAE 7041323VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY..A...ADLv BB..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLwBDL[01-704-1323A@CDISCPILOT01ADAE 7041323VERBATIM_0248OEDEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY.AA....DLv BB..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0036 HLT_0656 EDEMA DLwBDL[01-704-1325ACDISCPILOT01ADAE 7041325VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YYAAA...ADM BB..Xanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DMBIDM|01-704-1325A CDISCPILOT01ADAE 7041325VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY..A...ADM BIBI..Xanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DMBIDM|01-704-1332ACDISCPILOT01ADAE 7041332VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NNONE YYYAAA...ADL A A DMBBNXanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DM8BDDL01-704-1332A CDISCPILOT01ADAE 7041332VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY..A...ADM B)B)DMBBNXanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DM8BDDL01-704-1332A0CDISCPILOT01ADAE 7041332VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENNONE YYY......ADL A A DMBBNXanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DM8BDDL01-704-1332A@CDISCPILOT01ADAE 7041332VERBATIM_1128BURNING SENSATION NERVOUS SYSTEM DISORDERS MILD NPROBABLEYYY.AA....DM- B9B9..Xanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0456 HLT_0775 BURNING SENSATION DM8BDDL01-704-1332APCDISCPILOT01ADAE 7041332VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENNONE YYY......ADL A A DMBBNXanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DM8BDDL01-704-1332A`CDISCPILOT01ADAE 7041332VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY......ADM B)B)DMBBNXanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DM8BDDL01-704-1351ACDISCPILOT01ADAE 7041351VERBATIM_1701POLLAKIURIA RENAL AND URINARY DISORDERS MILD NNONE YYAAA....DL BBDMiBPlacebo Pbo BF65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0560 HLT_0393 URINARY FREQUENCY DMwBDL01-704-1351A CDISCPILOT01ADAE 7041351VERBATIM_0867FLATULENCE GASTROINTESTINAL DISORDERS MILD NNONE YY.AA....DL BBDMiBPlacebo Pbo BF65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0504 HLT_0356 GAS DMwBDL01-704-1351A0CDISCPILOT01ADAE 7041351VERBATIM_1701POLLAKIURIA RENAL AND URINARY DISORDERS MILD NNONE YY.......DL BBDMiBPlacebo Pbo BF65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0560 HLT_0393 URINARY FREQUENCY DMwBDL01-704-1351A@CDISCPILOT01ADAE 7041351VERBATIM_0867FLATULENCE GASTROINTESTINAL DISORDERS MILD NNONE YY.......DL BBDMiBPlacebo Pbo BF65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0504 HLT_0356 GAS DMwBDL01-704-1388ACDISCPILOT01ADAE 7041388VERBATIM_0301HEADACHE NERVOUS SYSTEM DISORDERS MODERATENNONE NN.......DK ji..Placebo Pbo BQ>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DL@BDK01-704-1435ACDISCPILOT01ADAE 7041435VERBATIM_1127PARKINSON'S DISEASE NERVOUS SYSTEM DISORDERS MILD NNONE YYAAA....DK B3B3..Placebo Pbo BJ65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0313 HLT_0279 DISEASE PARKINSON'S DKB6DKr01-704-1445ACDISCPILOT01ADAE 7041445VERBATIM_0276COMPLETED SUICIDE PSYCHIATRIC DISORDERS SEVERE NNONE YYAAA....DN; BBDN;BPlacebo Pbo BK65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNYNNHLGT_0013 HLT_0625 SUICIDE DN<BDM01-705-1031ACDISCPILOT01ADAE 7051031VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YYAAA...ADM BB..Xanomeline Low Dose Xan_Lo AB8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DMBDL01-705-1059ACDISCPILOT01ADAE 7051059VERBATIM_0314ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYYAAA...ADL BZBZ..Placebo Pbo BB65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLB{DLw01-705-1186ACDISCPILOT01ADAE 7051186VERBATIM_0669HYPERBILIRUBINAEMIA HEPATOBILIARY DISORDERS MODERATENREMOTE YYAAA....DM% BB..Placebo Pbo BT>80 A0CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0087 HLT_0478 HYPERBILIRUBINEMIA DM%BDM01-705-1199ACDISCPILOT01ADAE 7051199VERBATIM_0697DYSPEPSIA GASTROINTESTINAL DISORDERS MODERATENPOSSIBLEYYYAAA....DL A A DLAXanomeline Low Dose Xan_Lo ABW>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0716 HLT_0244 PYROSIS DLADL01-705-1199A CDISCPILOT01ADAE 7051199VERBATIM_0697DYSPEPSIA GASTROINTESTINAL DISORDERS MODERATENPOSSIBLEYYY.......DL A A DLAXanomeline Low Dose Xan_Lo ABW>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0716 HLT_0244 PYROSIS DLADL01-705-1280ACDISCPILOT01ADAE 7051280VERBATIM_0215PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YYAAA...ADMy B^B^..Xanomeline High DoseXan_Hi A B8<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITUS DMBDM01-705-1281ACDISCPILOT01ADAE 7051281VERBATIM_0215PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYYAAA...ADM) B@B@..Xanomeline High DoseXan_Hi A BI65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITUS DMEB\DL01-705-1281A CDISCPILOT01ADAE 7051281VERBATIM_1755EXCORIATION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MODERATENPROBABLEYYY.AA....DM) B@B@..Xanomeline High DoseXan_Hi A BI65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0511 HLT_0738 ABRASIONS DMEB\DL01-705-1281A0CDISCPILOT01ADAE 7051281VERBATIM_0215PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY......ADM) B@B@..Xanomeline High DoseXan_Hi A BI65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITUS DMEB\DL01-705-1292ACDISCPILOT01ADAE 7051292VERBATIM_0373PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YYAAA...ADL AA..Xanomeline Low Dose Xan_Lo AB<<65 AAFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHY DMBDL01-705-1292A CDISCPILOT01ADAE 7051292VERBATIM_0314ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLE YY..A...ADM7 B{B{..Xanomeline Low Dose Xan_Lo AB<<65 AAFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DMBDL01-705-1303ACDISCPILOT01ADAE 7051303VERBATIM_0215PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYYAAA...ADM/ B4B4DMIBNXanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITUS DMBDL01-705-1303A CDISCPILOT01ADAE 7051303VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY..A...ADM/ B4B4DMIBNXanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DMBDL01-705-1303A0CDISCPILOT01ADAE 7051303VERBATIM_0215PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY......ADM/ B4B4DMIBNXanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITUS DMBDL01-705-1303A@CDISCPILOT01ADAE 7051303VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY......ADM/ B4B4DMIBNXanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DMBDL01-705-1310ACDISCPILOT01ADAE 7051310VERBATIM_0158RASH PRURITIC SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYYAAA...ADL AA..Xanomeline High DoseXan_Hi A BJ65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0753 HLT_0127 PRURITIC RASH DM"BSDL01-705-1310A CDISCPILOT01ADAE 7051310VERBATIM_1798WOUND HAEMORRHAGE VASCULAR DISORDERS MODERATENPOSSIBLEYYY.AA....DM BEBE..Xanomeline High DoseXan_Hi A BJ65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0162 HLT_0154 WOUND BLEEDING DM"BSDL01-705-1349ACDISCPILOT01ADAE 7051349VERBATIM_0775NAUSEA GASTROINTESTINAL DISORDERS MILD NREMOTE YYAAA....DL BBDLBPlacebo Pbo BV>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0326 HLT_0742 NAUSEA DLBDK01-705-1349A CDISCPILOT01ADAE 7051349VERBATIM_0897VOMITING GASTROINTESTINAL DISORDERS MILD NREMOTE YY..A....DL B!B!DLB!Placebo Pbo BV>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 VOMITING DLBDK01-705-1349A0CDISCPILOT01ADAE 7051349VERBATIM_1214VENTRICULAR HYPERTROPHY CARDIAC DISORDERS MILD NREMOTE YY.AA....DL BB..Placebo Pbo BV>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0259 HLT_0104 LEFT VENTRICULAR HYPERTROPHY DLBDK01-705-1349A@CDISCPILOT01ADAE 7051349VERBATIM_1153ELECTROCARDIOGRAM ST SEGMENT DEPRESSION INVESTIGATIONS MILD NREMOTE YY.AA....DL BB..Placebo Pbo BV>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0220 HLT_0610 ST SEGMENT DEPRESSED DLBDK01-705-1393ACDISCPILOT01ADAE 7051393VERBATIM_1719ABDOMINAL PAIN GASTROINTESTINAL DISORDERS MILD NREMOTE YYYAAA....DK7 AADK<BXanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0419 HLT_0217 ABDOMINAL CRAMPS DKBDK+01-705-1393A CDISCPILOT01ADAE 7051393VERBATIM_0215PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYNN......ADJ P@DKBXanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITUS DKBDK+01-705-1393A0CDISCPILOT01ADAE 7051393VERBATIM_0544COLON CANCER NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)SEVERE NNONE YYY.AA....DK BBDKBXanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)YNNNYNHLGT_0339 HLT_0597 COLON CANCER DKBDK+01-705-1393A@CDISCPILOT01ADAE 7051393VERBATIM_0215PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYNN......ADJ P@DKBXanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITUS DKBDK+01-705-1431ACDISCPILOT01ADAE 7051431VERBATIM_0188RASH ERYTHEMATOUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE NN......ADLK ..Xanomeline Low Dose Xan_Lo ABD65-80A HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0701 HLT_0336 ERYTHEMATOUS RASH DLBDLL01-705-1431A CDISCPILOT01ADAE 7051431VERBATIM_0363ANXIETY PSYCHIATRIC DISORDERS MILD NPOSSIBLE YYAAA....DLW AADLYAXanomeline Low Dose Xan_Lo ABD65-80A HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0570 HLT_0559 FEELING ANXIOUS DLBDLL01-706-1041ACDISCPILOT01ADAE 7061041VERBATIM_1033ANXIETY PSYCHIATRIC DISORDERS MODERATENREMOTE NN.......DJD&&..Placebo Pbo B@<65 AAFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0570 HLT_0559 ANXIETY ATTACK DMBDM 01-706-1041A CDISCPILOT01ADAE 7061041VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MILD NREMOTE YYAAA....DM AADMAPlacebo Pbo B@<65 AAFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DMBDM 01-706-1041A0CDISCPILOT01ADAE 7061041VERBATIM_1679EXCORIATION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NNONE YY.AA....DM AADM'BPlacebo Pbo B@<65 AAFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0511 HLT_0738 ABRASIONS DMBDM 01-706-1041A@CDISCPILOT01ADAE 7061041VERBATIM_1106IRRITABILITY PSYCHIATRIC DISORDERS MODERATENPOSSIBLE YY.AA....DM BBDMBPlacebo Pbo B@<65 AAFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0461 HLT_0627 IRRITABILITY DMBDM 01-706-1041APCDISCPILOT01ADAE 7061041VERBATIM_1679EXCORIATION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NNONE YY.......DM AADM'BPlacebo Pbo B@<65 AAFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0511 HLT_0738 ABRASIONS DMBDM 01-706-1041A`CDISCPILOT01ADAE 7061041VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY.AA...ADMJ B@B@DMBPlacebo Pbo B@<65 AAFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DMBDM 01-706-1041ApCDISCPILOT01ADAE 7061041VERBATIM_1033ANXIETY PSYCHIATRIC DISORDERS MILD NREMOTE NN.......DJD&&..Placebo Pbo B@<65 AAFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0570 HLT_0559 ANXIETY ATTACK DMBDM 01-706-1041ACDISCPILOT01ADAE 7061041VERBATIM_1106IRRITABILITY PSYCHIATRIC DISORDERS MODERATENPOSSIBLE YY.......DM BBDMBPlacebo Pbo B@<65 AAFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0461 HLT_0627 IRRITABILITY DMBDM 01-706-1041ACDISCPILOT01ADAE 7061041VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY......ADMJ B@B@DMBPlacebo Pbo B@<65 AAFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DMBDM 01-706-1049ACDISCPILOT01ADAE 7061049VERBATIM_1235SYNCOPE NERVOUS SYSTEM DISORDERS MODERATENPOSSIBLEYYYAAA....DL8 BBDL8BXanomeline High DoseXan_Hi A B<<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0310 HLT_0440 FAINTING DLGB$DL$01-706-1049A CDISCPILOT01ADAE 7061049VERBATIM_0436SYNCOPE NERVOUS SYSTEM DISORDERS SEVERE NPROBABLEYYY.......DLG B$B$DLGB$Xanomeline High DoseXan_Hi A B<<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0310 HLT_0440 SYNCOPAL ATTACK DLGB$DL$01-706-1384ACDISCPILOT01ADAE 7061384VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENNONE YYYAAA...ADK3 AADKAAXanomeline Low Dose Xan_Lo ABJ65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DK<ADK301-706-1384A CDISCPILOT01ADAE 7061384VERBATIM_1586PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENNONE YYY..A...ADK3 AADKAAXanomeline Low Dose Xan_Lo ABJ65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITIS DK<ADK301-706-1384A0CDISCPILOT01ADAE 7061384VERBATIM_0354EXCORIATION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MODERATENNONE YYY.AA....DK3 AADKAAXanomeline Low Dose Xan_Lo ABJ65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0511 HLT_0738 ABRASIONS DK<ADK301-706-1384A@CDISCPILOT01ADAE 7061384VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADK; AADKAAXanomeline Low Dose Xan_Lo ABJ65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DK<ADK301-706-1384APCDISCPILOT01ADAE 7061384VERBATIM_1586PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADK; AADKAAXanomeline Low Dose Xan_Lo ABJ65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITIS DK<ADK301-706-1384A`CDISCPILOT01ADAE 7061384VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENNONE YYY......ADK3 AADKAAXanomeline Low Dose Xan_Lo ABJ65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DK<ADK301-706-1384ApCDISCPILOT01ADAE 7061384VERBATIM_1586PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENNONE YYY......ADK3 AADKAAXanomeline Low Dose Xan_Lo ABJ65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITIS DK<ADK301-706-1384ACDISCPILOT01ADAE 7061384VERBATIM_0354EXCORIATION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MODERATENNONE YYY.......DK3 AADKAAXanomeline Low Dose Xan_Lo ABJ65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0511 HLT_0738 ABRASIONS DK<ADK301-706-1384ACDISCPILOT01ADAE 7061384VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADK; AADKAAXanomeline Low Dose Xan_Lo ABJ65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DK<ADK301-706-1384ACDISCPILOT01ADAE 7061384VERBATIM_1586PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADK; AADKAAXanomeline Low Dose Xan_Lo ABJ65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITIS DK<ADK301-707-1206ACDISCPILOT01ADAE 7071206VERBATIM_1645SINUS ARRHYTHMIA CARDIAC DISORDERS MILD NPOSSIBLE YYAAA....DL BBDMB9Placebo Pbo BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0630 HLT_0094 SINUS ARRHYTHMIA DMBDL01-707-1206A CDISCPILOT01ADAE 7071206VERBATIM_1741BLOOD CREATINE PHOSPHOKINASE INCREASED INVESTIGATIONS MODERATENPOSSIBLE YY.AA....DL BBDLB+Placebo Pbo BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0008 HLT_0404 CPK INCREASE DMBDL01-707-1206A0CDISCPILOT01ADAE 7071206VERBATIM_1588POSTNASAL DRIP RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.AA....DL B%B%DLB,Placebo Pbo BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0032 HLT_0172 POSTNASAL DRIP DMBDL01-707-1206A@CDISCPILOT01ADAE 7071206VERBATIM_1741BLOOD CREATINE PHOSPHOKINASE INCREASED INVESTIGATIONS MODERATENPOSSIBLE YY.......DL BBDLB+Placebo Pbo BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0008 HLT_0404 CPK INCREASE DMBDL01-707-1206APCDISCPILOT01ADAE 7071206VERBATIM_1588POSTNASAL DRIP RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.......DL B%B%DLB,Placebo Pbo BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0032 HLT_0172 POSTNASAL DRIP DMBDL01-707-1206A`CDISCPILOT01ADAE 7071206VERBATIM_1645SINUS ARRHYTHMIA CARDIAC DISORDERS MILD NPOSSIBLE YY.......DL BBDMB9Placebo Pbo BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0630 HLT_0094 SINUS ARRHYTHMIA DMBDL01-707-1206ApCDISCPILOT01ADAE 7071206VERBATIM_0757CONJUNCTIVITIS EYE DISORDERS MODERATENREMOTE YY.AA....DM2 BhBhDM@BvPlacebo Pbo BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0335 HLT_0584 CONJUNCTIVITIS DMBDL01-707-1206ACDISCPILOT01ADAE 7071206VERBATIM_0757CONJUNCTIVITIS EYE DISORDERS MODERATENREMOTE YY.......DM2 BhBhDM@BvPlacebo Pbo BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0335 HLT_0584 CONJUNCTIVITIS DMBDL01-708-1019ACDISCPILOT01ADAE 7081019VERBATIM_0520HEADACHE NERVOUS SYSTEM DISORDERS SEVERE NPOSSIBLEYYYAAA....DM AADM AXanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 FRONTAL HEADACHE DM ADM01-708-1019A CDISCPILOT01ADAE 7081019VERBATIM_0442STUPOR NERVOUS SYSTEM DISORDERS SEVERE NPOSSIBLEYYY..A....DM AADM AXanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0513 HLT_0595 STUPOR DM ADM01-708-1019A0CDISCPILOT01ADAE 7081019VERBATIM_1021TRANSIENT ISCHAEMIC ATTACK NERVOUS SYSTEM DISORDERS SEVERE NPOSSIBLEYYY..A....DM AADM AXanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0433 HLT_0041 TRANSIENT ISCHEMIC ATTACKS DM ADM01-708-1019A@CDISCPILOT01ADAE 7081019VERBATIM_0911VISION BLURRED EYE DISORDERS MILD NPOSSIBLEYYY.AA....DM AADM AXanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0598 HLT_0120 BLURRED VISION DM ADM01-708-1019APCDISCPILOT01ADAE 7081019VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLEYYY..A....DM AADM AXanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DM ADM01-708-1032ACDISCPILOT01ADAE 7081032VERBATIM_0318APPLICATION SITE VESICLES GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYYAAA...ADK BBDKBXanomeline Low Dose Xan_Lo AB><65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0576 HLT_0180 APPLICATION SITE BLISTER DKBDK01-708-1084ACDISCPILOT01ADAE 7081084VERBATIM_0279DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YYAAA....DL- AADL-AXanomeline Low Dose Xan_Lo ABI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DLBDL01-708-1084A CDISCPILOT01ADAE 7081084VERBATIM_0279DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YY.......DL- AADL-AXanomeline Low Dose Xan_Lo ABI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DLBDL01-708-1084A0CDISCPILOT01ADAE 7081084VERBATIM_1635MYOCARDIAL INFARCTION CARDIAC DISORDERS MILD NREMOTE YY.AA....DL> B B DL>B Xanomeline Low Dose Xan_Lo ABI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0688 HLT_0649 MYOCARDIAL INFARCTION DLBDL01-708-1084A@CDISCPILOT01ADAE 7081084VERBATIM_1635MYOCARDIAL INFARCTION CARDIAC DISORDERS MILD NREMOTE YY.......DL> B B DL>B Xanomeline Low Dose Xan_Lo ABI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0688 HLT_0649 MYOCARDIAL INFARCTION DLBDL01-708-1084APCDISCPILOT01ADAE 7081084VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MILD NREMOTE YY..A....DLL B.B.DLLB.Xanomeline Low Dose Xan_Lo ABI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DLBDL01-708-1084A`CDISCPILOT01ADAE 7081084VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MILD NREMOTE YY.......DLL B.B.DLLB.Xanomeline Low Dose Xan_Lo ABI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DLBDL01-708-1087ACDISCPILOT01ADAE 7081087VERBATIM_0160HEART RATE IRREGULAR INVESTIGATIONS MILD NPOSSIBLE YYAAA....DK BZBZDKBZPlacebo Pbo BJ65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0140 HLT_0765 HEARTBEATS IRREGULAR DLBDKX01-708-1087A CDISCPILOT01ADAE 7081087VERBATIM_0160HEART RATE IRREGULAR INVESTIGATIONS MILD NPOSSIBLE YY.......DK BZBZDKBZPlacebo Pbo BJ65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0140 HLT_0765 HEARTBEATS IRREGULAR DLBDKX01-708-1087A0CDISCPILOT01ADAE 7081087VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YY.AA....DK BjBjDKBnPlacebo Pbo BJ65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DLBDKX01-708-1087A@CDISCPILOT01ADAE 7081087VERBATIM_1743HEADACHE NERVOUS SYSTEM DISORDERS MILD NNONE YY..A....DK BvBv..Placebo Pbo BJ65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DLBDKX01-708-1087APCDISCPILOT01ADAE 7081087VERBATIM_0160HEART RATE IRREGULAR INVESTIGATIONS MILD NPOSSIBLE YY.......DK BBDKBPlacebo Pbo BJ65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0140 HLT_0765 HEARTBEATS IRREGULAR DLBDKX01-708-1087A`CDISCPILOT01ADAE 7081087VERBATIM_0160HEART RATE IRREGULAR INVESTIGATIONS MILD NPOSSIBLE YY.......DK BBDKBPlacebo Pbo BJ65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0140 HLT_0765 HEARTBEATS IRREGULAR DLBDKX01-708-1158ACDISCPILOT01ADAE 7081158VERBATIM_0499AGITATION PSYCHIATRIC DISORDERS MILD NREMOTE YYYAAA....DMC BB..Placebo Pbo BQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0170 HLT_0140 AGITATION DM[B*DM201-708-1158A CDISCPILOT01ADAE 7081158VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYNY.AA...ADM\ B+B+DM\B+Placebo Pbo BQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DM[B*DM201-708-1178ACDISCPILOT01ADAE 7081178VERBATIM_1110FLANK PAIN MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MILD NNONE NN.......DL ..Xanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0543 HLT_0484 FLANK PAIN DMkBcDM 01-708-1178A CDISCPILOT01ADAE 7081178VERBATIM_1698NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YYAAA....DMG B?B?DMNBFXanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD DMkBcDM 01-708-1178A0CDISCPILOT01ADAE 7081178VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADMO BGBGDMkBcXanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMkBcDM 01-708-1178A@CDISCPILOT01ADAE 7081178VERBATIM_1611VENTRICULAR SEPTAL DEFECT CONGENITAL, FAMILIAL AND GENETIC DISORDERS MILD NNONE YY.AA....DMO BGBG..Xanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0747 HLT_0589 VENTRICULAR SEPTAL DEFECT DMkBcDM 01-708-1178APCDISCPILOT01ADAE 7081178VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADMO BGBGDMkBcXanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMkBcDM 01-708-1178A`CDISCPILOT01ADAE 7081178VERBATIM_0278DIZZINESS NERVOUS SYSTEM DISORDERS SEVERE NPOSSIBLE YY.AA....DM^ BVBVDM`BXXanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0751 HLT_0619 LIGHT-HEADED DMkBcDM 01-708-1178ApCDISCPILOT01ADAE 7081178VERBATIM_0402ATRIAL FIBRILLATION CARDIAC DISORDERS SEVERE NPOSSIBLE YY.AA....DM^ BVBVDM`BXXanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0012 HLT_0365 ATRIAL FIBRILLATION DMkBcDM 01-708-1178ACDISCPILOT01ADAE 7081178VERBATIM_0361CYSTITIS INFECTIONS AND INFESTATIONS MILD NREMOTE YY..A....DM^ BVBVDMbBZXanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0129 HLT_0739 BLADDER INFECTION DMkBcDM 01-708-1178ACDISCPILOT01ADAE 7081178VERBATIM_0340ALCOHOL USE SOCIAL CIRCUMSTANCES MILD NNONE YY.AA....DM^ BVBVDM^BVXanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0182 HLT_0138 ALCOHOL USE DMkBcDM 01-708-1213ACDISCPILOT01ADAE 7081213VERBATIM_0402ATRIAL FIBRILLATION CARDIAC DISORDERS MILD NPOSSIBLEYYYAAA....DK AADKAXanomeline High DoseXan_Hi A BL65-80A CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0012 HLT_0365 ATRIAL FIBRILLATION DKADK01-708-1213A CDISCPILOT01ADAE 7081213VERBATIM_0402ATRIAL FIBRILLATION CARDIAC DISORDERS MILD NPOSSIBLEYYY.......DK AADKAXanomeline High DoseXan_Hi A BL65-80A CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0012 HLT_0365 ATRIAL FIBRILLATION DKADK01-708-1216ACDISCPILOT01ADAE 7081216VERBATIM_0953APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYYAAA...ADKg AA..Xanomeline High DoseXan_Hi A BN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DK~B%DKZ01-708-1216A CDISCPILOT01ADAE 7081216VERBATIM_0798APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY..A...ADKg AADKB3Xanomeline High DoseXan_Hi A BN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DK~B%DKZ01-708-1216A0CDISCPILOT01ADAE 7081216VERBATIM_0246APPLICATION SITE SWELLING GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY..A...ADKw BB..Xanomeline High DoseXan_Hi A BN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0236 HLT_0105 APPLICATION SITE SWELLING DK~B%DKZ01-708-1216A@CDISCPILOT01ADAE 7081216VERBATIM_0798APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY......ADKg AADKB3Xanomeline High DoseXan_Hi A BN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DK~B%DKZ01-708-1253ACDISCPILOT01ADAE 7081253VERBATIM_0910COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE NN.......DL DL&APlacebo Pbo B=<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DLBDL01-708-1253A CDISCPILOT01ADAE 7081253VERBATIM_0757CONJUNCTIVITIS EYE DISORDERS MILD NNONE NN.......DL DL&APlacebo Pbo B=<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0335 HLT_0584 CONJUNCTIVITIS DLBDL01-708-1253A0CDISCPILOT01ADAE 7081253VERBATIM_0756HEART RATE INCREASED INVESTIGATIONS MILD NPOSSIBLE YYAAA....DL AADL A@Placebo Pbo B=<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0673 HLT_0646 HEART RATE INCREASED DLBDL01-708-1253A@CDISCPILOT01ADAE 7081253VERBATIM_0910COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE NN.......DL DL&APlacebo Pbo B=<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DLBDL01-708-1253APCDISCPILOT01ADAE 7081253VERBATIM_0757CONJUNCTIVITIS EYE DISORDERS MILD NNONE NN.......DL DL&APlacebo Pbo B=<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0335 HLT_0584 CONJUNCTIVITIS DLBDL01-708-1253A`CDISCPILOT01ADAE 7081253VERBATIM_0756HEART RATE INCREASED INVESTIGATIONS MILD NPOSSIBLE YY.......DL AADL A@Placebo Pbo B=<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0673 HLT_0646 HEART RATE INCREASED DLBDL01-708-1253ApCDISCPILOT01ADAE 7081253VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YY.AA....DL< B B DL<B Placebo Pbo B=<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DLBDL01-708-1253ACDISCPILOT01ADAE 7081253VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YY.......DL< B B DL<B Placebo Pbo B=<65 ACAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DLBDL01-708-1272ACDISCPILOT01ADAE 7081272VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MILD NNONE YYAAA....DK A`A`DKA`Xanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DKB-DK01-708-1272A CDISCPILOT01ADAE 7081272VERBATIM_0534MUSCLE SPASMS MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS SEVERE NNONE YY.AA....DK AADKAXanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0750 HLT_0078 LEG CRAMPS DKB-DK01-708-1272A0CDISCPILOT01ADAE 7081272VERBATIM_0981VENTRICULAR EXTRASYSTOLES CARDIAC DISORDERS MILD NREMOTE YY.AA....DK BBDKB+Xanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0594 HLT_0050 VENTRICULAR BIGEMINY DKB-DK01-708-1272A@CDISCPILOT01ADAE 7081272VERBATIM_1621APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADK BBDKBXanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DKB-DK01-708-1272APCDISCPILOT01ADAE 7081272VERBATIM_0910COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.AA....DK BBDKBXanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DKB-DK01-708-1272A`CDISCPILOT01ADAE 7081272VERBATIM_1698NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YY.AA....DK BBDKBXanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD DKB-DK01-708-1272ApCDISCPILOT01ADAE 7081272VERBATIM_0929HEADACHE NERVOUS SYSTEM DISORDERS MILD NNONE YY.AA....DK BBDKBXanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DKB-DK01-708-1272ACDISCPILOT01ADAE 7081272VERBATIM_0910COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.......DK BBDKBXanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DKB-DK01-708-1272ACDISCPILOT01ADAE 7081272VERBATIM_1698NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YY.......DK BBDKBXanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD DKB-DK01-708-1272ACDISCPILOT01ADAE 7081272VERBATIM_0929HEADACHE NERVOUS SYSTEM DISORDERS MILD NNONE YY.......DK BBDKBXanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DKB-DK01-708-1272ACDISCPILOT01ADAE 7081272VERBATIM_0490HOT FLUSH VASCULAR DISORDERS MILD NNONE YY.AA....DK B*B*DKB*Xanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0773 HLT_0737 HOT FLASHES DKB-DK01-708-1272ACDISCPILOT01ADAE 7081272VERBATIM_0981VENTRICULAR EXTRASYSTOLES CARDIAC DISORDERS MILD NREMOTE YY.......DK BBDKB+Xanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0594 HLT_0050 VENTRICULAR BIGEMINY DKB-DK01-708-1286ACDISCPILOT01ADAE 7081286VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADL A0A0..Placebo Pbo BP65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMNBDL01-708-1286A CDISCPILOT01ADAE 7081286VERBATIM_0284MYOCARDIAL INFARCTION CARDIAC DISORDERS MILD NREMOTE YY.AA....DL AA..Placebo Pbo BP65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0688 HLT_0649 INFERIOR MYOCARDIAL INFARCTION DMNBDL01-708-1286A0CDISCPILOT01ADAE 7081286VERBATIM_0554ABDOMINAL PAIN GASTROINTESTINAL DISORDERS MILD NREMOTE YY.AA....DM< BBDM<BPlacebo Pbo BP65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0419 HLT_0217 ABDOMINAL PAIN DMNBDL01-708-1286A@CDISCPILOT01ADAE 7081286VERBATIM_0443CONSTIPATION GASTROINTESTINAL DISORDERS MILD NREMOTE YY..A....DM< BBDM<BPlacebo Pbo BP65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0635 HLT_0402 CONSTIPATION DMNBDL01-708-1296ACDISCPILOT01ADAE 7081296VERBATIM_1263ATRIAL HYPERTROPHY CARDIAC DISORDERS MILD NREMOTE YYAAA....DLP AADLPAPlacebo Pbo B9<65 AAFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0067 HLT_0271 LEFT ATRIAL HYPERTROPHY DLBDLC01-708-1296A CDISCPILOT01ADAE 7081296VERBATIM_1263ATRIAL HYPERTROPHY CARDIAC DISORDERS MILD NREMOTE YY.......DLP AADLPAPlacebo Pbo B9<65 AAFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0067 HLT_0271 LEFT ATRIAL HYPERTROPHY DLBDLC01-708-1296A0CDISCPILOT01ADAE 7081296VERBATIM_0445APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADL BSBSDLBaPlacebo Pbo B9<65 AAFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLBDLC01-708-1296A@CDISCPILOT01ADAE 7081296VERBATIM_0445APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADL BSBSDLBaPlacebo Pbo B9<65 AAFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLBDLC01-708-1296APCDISCPILOT01ADAE 7081296VERBATIM_0133APPLICATION SITE VESICLES GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADL BqBqDLBPlacebo Pbo B9<65 AAFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0576 HLT_0180 APPLICATION SITE BLISTER DLBDLC01-708-1296A`CDISCPILOT01ADAE 7081296VERBATIM_0133APPLICATION SITE VESICLES GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADL BqBqDLBPlacebo Pbo B9<65 AAFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0576 HLT_0180 APPLICATION SITE BLISTER DLBDLC01-708-1296ApCDISCPILOT01ADAE 7081296VERBATIM_1008PAIN IN EXTREMITY MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MILD NREMOTE YY.AA....DL BBDLBPlacebo Pbo B9<65 AAFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0764 HLT_0213 PAIN IN THIGH DLBDLC01-708-1297ACDISCPILOT01ADAE 7081297VERBATIM_1038APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYYAAA...ADK BDBD..Xanomeline Low Dose Xan_Lo AB=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLBcDK01-708-1297A CDISCPILOT01ADAE 7081297VERBATIM_0246APPLICATION SITE SWELLING GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY..A...ADK BDBD..Xanomeline Low Dose Xan_Lo AB=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0236 HLT_0105 APPLICATION SITE SWELLING DLBcDK01-708-1297A0CDISCPILOT01ADAE 7081297VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MILD NREMOTE YNY.AA....DL BhBh..Xanomeline Low Dose Xan_Lo AB=<65 ACAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DLBcDK01-708-1316ACDISCPILOT01ADAE 7081316VERBATIM_0301HEADACHE NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YYAAA....DM( BB..Placebo Pbo BJ65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DMGBDL01-708-1316A CDISCPILOT01ADAE 7081316VERBATIM_0178APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADM9 BB..Placebo Pbo BJ65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DMGBDL01-708-1336ACDISCPILOT01ADAE 7081336VERBATIM_1049DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YYAAA....DK AADKAXanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 LIGHTHEADEDNESS DL:BDK01-708-1336A CDISCPILOT01ADAE 7081336VERBATIM_0445APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADK B%B%DKB%Xanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DL:BDK01-708-1336A0CDISCPILOT01ADAE 7081336VERBATIM_0005DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YY.......DK B:B:DKB:Xanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 LIGHT HEADEDNESS DL:BDK01-708-1336A@CDISCPILOT01ADAE 7081336VERBATIM_0445APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADL B}B}DL:BXanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DL:BDK01-708-1336APCDISCPILOT01ADAE 7081336VERBATIM_0798APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADL B}B}DL:BXanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DL:BDK01-708-1336A`CDISCPILOT01ADAE 7081336VERBATIM_0445APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADL B}B}DL:BXanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DL:BDK01-708-1336ApCDISCPILOT01ADAE 7081336VERBATIM_0798APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADL B}B}DL:BXanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DL:BDK01-708-1347ACDISCPILOT01ADAE 7081347VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYYAAA...ADLB B7B7DLNBCXanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLGB<DL 01-708-1347A CDISCPILOT01ADAE 7081347VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY..A...ADLB B7B7DLNBCXanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLGB<DL 01-708-1347A0CDISCPILOT01ADAE 7081347VERBATIM_1011APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY.AA...ADLB B7B7DLNBCXanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DLGB<DL 01-708-1347A@CDISCPILOT01ADAE 7081347VERBATIM_1691APPLICATION SITE SWELLING GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY..A...ADLB B7B7DLNBCXanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0236 HLT_0105 APPLICATION SITE SWELLING DLGB<DL 01-708-1347APCDISCPILOT01ADAE 7081347VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY......ADLB B7B7DLNBCXanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLGB<DL 01-708-1347A`CDISCPILOT01ADAE 7081347VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADLB B7B7DLNBCXanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLGB<DL 01-708-1347ApCDISCPILOT01ADAE 7081347VERBATIM_1011APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADLB B7B7DLNBCXanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DLGB<DL 01-708-1347ACDISCPILOT01ADAE 7081347VERBATIM_1691APPLICATION SITE SWELLING GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADLB B7B7DLNBCXanomeline High DoseXan_Hi A B=<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0236 HLT_0105 APPLICATION SITE SWELLING DLGB<DL 01-708-1348ACDISCPILOT01ADAE 7081348VERBATIM_0335MYOCARDIAL INFARCTION CARDIAC DISORDERS MILD NPOSSIBLE YYAAA....DL AADLBXanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0688 HLT_0649 ANTEROSEPTAL INFARCTION DM7BDLw01-708-1348A CDISCPILOT01ADAE 7081348VERBATIM_0335MYOCARDIAL INFARCTION CARDIAC DISORDERS MILD NPOSSIBLE YY.......DL AADLBXanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0688 HLT_0649 ANTEROSEPTAL INFARCTION DM7BDLw01-708-1348A0CDISCPILOT01ADAE 7081348VERBATIM_0445APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADL BwBw..Xanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DM7BDLw01-708-1353ACDISCPILOT01ADAE 7081353VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MILD NREMOTE YYYAAA....DL B.B.DLBEXanomeline Low Dose Xan_Lo ABW>80 A0AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DLB8DLW01-708-1353A CDISCPILOT01ADAE 7081353VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MILD NREMOTE YYY.......DL B.B.DLBEXanomeline Low Dose Xan_Lo ABW>80 A0AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DLB8DLW01-708-1353A0CDISCPILOT01ADAE 7081353VERBATIM_0755HYPOTENSION VASCULAR DISORDERS MILD NPOSSIBLEYYY.AA....DL B8B8DLBEXanomeline Low Dose Xan_Lo ABW>80 A0AFRICAN DESCENT (NEGRO, BLACK) A FYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0412 HLT_0761 LOW BLOOD PRESSURE DLB8DLW01-708-1372ACDISCPILOT01ADAE 7081372VERBATIM_1650ATRIOVENTRICULAR BLOCK SECOND DEGREE CARDIAC DISORDERS MODERATENNONE NN.......DL ..Xanomeline High DoseXan_Hi A BT>80 A0CAUCASIAN AMYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0086 HLT_0415 AV BLOCK SECOND DEGREE DL ADL01-708-1406ACDISCPILOT01ADAE 7081406VERBATIM_0397OEDEMA PERIPHERAL GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NNONE YYAAA....DM BB..Xanomeline High DoseXan_Hi A BG65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0137 HLT_0661 SWELLING OF LEGS DMBDM01-708-1406A CDISCPILOT01ADAE 7081406VERBATIM_0896OEDEMA PERIPHERAL GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NNONE YY.......DM BB..Xanomeline High DoseXan_Hi A BG65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0137 HLT_0661 SWELLING OF LEGS DMBDM01-708-1428ACDISCPILOT01ADAE 7081428VERBATIM_0847EPISTAXIS RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NREMOTE YYYAAA....DL AADLAXanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0577 HLT_0386 NOSE BLEED DLB$DL01-708-1428A CDISCPILOT01ADAE 7081428VERBATIM_1038APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY.AA...ADL B B DMB+Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLB$DL01-708-1428A0CDISCPILOT01ADAE 7081428VERBATIM_0798APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY..A...ADL B B DMB+Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DLB$DL01-708-1428A@CDISCPILOT01ADAE 7081428VERBATIM_0979APPLICATION SITE WARMTH GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY..A...ADL B B DMB+Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0301 HLT_0260 APPLICATION SITE WARMTH DLB$DL01-708-1428APCDISCPILOT01ADAE 7081428VERBATIM_1038APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS SEVERE NPROBABLEYYY......ADL B B DMB+Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLB$DL01-708-1428A`CDISCPILOT01ADAE 7081428VERBATIM_0798APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS SEVERE NPROBABLEYYY......ADL B B DMB+Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DLB$DL01-708-1428ApCDISCPILOT01ADAE 7081428VERBATIM_0979APPLICATION SITE WARMTH GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS SEVERE NPROBABLEYYY......ADL B B DMB+Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0301 HLT_0260 APPLICATION SITE WARMTH DLB$DL01-709-1007ACDISCPILOT01ADAE 7091007VERBATIM_1481APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYYAAA...ADK BBDKBXanomeline Low Dose Xan_Lo AB6<65 ACAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DK!BDK01-709-1007A CDISCPILOT01ADAE 7091007VERBATIM_1481APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY......ADK BBDKBXanomeline Low Dose Xan_Lo AB6<65 ACAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DK!BDK01-709-1007A0CDISCPILOT01ADAE 7091007VERBATIM_0008APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS SEVERE NPROBABLEYYY......ADK BB..Xanomeline Low Dose Xan_Lo AB6<65 ACAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DK!BDK01-709-1007A@CDISCPILOT01ADAE 7091007VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MILD NPOSSIBLEYNY.AA....DK# BBDK#BXanomeline Low Dose Xan_Lo AB6<65 ACAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DK!BDK01-709-1020ACDISCPILOT01ADAE 7091020VERBATIM_0684APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADK BB..Xanomeline Low Dose Xan_Lo ABH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DL6BDK01-709-1020A CDISCPILOT01ADAE 7091020VERBATIM_1107DIARRHOEA GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YY.AA....DK B"B"DKB*Xanomeline Low Dose Xan_Lo ABH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DL6BDK01-709-1020A0CDISCPILOT01ADAE 7091020VERBATIM_0554ABDOMINAL PAIN GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YY..A....DK B"B"DKB*Xanomeline Low Dose Xan_Lo ABH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0419 HLT_0217 ABDOMINAL PAIN DL6BDK01-709-1020A@CDISCPILOT01ADAE 7091020VERBATIM_0179APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADK B.B...Xanomeline Low Dose Xan_Lo ABH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DL6BDK01-709-1029ACDISCPILOT01ADAE 7091029VERBATIM_0011MYOCARDIAL INFARCTION CARDIAC DISORDERS MILD NNONE YYAAA....DK BBDKB9Xanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0688 HLT_0649 SEPTAL MYOCARDIAL INFARCTION DLOBDK01-709-1029A CDISCPILOT01ADAE 7091029VERBATIM_0716APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADK BB..Xanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DLOBDK01-709-1029A0CDISCPILOT01ADAE 7091029VERBATIM_0262MUSCLE SPASMS MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MILD NREMOTE YY.AA....DK BBDKBAXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0750 HLT_0078 CRAMP DLOBDK01-709-1029A@CDISCPILOT01ADAE 7091029VERBATIM_0011MYOCARDIAL INFARCTION CARDIAC DISORDERS MILD NNONE YY.......DK BBDKB9Xanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0688 HLT_0649 SEPTAL MYOCARDIAL INFARCTION DLOBDK01-709-1029APCDISCPILOT01ADAE 7091029VERBATIM_0262MUSCLE SPASMS MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MILD NREMOTE YY.......DK BBDKBAXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0750 HLT_0078 CRAMP DLOBDK01-709-1029A`CDISCPILOT01ADAE 7091029VERBATIM_1150MYOCARDIAL INFARCTION CARDIAC DISORDERS MILD NNONE YY.......DK BVBVDLBqXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0688 HLT_0649 SEPTAL MYOCARDIAL INFARCTION DLOBDK01-709-1029ApCDISCPILOT01ADAE 7091029VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MILD NREMOTE YY..A....DK BVBVDLBqXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DLOBDK01-709-1029ACDISCPILOT01ADAE 7091029VERBATIM_1150MYOCARDIAL INFARCTION CARDIAC DISORDERS MILD NNONE YY.......DK BVBVDLBqXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0688 HLT_0649 SEPTAL MYOCARDIAL INFARCTION DLOBDK01-709-1029ACDISCPILOT01ADAE 7091029VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MILD NREMOTE YY.......DK BVBVDLBqXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DLOBDK01-709-1029ACDISCPILOT01ADAE 7091029VERBATIM_1421COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.AA....DL" BBDL)BXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DLOBDK01-709-1029ACDISCPILOT01ADAE 7091029VERBATIM_1086PHARYNGEAL ERYTHEMA RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY..A...ADL" BBDL)BXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0398 HLT_0591 RED THROAT DLOBDK01-709-1029ACDISCPILOT01ADAE 7091029VERBATIM_1150MYOCARDIAL INFARCTION CARDIAC DISORDERS MILD NREMOTE YY.......DL% BB..Xanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0688 HLT_0649 SEPTAL MYOCARDIAL INFARCTION DLOBDK01-709-1029ACDISCPILOT01ADAE 7091029VERBATIM_1421COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.......DL" BBDL)BXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DLOBDK01-709-1029ACDISCPILOT01ADAE 7091029VERBATIM_1086PHARYNGEAL ERYTHEMA RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY......ADL" BBDL)BXanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0398 HLT_0591 RED THROAT DLOBDK01-709-1029ACDISCPILOT01ADAE 7091029VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MILD NREMOTE YY.......DLA BB..Xanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DLOBDK01-709-1029BCDISCPILOT01ADAE 7091029VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY.AA...ADLH BB..Xanomeline High DoseXan_Hi A BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLOBDK01-709-1081ACDISCPILOT01ADAE 7091081VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYYAAA...ADMl BPBP..Xanomeline Low Dose Xan_Lo ABV>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DMBdDM01-709-1081A CDISCPILOT01ADAE 7091081VERBATIM_1418OEDEMA PERIPHERAL GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENREMOTE YNY.AA....DM BhBh..Xanomeline Low Dose Xan_Lo ABV>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0137 HLT_0661 PERIPHERAL SWELLING DMBdDM01-709-1088ACDISCPILOT01ADAE 7091088VERBATIM_0968APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADM BB..Placebo Pbo BE65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DN%BDMq01-709-1088A CDISCPILOT01ADAE 7091088VERBATIM_0271RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NNONE YY.AA...ADM BqBq..Placebo Pbo BE65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DN%BDMq01-709-1099ACDISCPILOT01ADAE 7091099VERBATIM_1552NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YYAAA....DL AADLBXanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD SYMPTOMS DM~BDL01-709-1099A CDISCPILOT01ADAE 7091099VERBATIM_1069APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADL BB..Xanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DM~BDL01-709-1099A0CDISCPILOT01ADAE 7091099VERBATIM_1087APPLICATION SITE VESICLES GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADL BB..Xanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0576 HLT_0180 APPLICATION SITE VESICLES DM~BDL01-709-1099A@CDISCPILOT01ADAE 7091099VERBATIM_1663APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADL BB..Xanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DM~BDL01-709-1099APCDISCPILOT01ADAE 7091099VERBATIM_1552NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YY.......DL AADLBXanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD SYMPTOMS DM~BDL01-709-1099A`CDISCPILOT01ADAE 7091099VERBATIM_1069APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY......ADL BB..Xanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DM~BDL01-709-1099ApCDISCPILOT01ADAE 7091099VERBATIM_1663APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY......ADL BB..Xanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DM~BDL01-709-1099ACDISCPILOT01ADAE 7091099VERBATIM_1217ACROCHORDON EXCISION SURGICAL AND MEDICAL PROCEDURES MILD NNONE YY.AA....DM] BBDM]BXanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0103 HLT_0629 SKIN TAG REMOVAL DM~BDL01-709-1102ACDISCPILOT01ADAE 7091102VERBATIM_1069APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYYAAA...ADK BB..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DKBHDK01-709-1102A CDISCPILOT01ADAE 7091102VERBATIM_1551APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY..A...ADK BB..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DKBHDK01-709-1102A0CDISCPILOT01ADAE 7091102VERBATIM_1069APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADK BB..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DKBHDK01-709-1102A@CDISCPILOT01ADAE 7091102VERBATIM_1551APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADK BB..Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DKBHDK01-709-1102APCDISCPILOT01ADAE 7091102VERBATIM_0494DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLEYYY.AA....DK BABADKBGXanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DKBHDK01-709-1102A`CDISCPILOT01ADAE 7091102VERBATIM_0181APPLICATION SITE VESICLES GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY..A...ADK BGBGDKBHXanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0576 HLT_0180 APPLICATION SITE BLISTER DKBHDK01-709-1168ACDISCPILOT01ADAE 7091168VERBATIM_1165SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYYAAA...ADL BBDLB$Xanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 IRRITATION SKIN DLB8DLt01-709-1168A CDISCPILOT01ADAE 7091168VERBATIM_1165SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY......ADL BBDLB$Xanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 IRRITATION SKIN DLB8DLt01-709-1168A0CDISCPILOT01ADAE 7091168VERBATIM_0373PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY..A...ADL B$B$DLBGXanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHY DLB8DLt01-709-1168A@CDISCPILOT01ADAE 7091168VERBATIM_0324RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY..A...ADL B$B$DLBGXanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLB8DLt01-709-1168APCDISCPILOT01ADAE 7091168VERBATIM_0373PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADL B$B$DLBGXanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHY DLB8DLt01-709-1168A`CDISCPILOT01ADAE 7091168VERBATIM_0324RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADL B$B$DLBGXanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLB8DLt01-709-1217ACDISCPILOT01ADAE 7091217VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MODERATENPOSSIBLEYYYAAA....DK A0A0DKA0Xanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DL@BdDK01-709-1217A CDISCPILOT01ADAE 7091217VERBATIM_0620COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YYY.AA....DK BB..Xanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DL@BdDK01-709-1217A0CDISCPILOT01ADAE 7091217VERBATIM_1036APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY.AA...ADK BBDLGBkXanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DL@BdDK01-709-1217A@CDISCPILOT01ADAE 7091217VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLEYYY.......DK BBDKBXanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DL@BdDK01-709-1217APCDISCPILOT01ADAE 7091217VERBATIM_1077ELECTROCARDIOGRAM T WAVE INVERSION INVESTIGATIONS MILD NNONE YYY.AA....DK BB..Xanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0130 HLT_0289 T WAVE INVERTED DL@BdDK01-709-1217A`CDISCPILOT01ADAE 7091217VERBATIM_0494DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLEYYY.......DK BBDLB'Xanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DL@BdDK01-709-1217ApCDISCPILOT01ADAE 7091217VERBATIM_0494DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLEYYY.......DK BBDLB'Xanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DL@BdDK01-709-1217ACDISCPILOT01ADAE 7091217VERBATIM_1036APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADK BBDLGBkXanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DL@BdDK01-709-1217ACDISCPILOT01ADAE 7091217VERBATIM_0929HEADACHE NERVOUS SYSTEM DISORDERS MILD NREMOTE YYY..A....DL' BKBKDL(BLXanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DL@BdDK01-709-1217ACDISCPILOT01ADAE 7091217VERBATIM_1036APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADK BBDLGBkXanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DL@BdDK01-709-1217ACDISCPILOT01ADAE 7091217VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY.AA...ADL1 BUBUDLGBkXanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DL@BdDK01-709-1238ACDISCPILOT01ADAE 7091238VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MODERATENNONE YYYAAA....DL2 AADL2AXanomeline High DoseXan_Hi A BE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DLxBTDL%01-709-1238A CDISCPILOT01ADAE 7091238VERBATIM_1069APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY.AA...ADL4 BB..Xanomeline High DoseXan_Hi A BE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DLxBTDL%01-709-1238A0CDISCPILOT01ADAE 7091238VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY..A...ADL4 BB..Xanomeline High DoseXan_Hi A BE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLxBTDL%01-709-1238A@CDISCPILOT01ADAE 7091238VERBATIM_0012APPLICATION SITE DISCHARGE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY..A...ADL4 BB..Xanomeline High DoseXan_Hi A BE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0457 HLT_0200 APPLICATION SITE DISCHARGE DLxBTDL%01-709-1238APCDISCPILOT01ADAE 7091238VERBATIM_0163HIP FRACTURE INJURY, POISONING AND PROCEDURAL COMPLICATIONS MODERATENNONE YYY.AA....DL5 BBDL5BXanomeline High DoseXan_Hi A BE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0131 HLT_0097 HIP FRACTURE DLxBTDL%01-709-1238A`CDISCPILOT01ADAE 7091238VERBATIM_0910COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MODERATENNONE YYY.AA....DL> BB..Xanomeline High DoseXan_Hi A BE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DLxBTDL%01-709-1238ApCDISCPILOT01ADAE 7091238VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MODERATENNONE YYY.AA....DL> BB..Xanomeline High DoseXan_Hi A BE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DLxBTDL%01-709-1238ACDISCPILOT01ADAE 7091238VERBATIM_0989SKIN LESION EXCISION SURGICAL AND MEDICAL PROCEDURES MILD NNONE YYY.AA....DLQ B-B-DLQB-Xanomeline High DoseXan_Hi A BE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0450 HLT_0498 SKIN LESION EXCISION DLxBTDL%01-709-1259ACDISCPILOT01ADAE 7091259VERBATIM_0972LOCALISED INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YYAAA....DK AADKBPlacebo Pbo BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0557 HLT_0435 INFECTED FINGER DLBBDK01-709-1259A CDISCPILOT01ADAE 7091259VERBATIM_0972LOCALISED INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YY.......DK AADKBPlacebo Pbo BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0557 HLT_0435 INFECTED FINGER DLBBDK01-709-1259A0CDISCPILOT01ADAE 7091259VERBATIM_0664BLOOD URINE PRESENT INVESTIGATIONS MILD NNONE YY.AA....DK B0B0..Placebo Pbo BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0289 HLT_0458 BLOOD IN URINE DLBBDK01-709-1259A@CDISCPILOT01ADAE 7091259VERBATIM_1792CYSTOSCOPY INVESTIGATIONS MILD NNONE YY..A....DK B3B3DKB3Placebo Pbo BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0041 HLT_0436 CYSTOSCOPY DLBBDK01-709-1259APCDISCPILOT01ADAE 7091259VERBATIM_0255BENIGN PROSTATIC HYPERPLASIA REPRODUCTIVE SYSTEM AND BREAST DISORDERS MILD NNONE YY.AA....DK B3B3DKB@Placebo Pbo BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0568 HLT_0215 ENLARGED PROSTATE DLBBDK01-709-1259A`CDISCPILOT01ADAE 7091259VERBATIM_0255BENIGN PROSTATIC HYPERPLASIA REPRODUCTIVE SYSTEM AND BREAST DISORDERS SEVERE NNONE YY.......DK B3B3DKB@Placebo Pbo BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0568 HLT_0215 ENLARGED PROSTATE DLBBDK01-709-1259ApCDISCPILOT01ADAE 7091259VERBATIM_1401PYREXIA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NNONE YY.AA....DL BNBNDLBOPlacebo Pbo BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0652 HLT_0310 FEVER DLBBDK01-709-1259ACDISCPILOT01ADAE 7091259VERBATIM_1538DEHYDRATION METABOLISM AND NUTRITION DISORDERS MILD NNONE YY.AA....DL BNBNDLBOPlacebo Pbo BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0011 HLT_0533 DEHYDRATION DLBBDK01-709-1259ACDISCPILOT01ADAE 7091259VERBATIM_0755HYPOTENSION VASCULAR DISORDERS MILD NPOSSIBLE YY.AA....DL BNBNDLBOPlacebo Pbo BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0412 HLT_0761 LOW BLOOD PRESSURE DLBBDK01-709-1259ACDISCPILOT01ADAE 7091259VERBATIM_0913ORTHOSTATIC HYPOTENSION VASCULAR DISORDERS MILD NPOSSIBLE YY..A....DL BUBUDLBBPlacebo Pbo BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0111 HLT_0194 POSTURAL HYPOTENSION DLBBDK01-709-1259ACDISCPILOT01ADAE 7091259VERBATIM_0913ORTHOSTATIC HYPOTENSION VASCULAR DISORDERS MILD NPOSSIBLE YY.......DL BUBUDLBBPlacebo Pbo BR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0111 HLT_0194 POSTURAL HYPOTENSION DLBBDK01-709-1285ACDISCPILOT01ADAE 7091285VERBATIM_1501HEMIANOPIA HOMONYMOUS NERVOUS SYSTEM DISORDERS MILD NNONE YYAAA....DL BB..Xanomeline Low Dose Xan_Lo ABW>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNYNNNHLGT_0547 HLT_0639 HOMONYMOUS HEMIANOPSIA DL-B=DK01-709-1285A CDISCPILOT01ADAE 7091285VERBATIM_1329APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADL BBDL5BEXanomeline Low Dose Xan_Lo ABW>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DL-B=DK01-709-1285A0CDISCPILOT01ADAE 7091285VERBATIM_0886APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADL BBDL5BEXanomeline Low Dose Xan_Lo ABW>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DL-B=DK01-709-1285A@CDISCPILOT01ADAE 7091285VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MILD NPOSSIBLE YY.AA....DL) B9B9..Xanomeline Low Dose Xan_Lo ABW>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DL-B=DK01-709-1285APCDISCPILOT01ADAE 7091285VERBATIM_1329APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADL BBDL5BEXanomeline Low Dose Xan_Lo ABW>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DL-B=DK01-709-1285A`CDISCPILOT01ADAE 7091285VERBATIM_0886APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADL BBDL5BEXanomeline Low Dose Xan_Lo ABW>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DL-B=DK01-709-1301ACDISCPILOT01ADAE 7091301VERBATIM_0875DIABETES MELLITUS METABOLISM AND NUTRITION DISORDERS MILD NNONE YYAAA....DL B+B+..Placebo Pbo B><65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0572 HLT_0447 DIABETES DMBDLf01-709-1306ACDISCPILOT01ADAE 7091306VERBATIM_1724RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYYAAA...ADMy BMBMDMBPlacebo Pbo B<<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DMBDM-01-709-1306A CDISCPILOT01ADAE 7091306VERBATIM_1492APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY.AA...ADMy BMBMDMBPlacebo Pbo B<<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMBDM-01-709-1306A0CDISCPILOT01ADAE 7091306VERBATIM_1724RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADMy BMBMDMBPlacebo Pbo B<<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DMBDM-01-709-1306A@CDISCPILOT01ADAE 7091306VERBATIM_1492APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADMy BMBMDMBPlacebo Pbo B<<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMBDM-01-709-1306APCDISCPILOT01ADAE 7091306VERBATIM_0132APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY..A...ADM B[B[DMBPlacebo Pbo B<<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DMBDM-01-709-1306A`CDISCPILOT01ADAE 7091306VERBATIM_1657DRUG ERUPTION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NNONE YYY..A...ADM BkBkDMBnPlacebo Pbo B<<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0253 HLT_0430 DRUG RASH DMBDM-01-709-1306ApCDISCPILOT01ADAE 7091306VERBATIM_1724RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADMy BMBMDMBPlacebo Pbo B<<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DMBDM-01-709-1306ACDISCPILOT01ADAE 7091306VERBATIM_1492APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADMy BMBMDMBPlacebo Pbo B<<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMBDM-01-709-1306ACDISCPILOT01ADAE 7091306VERBATIM_0132APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADM B[B[DMBPlacebo Pbo B<<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DMBDM-01-709-1309ACDISCPILOT01ADAE 7091309VERBATIM_1060RASH MACULO-PAPULAR SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE NN......ADL? DLTAXanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0097 HLT_0500 MACULOPAPULAR RASH DLBDLH01-709-1309A CDISCPILOT01ADAE 7091309VERBATIM_0086RASH PAPULAR SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE NN......ADLG DLcBXanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0007 HLT_0549 PAPULAR RASH DLBDLH01-709-1309A0CDISCPILOT01ADAE 7091309VERBATIM_0897VOMITING GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YYAAA....DLH AADLHAXanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 VOMITING DLBDLH01-709-1309A@CDISCPILOT01ADAE 7091309VERBATIM_0897VOMITING GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YY.......DLH AADLHAXanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 VOMITING DLBDLH01-709-1309APCDISCPILOT01ADAE 7091309VERBATIM_0615NASAL CONGESTION RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NREMOTE YY.AA....DLH AADLIA Xanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0549 HLT_0118 NASAL CONGESTION DLBDLH01-709-1309A`CDISCPILOT01ADAE 7091309VERBATIM_0147NIGHTMARE PSYCHIATRIC DISORDERS MILD NREMOTE YY.AA....DLH AADLIA Xanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0049 HLT_0186 NIGHTMARE DLBDLH01-709-1309ApCDISCPILOT01ADAE 7091309VERBATIM_1060RASH MACULO-PAPULAR SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY.AA...ADLI A A ..Xanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0097 HLT_0500 MACULOPAPULAR RASH DLBDLH01-709-1309ACDISCPILOT01ADAE 7091309VERBATIM_0522BIOPSY INVESTIGATIONS MILD NNONE YY.AA....DLO AADLOAXanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0076 HLT_0685 BIOPSY DLBDLH01-709-1309ACDISCPILOT01ADAE 7091309VERBATIM_0712DIZZINESS NERVOUS SYSTEM DISORDERS MILD NNONE YY.AA....DLT AADLTAXanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DLBDLH01-709-1309ACDISCPILOT01ADAE 7091309VERBATIM_1060RASH MACULO-PAPULAR SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE NN......ADL? DLTAXanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0097 HLT_0500 MACULOPAPULAR RASH DLBDLH01-709-1309ACDISCPILOT01ADAE 7091309VERBATIM_0712DIZZINESS NERVOUS SYSTEM DISORDERS MILD NNONE YY.......DLT AADLTAXanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DLBDLH01-709-1309ACDISCPILOT01ADAE 7091309VERBATIM_0906ALLERGIC GRANULOMATOUS ANGIITIS RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY..A....DLW BBDLWBXanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0157 HLT_0114 ALLERGIC GRANULOMATOSIS DLBDLH01-709-1309ACDISCPILOT01ADAE 7091309VERBATIM_0086RASH PAPULAR SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE NN......ADLG DLcBXanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0007 HLT_0549 PAPULAR RASH DLBDLH01-709-1309ACDISCPILOT01ADAE 7091309VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADLo B(B(..Xanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLBDLH01-709-1309ACDISCPILOT01ADAE 7091309VERBATIM_1770FEELING COLD GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NNONE YY..A....DL BPBP..Xanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0717 HLT_0340 FEELING COLD DLBDLH01-709-1312ACDISCPILOT01ADAE 7091312VERBATIM_0684APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADM BB..Placebo Pbo BD65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DN/BDMy01-709-1312A CDISCPILOT01ADAE 7091312VERBATIM_1095ELECTROCARDIOGRAM ST SEGMENT DEPRESSION INVESTIGATIONS MILD NREMOTE YY.AA....DN/ BB..Placebo Pbo BD65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0220 HLT_0610 ST SEGMENT DEPRESSED DN/BDMy01-709-1326ACDISCPILOT01ADAE 7091326VERBATIM_0684APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADL BB..Xanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DLBDK01-709-1326A CDISCPILOT01ADAE 7091326VERBATIM_0179APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADL BB..Xanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLBDK01-709-1326A0CDISCPILOT01ADAE 7091326VERBATIM_0897VOMITING GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YY.AA....DL+ B/B/DL+B/Xanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 VOMITING DLBDK01-709-1326A@CDISCPILOT01ADAE 7091326VERBATIM_1537SYNCOPE NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YY.AA....DL+ B/B/DL+B/Xanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0310 HLT_0440 SYNCOPE DLBDK01-709-1326APCDISCPILOT01ADAE 7091326VERBATIM_1413APPLICATION SITE BLEEDING GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY..A...ADL< B@B@DLFBJXanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0324 HLT_0718 APPLICATION SITE BLEEDING DLBDK01-709-1326A`CDISCPILOT01ADAE 7091326VERBATIM_0910COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.AA....DL_ BcBc..Xanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DLBDK01-709-1329ACDISCPILOT01ADAE 7091329VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YYAAA....DL AADLAXanomeline High DoseXan_Hi A BF65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DLADL01-709-1329A CDISCPILOT01ADAE 7091329VERBATIM_1401PYREXIA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NREMOTE YY.AA....DL AADLAXanomeline High DoseXan_Hi A BF65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0652 HLT_0310 FEVER DLADL01-709-1339ACDISCPILOT01ADAE 7091339VERBATIM_0929HEADACHE NERVOUS SYSTEM DISORDERS MODERATENNONE NN.......DID ..Placebo Pbo BQ>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DLMBDK01-709-1339A CDISCPILOT01ADAE 7091339VERBATIM_0037BLOOD ALKALINE PHOSPHATASE INCREASED INVESTIGATIONS MODERATENNONE YYAAA....DL" BB..Placebo Pbo BQ>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0298 HLT_0615 ALK PHOS RAISED DLMBDK01-709-1424ACDISCPILOT01ADAE 7091424VERBATIM_1714SYNCOPE NERVOUS SYSTEM DISORDERS MODERATEYAPOSSIBLEYYYAAAAAA.DK APAPDKAPXanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0310 HLT_0440 SYNCOPE DKAPDK01-710-1002ACDISCPILOT01ADAE 7101002VERBATIM_1299TRANSIENT ISCHAEMIC ATTACK NERVOUS SYSTEM DISORDERS MILD NREMOTE YYYAAA....DM A0A0DMApXanomeline Low Dose Xan_Lo ABX>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0433 HLT_0041 TRANSIENT ISCHEMIC ATTACKS DMAPDM01-710-1002A CDISCPILOT01ADAE 7101002VERBATIM_1299TRANSIENT ISCHAEMIC ATTACK NERVOUS SYSTEM DISORDERS MILD NREMOTE YYY.......DM A0A0DMApXanomeline Low Dose Xan_Lo ABX>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0433 HLT_0041 TRANSIENT ISCHEMIC ATTACKS DMAPDM01-710-1006ACDISCPILOT01ADAE 7101006VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MILD NNONE YYAAA....DK AADKAXanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DL{BDK01-710-1006A CDISCPILOT01ADAE 7101006VERBATIM_1130SALIVARY HYPERSECRETION GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YY.AA....DK BB..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0488 HLT_0374 SALIVATION DL{BDK01-710-1006A0CDISCPILOT01ADAE 7101006VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY.AA...ADK BB..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DL{BDK01-710-1006A@CDISCPILOT01ADAE 7101006VERBATIM_0527DIZZINESS NERVOUS SYSTEM DISORDERS MILD NNONE YY.......DL BBBBDLBBXanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 FELT FAINT DL{BDK01-710-1006APCDISCPILOT01ADAE 7101006VERBATIM_0575URINARY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YY.AA....DL BCBCDL BEXanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0093 HLT_0161 URINARY INFECTION DL{BDK01-710-1006A`CDISCPILOT01ADAE 7101006VERBATIM_1752NEPHROLITHIASIS RENAL AND URINARY DISORDERS MODERATENNONE YY.AA....DL BCBCDL BCXanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0546 HLT_0439 KIDNEY STONE DL{BDK01-710-1006ApCDISCPILOT01ADAE 7101006VERBATIM_0215PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLE YY..A...ADL( BbBb..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITUS DL{BDK01-710-1006ACDISCPILOT01ADAE 7101006VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MODERATENREMOTE YY.AA....DLR BBDLWBXanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DL{BDK01-710-1006ACDISCPILOT01ADAE 7101006VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MODERATENREMOTE YY.......DLR BBDLWBXanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DL{BDK01-710-1006ACDISCPILOT01ADAE 7101006VERBATIM_0364FALL INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NNONE YY.AA....DLz BBDLzBXanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0446 HLT_0168 FALL DL{BDK01-710-1006ACDISCPILOT01ADAE 7101006VERBATIM_0240FACIAL BONES FRACTURE INJURY, POISONING AND PROCEDURAL COMPLICATIONS MODERATENNONE YY..A....DLz BB..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0585 HLT_0305 FRACTURED NOSE DL{BDK01-710-1006ACDISCPILOT01ADAE 7101006VERBATIM_1622CONTUSION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NNONE YY..A....DLz BB..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0381 HLT_0713 BRUISING OF FACE DL{BDK01-710-1021ACDISCPILOT01ADAE 7101021VERBATIM_0517CHEST PAIN GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NREMOTE YYYAAA....DL AADLAXanomeline High DoseXan_Hi A BO65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0195 HLT_0717 CHEST PAIN DLB!DL01-710-1021A CDISCPILOT01ADAE 7101021VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY.AA...ADL BBDLB#Xanomeline High DoseXan_Hi A BO65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLB!DL01-710-1021A0CDISCPILOT01ADAE 7101021VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY......ADL BBDLB#Xanomeline High DoseXan_Hi A BO65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLB!DL01-710-1027ACDISCPILOT01ADAE 7101027VERBATIM_0334HAEMOPTYSIS RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YYAAA....DM BGBGDMB^Placebo Pbo BS>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0680 HLT_0192 COUGHING BLOOD DMBDMF01-710-1027A CDISCPILOT01ADAE 7101027VERBATIM_1647RALES RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY..A....DM BUBUDMBqPlacebo Pbo BS>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0410 HLT_0020 RALES DMBDMF01-710-1027A0CDISCPILOT01ADAE 7101027VERBATIM_0334HAEMOPTYSIS RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.......DM BGBGDMB^Placebo Pbo BS>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0680 HLT_0192 COUGHING BLOOD DMBDMF01-710-1027A@CDISCPILOT01ADAE 7101027VERBATIM_1647RALES RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.......DM BUBUDMBqPlacebo Pbo BS>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0410 HLT_0020 RALES DMBDMF01-710-1045ACDISCPILOT01ADAE 7101045VERBATIM_0185VOMITING GASTROINTESTINAL DISORDERS MILD NREMOTE YYYAAA....DLK BBDLKBXanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 VOMITING DLBHDL801-710-1045A CDISCPILOT01ADAE 7101045VERBATIM_1552NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YYY.AA....DLU BBDL\B%Xanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD SYMPTOMS DLBHDL801-710-1045A0CDISCPILOT01ADAE 7101045VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY.AA...ADLU BBDLBLXanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DLBHDL801-710-1045A@CDISCPILOT01ADAE 7101045VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY..A...ADLU BBDLBLXanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLBHDL801-710-1045APCDISCPILOT01ADAE 7101045VERBATIM_1552NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YYY.......DLU BBDL\B%Xanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD SYMPTOMS DLBHDL801-710-1045A`CDISCPILOT01ADAE 7101045VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY..A...ADLi B2B2DLBLXanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLBHDL801-710-1045ApCDISCPILOT01ADAE 7101045VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY..A...ADLu B>B>DLBLXanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLBHDL801-710-1045ACDISCPILOT01ADAE 7101045VERBATIM_1321SKIN EXFOLIATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY..A...ADL BHBHDLBLXanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0726 HLT_0236 SKIN PEELING DLBHDL801-710-1045ACDISCPILOT01ADAE 7101045VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY......ADLU BBDLBLXanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DLBHDL801-710-1045ACDISCPILOT01ADAE 7101045VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY......ADLU BBDLBLXanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLBHDL801-710-1045ACDISCPILOT01ADAE 7101045VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY......ADLi B2B2DLBLXanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLBHDL801-710-1045ACDISCPILOT01ADAE 7101045VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY......ADLu B>B>DLBLXanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLBHDL801-710-1045ACDISCPILOT01ADAE 7101045VERBATIM_1321SKIN EXFOLIATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY......ADL BHBHDLBLXanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0726 HLT_0236 SKIN PEELING DLBHDL801-710-1053ACDISCPILOT01ADAE 7101053VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYYAAA...ADK B"B"DKB0Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DKB/DK01-710-1053A CDISCPILOT01ADAE 7101053VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY..A...ADK B"B"DKB0Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DKB/DK01-710-1053A0CDISCPILOT01ADAE 7101053VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY......ADK B"B"DKB0Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DKB/DK01-710-1053A@CDISCPILOT01ADAE 7101053VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY......ADK B"B"DKB0Xanomeline Low Dose Xan_Lo ABT>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DKB/DK01-710-1060ACDISCPILOT01ADAE 7101060VERBATIM_1612NASAL CONGESTION RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YYAAA....DK A A DKA Placebo Pbo BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0549 HLT_0118 NASAL CONGESTION DLXBDK01-710-1060A CDISCPILOT01ADAE 7101060VERBATIM_1504INSOMNIA PSYCHIATRIC DISORDERS MILD NNONE YY.AA....DK A@A@DKAPlacebo Pbo BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0469 HLT_0297 DIFFICULTY SLEEPING DLXBDK01-710-1060A0CDISCPILOT01ADAE 7101060VERBATIM_1504INSOMNIA PSYCHIATRIC DISORDERS MILD NNONE YY.......DK A@A@DKAPlacebo Pbo BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0469 HLT_0297 DIFFICULTY SLEEPING DLXBDK01-710-1060A@CDISCPILOT01ADAE 7101060VERBATIM_0685APPLICATION SITE INDURATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY.AA...ADK BBDKBPlacebo Pbo BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0715 HLT_0696 APPLICATION SITE INDURATION DLXBDK01-710-1060APCDISCPILOT01ADAE 7101060VERBATIM_0458APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY..A...ADK BBDKBPlacebo Pbo BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLXBDK01-710-1060A`CDISCPILOT01ADAE 7101060VERBATIM_0458APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY......ADK BBDKBPlacebo Pbo BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLXBDK01-710-1060ApCDISCPILOT01ADAE 7101060VERBATIM_1303FALL INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NNONE YY.AA....DK B'B'DKB'Placebo Pbo BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0446 HLT_0168 FALLING DOWN DLXBDK01-710-1060ACDISCPILOT01ADAE 7101060VERBATIM_1303FALL INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NNONE YY.......DK B(B(DKB(Placebo Pbo BR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0446 HLT_0168 FALLING DOWN DLXBDK01-710-1070ACDISCPILOT01ADAE 7101070VERBATIM_1717SUPRAVENTRICULAR EXTRASYSTOLES CARDIAC DISORDERS MILD NPOSSIBLEYYYAAA....DKH BB..Xanomeline High DoseXan_Hi A BU>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0279 HLT_0188 PREMATURE ATRIAL CONTRACTION DKBDK,01-710-1070A CDISCPILOT01ADAE 7101070VERBATIM_0373PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY.AA...ADK B`B`..Xanomeline High DoseXan_Hi A BU>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHY DKBDK,01-710-1070A0CDISCPILOT01ADAE 7101070VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY..A...ADK B`B`..Xanomeline High DoseXan_Hi A BU>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DKBDK,01-710-1070A@CDISCPILOT01ADAE 7101070VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY..A...ADK B`B`..Xanomeline High DoseXan_Hi A BU>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DKBDK,01-710-1070APCDISCPILOT01ADAE 7101070VERBATIM_0985HIP FRACTURE INJURY, POISONING AND PROCEDURAL COMPLICATIONS SEVERE NNONE YYY.AA....DK BBDKBXanomeline High DoseXan_Hi A BU>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0131 HLT_0097 HIP FRACTURE DKBDK,01-710-1070A`CDISCPILOT01ADAE 7101070VERBATIM_1577GASTROINTESTINAL HAEMORRHAGE GASTROINTESTINAL DISORDERS SEVERE NNONE YNY.AA....DK BBDKBXanomeline High DoseXan_Hi A BU>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0020 HLT_0354 GI BLEED DKBDK,01-710-1077ACDISCPILOT01ADAE 7101077VERBATIM_1298APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YYAAA...ADL BBDLBPlacebo Pbo BL65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DMBDL01-710-1077A CDISCPILOT01ADAE 7101077VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY.AA...ADM B)B)..Placebo Pbo BL65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DMBDL01-710-1077A0CDISCPILOT01ADAE 7101077VERBATIM_0499AGITATION PSYCHIATRIC DISORDERS MILD NREMOTE YY.AA....DM B9B9..Placebo Pbo BL65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0170 HLT_0140 AGITATION DMBDL01-710-1077A@CDISCPILOT01ADAE 7101077VERBATIM_1309ARTHRITIS MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS SEVERE NNONE NN........ ....Placebo Pbo BL65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0587 HLT_0019 ARTHRITIS DMBDL01-710-1077APCDISCPILOT01ADAE 7101077VERBATIM_1309ARTHRITIS MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MODERATENNONE NN........ ....Placebo Pbo BL65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0587 HLT_0019 ARTHRITIS DMBDL01-710-1083ACDISCPILOT01ADAE 7101083VERBATIM_0737MYOCARDIAL INFARCTION CARDIAC DISORDERS SEVERE NPOSSIBLE NYAAA....DLt AADLtAPlacebo Pbo BY>80 A0CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNYYYHLGT_0688 HLT_0649 MYOCARDIAL INFARCT DLsADLi01-710-1137ACDISCPILOT01ADAE 7101137VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYYAAA...ADL A0A0..Xanomeline High DoseXan_Hi A BO65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLB"DL01-710-1137A CDISCPILOT01ADAE 7101137VERBATIM_1639ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY..A...ADL A0A0..Xanomeline High DoseXan_Hi A BO65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 REDNESS DLB"DL01-710-1137A0CDISCPILOT01ADAE 7101137VERBATIM_1703VERTIGO EAR AND LABYRINTH DISORDERS MODERATENPOSSIBLEYYY.AA....DL BB..Xanomeline High DoseXan_Hi A BO65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0147 HLT_0255 VERTIGO DLB"DL01-710-1137A@CDISCPILOT01ADAE 7101137VERBATIM_0929HEADACHE NERVOUS SYSTEM DISORDERS MILD NREMOTE YYY.AA....DL B"B"..Xanomeline High DoseXan_Hi A BO65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DLB"DL01-710-1142ACDISCPILOT01ADAE 7101142VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MODERATENREMOTE YYYAAA....DKF A0A0DKHAPXanomeline High DoseXan_Hi A BL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DKVBDKD01-710-1142A CDISCPILOT01ADAE 7101142VERBATIM_0929HEADACHE NERVOUS SYSTEM DISORDERS MILD NREMOTE YYY..A....DKF A0A0DKHAPXanomeline High DoseXan_Hi A BL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DKVBDKD01-710-1142A0CDISCPILOT01ADAE 7101142VERBATIM_0775NAUSEA GASTROINTESTINAL DISORDERS MILD NNONE YYY.AA....DKP AADKPAXanomeline High DoseXan_Hi A BL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0326 HLT_0742 NAUSEA DKVBDKD01-710-1142A@CDISCPILOT01ADAE 7101142VERBATIM_0222MYOCARDIAL INFARCTION CARDIAC DISORDERS MODERATENPOSSIBLEYYY.AA....DKU BBDKUBXanomeline High DoseXan_Hi A BL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0688 HLT_0649 MYOCARDIAL INFARCTION DKVBDKD01-710-1142APCDISCPILOT01ADAE 7101142VERBATIM_0210SYNCOPE VASOVAGAL NERVOUS SYSTEM DISORDERS MODERATENPOSSIBLEYYY..A....DKU BBDKUBXanomeline High DoseXan_Hi A BL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0687 HLT_0003 SYNCOPE VASOVAGAL DKVBDKD01-710-1154ACDISCPILOT01ADAE 7101154VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYYAAA...ADMw BB..Xanomeline Low Dose Xan_Lo ABT>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DMBDMc01-710-1154A CDISCPILOT01ADAE 7101154VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS SEVERE NPOSSIBLEYYY......ADMw BB..Xanomeline Low Dose Xan_Lo ABT>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DMBDMc01-710-1166ACDISCPILOT01ADAE 7101166VERBATIM_0992FALL INJURY, POISONING AND PROCEDURAL COMPLICATIONS MODERATENPOSSIBLEYYYAAA....DK BnBnDKBnXanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0446 HLT_0168 FALL DKBnDK01-710-1166A CDISCPILOT01ADAE 7101166VERBATIM_0587SKIN LACERATION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MODERATENPOSSIBLEYYY..A....DK BnBnDKBnXanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0118 HLT_0075 LACERATION OF HEAD DKBnDK01-710-1166A0CDISCPILOT01ADAE 7101166VERBATIM_0455SYNCOPE NERVOUS SYSTEM DISORDERS MODERATENPOSSIBLEYYY.AA....DK BnBnDKBnXanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0310 HLT_0440 SYNCOPE DKBnDK01-710-1166A@CDISCPILOT01ADAE 7101166VERBATIM_1135COMPLEX PARTIAL SEIZURES NERVOUS SYSTEM DISORDERS MODERATENPOSSIBLEYYY..A....DK BnBnDKBoXanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0656 HLT_0558 COMPLEX PARTIAL SEIZURES DKBnDK01-710-1166APCDISCPILOT01ADAE 7101166VERBATIM_0455SYNCOPE NERVOUS SYSTEM DISORDERS MODERATENPOSSIBLEYNY.......DK BoBoDKBoXanomeline Low Dose Xan_Lo ABQ>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0310 HLT_0440 SYNCOPE DKBnDK01-710-1183ACDISCPILOT01ADAE 7101183VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MODERATENPOSSIBLE YYAAA....DMP BsBs..Placebo Pbo BP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DMBDL01-710-1183A CDISCPILOT01ADAE 7101183VERBATIM_0166ATRIOVENTRICULAR BLOCK FIRST DEGREE CARDIAC DISORDERS MILD NPOSSIBLE YY..A....DMP BsBs..Placebo Pbo BP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0464 HLT_0419 FIRST DEGREE ATRIOVENTRICULAR BLOCK DMBDL01-710-1187ACDISCPILOT01ADAE 7101187VERBATIM_1336APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YYAAA...ADK B,B,..Xanomeline High DoseXan_Hi A BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DL"BDKk01-710-1235ACDISCPILOT01ADAE 7101235VERBATIM_0910COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MODERATENNONE YYAAA....DKw B:B:DKBPXanomeline Low Dose Xan_Lo AB8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DKBDK>01-710-1235A CDISCPILOT01ADAE 7101235VERBATIM_0634SHOULDER PAIN MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MILD NNONE YY.AA....DK BnBn..Xanomeline Low Dose Xan_Lo AB8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0288 HLT_0527 SHOULDER PAIN DKBDK>01-710-1235A0CDISCPILOT01ADAE 7101235VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY.AA...ADK B~B~..Xanomeline Low Dose Xan_Lo AB8<65 AHISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DKBDK>01-710-1249ACDISCPILOT01ADAE 7101249VERBATIM_0373PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YYAAA...ADM5 B.B.DM5B.Xanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHY DMBDM01-710-1249A CDISCPILOT01ADAE 7101249VERBATIM_0373PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY......ADM< B5B5DM<B5Xanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHY DMBDM01-710-1249A0CDISCPILOT01ADAE 7101249VERBATIM_0254ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY..A...ADMA B:B:..Xanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DMBDM01-710-1249A@CDISCPILOT01ADAE 7101249VERBATIM_1202PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLE YY......ADM} BvBv..Xanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITUS DMBDM01-710-1264ACDISCPILOT01ADAE 7101264VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MILD NPOSSIBLEYYYAAA....DLV BBDLXBPlacebo Pbo BN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DLByDLB01-710-1264A CDISCPILOT01ADAE 7101264VERBATIM_0215PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY.AA...ADL BFBF..Placebo Pbo BN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITUS DLByDLB01-710-1264A0CDISCPILOT01ADAE 7101264VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY..A...ADL BFBF..Placebo Pbo BN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLByDLB01-710-1264A@CDISCPILOT01ADAE 7101264VERBATIM_1477COLD SWEAT SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY..A....DL BmBmDLBmPlacebo Pbo BN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0208 HLT_0124 COLD SWEAT DLByDLB01-710-1264APCDISCPILOT01ADAE 7101264VERBATIM_1398CHILLS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPOSSIBLEYYY.AA....DL BmBmDLBmPlacebo Pbo BN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0161 HLT_0586 CHILLS DLByDLB01-710-1264A`CDISCPILOT01ADAE 7101264VERBATIM_1477COLD SWEAT SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY.......DL BwBwDLBwPlacebo Pbo BN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0208 HLT_0124 COLD SWEAT DLByDLB01-710-1264ApCDISCPILOT01ADAE 7101264VERBATIM_1398CHILLS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPOSSIBLEYYY.......DL BwBwDLBwPlacebo Pbo BN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0161 HLT_0586 CHILLS DLByDLB01-710-1264ACDISCPILOT01ADAE 7101264VERBATIM_1477COLD SWEAT SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY.......DL ByByDLByPlacebo Pbo BN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0208 HLT_0124 COLD SWEAT DLByDLB01-710-1264ACDISCPILOT01ADAE 7101264VERBATIM_1398CHILLS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPOSSIBLEYYY.......DL ByByDLByPlacebo Pbo BN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0161 HLT_0586 CHILLS DLByDLB01-710-1270ACDISCPILOT01ADAE 7101270VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYYAAA...ADMA AA..Xanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DMGBDM601-710-1270A CDISCPILOT01ADAE 7101270VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY..A...ADMA AA..Xanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DMGBDM601-710-1271ACDISCPILOT01ADAE 7101271VERBATIM_1509DYSPNOEA RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MODERATENPOSSIBLEYYYAAA....DKv B8B8DKvB8Placebo Pbo BV>80 A0CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0255 HLT_0296 SHORTNESS OF BREATH DKvB8DK?01-710-1271A CDISCPILOT01ADAE 7101271VERBATIM_0737MYOCARDIAL INFARCTION CARDIAC DISORDERS SEVERE NPOSSIBLEYYY.AA....DKv B8B8DKvB8Placebo Pbo BV>80 A0CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYYHLGT_0688 HLT_0649 MYOCARDIAL INFARCT DKvB8DK?01-710-1271A0CDISCPILOT01ADAE 7101271VERBATIM_0571ATRIAL FIBRILLATION CARDIAC DISORDERS MODERATENPOSSIBLEYYY..A....DKv B8B8DK{B=Placebo Pbo BV>80 A0CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYYHLGT_0012 HLT_0365 PAROXYSMAL ATRIAL FIBRILLATION DKvB8DK?01-710-1271A@CDISCPILOT01ADAE 7101271VERBATIM_0411CARDIAC FAILURE CONGESTIVE CARDIAC DISORDERS MODERATENPOSSIBLEYNY..A....DKw B9B9..Placebo Pbo BV>80 A0CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYYHLGT_0413 HLT_0511 CONGESTIVE HEART FAILURE DKvB8DK?01-710-1271APCDISCPILOT01ADAE 7101271VERBATIM_0078HYPONATRAEMIA METABOLISM AND NUTRITION DISORDERS MODERATENREMOTE YNY.AA....DKw B9B9DK{B=Placebo Pbo BV>80 A0CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0102 HLT_0688 HYPONATREMIA DKvB8DK?01-710-1278ACDISCPILOT01ADAE 7101278VERBATIM_0485SOMNOLENCE NERVOUS SYSTEM DISORDERS MILD NREMOTE YYYAAA....DK BBDKBXanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0254 HLT_0160 DROWSINESS DKBADK01-710-1278A CDISCPILOT01ADAE 7101278VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY.AA...ADK B.B.DKBFXanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DKBADK01-710-1278A0CDISCPILOT01ADAE 7101278VERBATIM_0159APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYY.AA...ADK B?B?DKBFXanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE ERYTHEMA DKBADK01-710-1278A@CDISCPILOT01ADAE 7101278VERBATIM_0152BURNING SENSATION NERVOUS SYSTEM DISORDERS MODERATENPOSSIBLEYYY..A....DK B?B?DKBAXanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0456 HLT_0775 BURNING SENSATION DKBADK01-710-1278APCDISCPILOT01ADAE 7101278VERBATIM_0185VOMITING GASTROINTESTINAL DISORDERS MILD NREMOTE YNY.AA....DK BEBEDKBEXanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 VOMITING DKBADK01-710-1278A`CDISCPILOT01ADAE 7101278VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY......ADK B.B.DKBFXanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DKBADK01-710-1278ApCDISCPILOT01ADAE 7101278VERBATIM_0159APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYY......ADK B?B?DKBFXanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE ERYTHEMA DKBADK01-710-1300ACDISCPILOT01ADAE 7101300VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYYAAA...ADK B0B0..Xanomeline Low Dose Xan_Lo ABN65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DKB?DK01-710-1300A CDISCPILOT01ADAE 7101300VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY..A...ADK B:B:..Xanomeline Low Dose Xan_Lo ABN65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DKB?DK01-710-1300A0CDISCPILOT01ADAE 7101300VERBATIM_1655BLISTER SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY..A...ADK B:B:..Xanomeline Low Dose Xan_Lo ABN65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0267 HLT_0752 BLISTERS DKB?DK01-710-1300A@CDISCPILOT01ADAE 7101300VERBATIM_1523APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYY.AA...ADK B=B=..Xanomeline Low Dose Xan_Lo ABN65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DKB?DK01-710-1314ACDISCPILOT01ADAE 7101314VERBATIM_0887NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YYAAA....DL* BBDL.BPlacebo Pbo BN65-80A CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COMMON COLD DL-BDL01-710-1314A CDISCPILOT01ADAE 7101314VERBATIM_0887NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YY.......DL* BBDL.BPlacebo Pbo BN65-80A CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COMMON COLD DL-BDL01-710-1315ACDISCPILOT01ADAE 7101315VERBATIM_0929HEADACHE NERVOUS SYSTEM DISORDERS MILD NREMOTE YNN.......DK DKPlacebo Pbo BS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DLYBDK01-710-1315A CDISCPILOT01ADAE 7101315VERBATIM_0215PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYYAAA...ADL$ BMBMDLZBPlacebo Pbo BS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITUS DLYBDK01-710-1315A0CDISCPILOT01ADAE 7101315VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY..A...ADLG BpBpDLZBPlacebo Pbo BS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLYBDK01-710-1315A@CDISCPILOT01ADAE 7101315VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY..A...ADLG BpBpDLZBPlacebo Pbo BS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLYBDK01-710-1315APCDISCPILOT01ADAE 7101315VERBATIM_0215PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY......ADL$ BMBMDLZBPlacebo Pbo BS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITUS DLYBDK01-710-1315A`CDISCPILOT01ADAE 7101315VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY......ADLG BpBpDLZBPlacebo Pbo BS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLYBDK01-710-1315ApCDISCPILOT01ADAE 7101315VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY......ADLG BpBpDLZBPlacebo Pbo BS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLYBDK01-710-1354ACDISCPILOT01ADAE 7101354VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YYAAA...ADK B2B2..Xanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLBDKl01-710-1354A CDISCPILOT01ADAE 7101354VERBATIM_0215PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY..A...ADK B`B`..Xanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITUS DLBDKl01-710-1358ACDISCPILOT01ADAE 7101358VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YYAAA...ADK BaBa..Xanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DKBDK501-710-1358A CDISCPILOT01ADAE 7101358VERBATIM_0373PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY..A...ADK BaBa..Xanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHY DKBDK501-710-1358A0CDISCPILOT01ADAE 7101358VERBATIM_1636APPLICATION SITE DESQUAMATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY.AA...ADK BB..Xanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0193 HLT_0351 APPLICATION SITE DESQUAMATION DKBDK501-710-1368ACDISCPILOT01ADAE 7101368VERBATIM_1155HIP FRACTURE INJURY, POISONING AND PROCEDURAL COMPLICATIONS SEVERE NNONE YYAAA....DM B@B@DM}BPlacebo Pbo BX>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0131 HLT_0097 FRACTURED HIP DM}BDL01-710-1368A CDISCPILOT01ADAE 7101368VERBATIM_1218DELUSION PSYCHIATRIC DISORDERS MILD NREMOTE YY.AA....DM` BB..Placebo Pbo BX>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0565 HLT_0198 DELUSIONS DM}BDL01-710-1368A0CDISCPILOT01ADAE 7101368VERBATIM_1347PSYCHOMOTOR HYPERACTIVITY NERVOUS SYSTEM DISORDERS MILD NREMOTE YY.AA....DM` BB..Placebo Pbo BX>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0277 HLT_0383 INCREASED ACTIVITY DM}BDL01-710-1368A@CDISCPILOT01ADAE 7101368VERBATIM_1155HIP FRACTURE INJURY, POISONING AND PROCEDURAL COMPLICATIONS SEVERE NNONE YY.......DM B@B@DM}BPlacebo Pbo BX>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0131 HLT_0097 FRACTURED HIP DM}BDL01-710-1385ACDISCPILOT01ADAE 7101385VERBATIM_1557SUPRAVENTRICULAR TACHYCARDIA CARDIAC DISORDERS MODERATENNONE YYYAAA....DKm AADKnBXanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0619 HLT_0692 SUPRAVENTRICULAR TACHYCARDIA DKBqDK_01-710-1385A CDISCPILOT01ADAE 7101385VERBATIM_1557SUPRAVENTRICULAR TACHYCARDIA CARDIAC DISORDERS MODERATENNONE YYY.......DKm AADKnBXanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0619 HLT_0692 SUPRAVENTRICULAR TACHYCARDIA DKBqDK_01-710-1385A0CDISCPILOT01ADAE 7101385VERBATIM_1564ATRIOVENTRICULAR BLOCK FIRST DEGREE CARDIAC DISORDERS MILD NNONE YYY..A....DK{ BB..Xanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0464 HLT_0419 FIRST DEGREE ATRIOVENTRICULAR BLOCK DKBqDK_01-710-1385A@CDISCPILOT01ADAE 7101385VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY.AA...ADK B3B3..Xanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DKBqDK_01-710-1385APCDISCPILOT01ADAE 7101385VERBATIM_1452RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY..A...ADK B<B<..Xanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DKBqDK_01-710-1385A`CDISCPILOT01ADAE 7101385VERBATIM_1655BLISTER SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY..A...ADK B<B<..Xanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0267 HLT_0752 BLISTERS DKBqDK_01-710-1385ApCDISCPILOT01ADAE 7101385VERBATIM_0402ATRIAL FIBRILLATION CARDIAC DISORDERS MODERATENNONE YYY..A....DK BqBq..Xanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0012 HLT_0365 ATRIAL FIBRILLATION DKBqDK_01-710-1385ACDISCPILOT01ADAE 7101385VERBATIM_1711ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED INVESTIGATIONS MILD NREMOTE YYY.AA....DK BqBq..Xanomeline Low Dose Xan_Lo ABM65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0030 HLT_0037 T WAVE FLATTENING OF DKBqDK_01-710-1408ACDISCPILOT01ADAE 7101408VERBATIM_1552NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YYAAA....DK BBDKB$Xanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD SYMPTOMS DL_BDK01-710-1408A CDISCPILOT01ADAE 7101408VERBATIM_1552NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YY.......DK BBDKB$Xanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD SYMPTOMS DL_BDK01-710-1408A0CDISCPILOT01ADAE 7101408VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY.AA...ADK B3B3DL5BXanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DL_BDK01-710-1408A@CDISCPILOT01ADAE 7101408VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY......ADK B3B3DL5BXanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DL_BDK01-711-1012ACDISCPILOT01ADAE 7111012VERBATIM_0950APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYYAAA...ADL AA..Xanomeline High DoseXan_Hi A BC65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DLBDK01-711-1012A CDISCPILOT01ADAE 7111012VERBATIM_0905APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY..A...ADL AADLBXanomeline High DoseXan_Hi A BC65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLBDK01-711-1012A0CDISCPILOT01ADAE 7111012VERBATIM_0950APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADL AA..Xanomeline High DoseXan_Hi A BC65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DLBDK01-711-1012A@CDISCPILOT01ADAE 7111012VERBATIM_0905APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADL AADLBXanomeline High DoseXan_Hi A BC65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLBDK01-711-1012APCDISCPILOT01ADAE 7111012VERBATIM_1552NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MODERATENNONE YYY.AA....DL BB..Xanomeline High DoseXan_Hi A BC65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD SYMPTOMS DLBDK01-711-1012A`CDISCPILOT01ADAE 7111012VERBATIM_0937APPLICATION SITE URTICARIA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY..A...ADL BBDLBXanomeline High DoseXan_Hi A BC65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0233 HLT_0196 APPLICATION SITE URTICARIA DLBDK01-711-1012ApCDISCPILOT01ADAE 7111012VERBATIM_0905APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADL AADLBXanomeline High DoseXan_Hi A BC65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLBDK01-711-1036ACDISCPILOT01ADAE 7111036VERBATIM_0292HEADACHE NERVOUS SYSTEM DISORDERS MILD NNONE YYAAA....DK AA..Placebo Pbo BF65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 INTERMITTENT HEADACHE DKBDK01-711-1036A CDISCPILOT01ADAE 7111036VERBATIM_1034EAR INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YY.AA....DK ApApDKAPlacebo Pbo BF65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0760 HLT_0757 EAR INFECTION DKBDK01-711-1036A0CDISCPILOT01ADAE 7111036VERBATIM_0701GLOSSITIS GASTROINTESTINAL DISORDERS MILD NNONE YY.AA....DK AA..Placebo Pbo BF65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0427 HLT_0250 GLOSSITIS DKBDK01-711-1036A@CDISCPILOT01ADAE 7111036VERBATIM_1034EAR INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YY.......DK ApApDKAPlacebo Pbo BF65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0760 HLT_0757 EAR INFECTION DKBDK01-711-1143ACDISCPILOT01ADAE 7111143VERBATIM_1065TINNITUS EAR AND LABYRINTH DISORDERS MODERATENPOSSIBLEYNN.......DD D}}..Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0180 HLT_0570 TINNITUS DL4B:DK01-711-1143A CDISCPILOT01ADAE 7111143VERBATIM_0872PARAESTHESIA ORAL NERVOUS SYSTEM DISORDERS MILD NPOSSIBLEYYYAAA....DL AA..Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0035 HLT_0727 TINGLING MOUTH DL4B:DK01-711-1143A0CDISCPILOT01ADAE 7111143VERBATIM_1698NASOPHARYNGITIS INFECTIONS AND INFESTATIONS SEVERE NNONE YYY.AA....DL BBDL!B'Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD DL4B:DK01-711-1143A@CDISCPILOT01ADAE 7111143VERBATIM_0401SUPRAVENTRICULAR EXTRASYSTOLES CARDIAC DISORDERS MILD NPOSSIBLEYYY.AA....DL BBDL%B+Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0279 HLT_0188 ECTOPIC ATRIAL BEATS DL4B:DK01-711-1143APCDISCPILOT01ADAE 7111143VERBATIM_1698NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YYY.......DL BBDL!B'Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD DL4B:DK01-711-1143A`CDISCPILOT01ADAE 7111143VERBATIM_1698NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YYY.......DL BBDL!B'Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD DL4B:DK01-711-1143ApCDISCPILOT01ADAE 7111143VERBATIM_0401SUPRAVENTRICULAR EXTRASYSTOLES CARDIAC DISORDERS MILD NPOSSIBLEYYY.......DL BBDL%B+Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0279 HLT_0188 ECTOPIC ATRIAL BEATS DL4B:DK01-711-1143ACDISCPILOT01ADAE 7111143VERBATIM_0950APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY.AA...ADL( B.B...Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DL4B:DK01-711-1143ACDISCPILOT01ADAE 7111143VERBATIM_1328RASH PRURITIC SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY.AA...ADL1 B7B7DL5B;Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0753 HLT_0127 ITCHY RASH DL4B:DK01-711-1143ACDISCPILOT01ADAE 7111143VERBATIM_0139VENTRICULAR EXTRASYSTOLES CARDIAC DISORDERS MODERATENPROBABLEYYY..A....DL2 B8B8DL6B<Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0594 HLT_0050 PREMATURE VENTRICULAR CONTRACTIONS DL4B:DK01-711-1143ACDISCPILOT01ADAE 7111143VERBATIM_1328RASH PRURITIC SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADL1 B7B7DL5B;Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0753 HLT_0127 ITCHY RASH DL4B:DK01-711-1143ACDISCPILOT01ADAE 7111143VERBATIM_0600CONJUNCTIVAL HAEMORRHAGE EYE DISORDERS MODERATENREMOTE YYY.AA....DL4 B:B:..Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0720 HLT_0013 SUBCONJUNCTIVAL HEMORRHAGE DL4B:DK01-711-1143ACDISCPILOT01ADAE 7111143VERBATIM_0856CERUMEN IMPACTION EAR AND LABYRINTH DISORDERS MILD NNONE YNY.AA....DL6 B<B<..Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0158 HLT_0018 CERUMEN IMPACTION DL4B:DK01-711-1143ACDISCPILOT01ADAE 7111143VERBATIM_0139VENTRICULAR EXTRASYSTOLES CARDIAC DISORDERS MODERATENPROBABLEYYY.......DL2 B8B8DL6B<Xanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0594 HLT_0050 PREMATURE VENTRICULAR CONTRACTIONS DL4B:DK01-711-1433ACDISCPILOT01ADAE 7111433VERBATIM_0342HYPERTENSION VASCULAR DISORDERS MILD NNONE YNN.......DJ ¼»..Xanomeline High DoseXan_Hi A BT>80 A0CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0476 HLT_0228 HYPERTENSION DKADK01-711-1433A CDISCPILOT01ADAE 7111433VERBATIM_0342HYPERTENSION VASCULAR DISORDERS MODERATENNONE YNN.......DJ ¼»..Xanomeline High DoseXan_Hi A BT>80 A0CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0476 HLT_0228 HYPERTENSION DKADK01-711-1433A0CDISCPILOT01ADAE 7111433VERBATIM_0281ASTHENIA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENREMOTE YYYAAA....DK AA..Xanomeline High DoseXan_Hi A BT>80 A0CAUCASIAN AFYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0614 HLT_0205 WEAKNESS DKADK01-713-1043ACDISCPILOT01ADAE 7131043VERBATIM_0552APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADL AA..Xanomeline Low Dose Xan_Lo ABN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DM^BDL01-713-1043A CDISCPILOT01ADAE 7131043VERBATIM_0775NAUSEA GASTROINTESTINAL DISORDERS MODERATENPOSSIBLE YY.AA....DL BBDLBXanomeline Low Dose Xan_Lo ABN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0326 HLT_0742 NAUSEA DM^BDL01-713-1043A0CDISCPILOT01ADAE 7131043VERBATIM_0782VOMITING GASTROINTESTINAL DISORDERS MODERATENPOSSIBLE YY..A....DL BBDLBXanomeline Low Dose Xan_Lo ABN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 EMESIS DM^BDL01-713-1043A@CDISCPILOT01ADAE 7131043VERBATIM_0552APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY......ADL AA..Xanomeline Low Dose Xan_Lo ABN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DM^BDL01-713-1043APCDISCPILOT01ADAE 7131043VERBATIM_0775NAUSEA GASTROINTESTINAL DISORDERS MODERATENPOSSIBLE YY.......DL BBDLBXanomeline Low Dose Xan_Lo ABN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0326 HLT_0742 NAUSEA DM^BDL01-713-1043A`CDISCPILOT01ADAE 7131043VERBATIM_0782VOMITING GASTROINTESTINAL DISORDERS MODERATENPOSSIBLE YY.......DL BBDLBXanomeline Low Dose Xan_Lo ABN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 EMESIS DM^BDL01-713-1043ApCDISCPILOT01ADAE 7131043VERBATIM_1581CATARACT OPERATION SURGICAL AND MEDICAL PROCEDURES MILD NNONE YY.AA....DMN BBDMNBXanomeline Low Dose Xan_Lo ABN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0058 HLT_0432 CATARACT EXTRACTION DM^BDL01-713-1073ACDISCPILOT01ADAE 7131073VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADM BkBk..Xanomeline Low Dose Xan_Lo ABJ65-80A AFRICAN DESCENT (NEGRO, BLACK) A FYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DN!BDMd01-713-1141ACDISCPILOT01ADAE 7131141VERBATIM_1375RASH PRURITIC SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYYAAA...ADLJ BBDLbB.Xanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AMYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0753 HLT_0127 PRURITIC RASH DLTB DL501-713-1141A CDISCPILOT01ADAE 7131141VERBATIM_1375RASH PRURITIC SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY......ADLJ BBDLbB.Xanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AMYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0753 HLT_0127 PRURITIC RASH DLTB DL501-713-1141A0CDISCPILOT01ADAE 7131141VERBATIM_1583BACK PAIN MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MODERATENREMOTE YYY.AA....DLS BB..Xanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AMYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0508 HLT_0115 BACK PAIN DLTB DL501-713-1141A@CDISCPILOT01ADAE 7131141VERBATIM_0372DELIRIUM PSYCHIATRIC DISORDERS MODERATENPOSSIBLEYYY.AA....DLT B B DLbB.Xanomeline High DoseXan_Hi A BO65-80A CAUCASIAN AMYYNNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0176 HLT_0376 DELIRIUM DLTB DL501-713-1179ACDISCPILOT01ADAE 7131179VERBATIM_1186DYSURIA RENAL AND URINARY DISORDERS MILD NREMOTE YYAAA....DL AADLAPlacebo Pbo B@<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0210 HLT_0637 MICTURITION BURNING DM/BDL{01-713-1179A CDISCPILOT01ADAE 7131179VERBATIM_0841DYSPEPSIA GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YY.AA....DL AADLAPlacebo Pbo B@<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0716 HLT_0244 HEARTBURN DM/BDL{01-713-1179A0CDISCPILOT01ADAE 7131179VERBATIM_1682URINARY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NREMOTE YY.AA....DL BBDLBPlacebo Pbo B@<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0093 HLT_0161 URINARY TRACT INFECTION DM/BDL{01-713-1179A@CDISCPILOT01ADAE 7131179VERBATIM_1430ASTHENIA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPOSSIBLE YY.AA....DL BB..Placebo Pbo B@<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0614 HLT_0205 LOWER EXTREMITIES WEAKNESS OF DM/BDL{01-713-1179APCDISCPILOT01ADAE 7131179VERBATIM_1682URINARY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NREMOTE YY.......DL BBDLBPlacebo Pbo B@<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0093 HLT_0161 URINARY TRACT INFECTION DM/BDL{01-713-1179A`CDISCPILOT01ADAE 7131179VERBATIM_1430ASTHENIA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY.......DL BB..Placebo Pbo B@<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0614 HLT_0205 LOWER EXTREMITIES WEAKNESS OF DM/BDL{01-713-1179ApCDISCPILOT01ADAE 7131179VERBATIM_0800DYSPEPSIA GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YY.......DL B#B#..Placebo Pbo B@<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0716 HLT_0244 INDIGESTION DM/BDL{01-713-1179ACDISCPILOT01ADAE 7131179VERBATIM_0230PELVIC PAIN REPRODUCTIVE SYSTEM AND BREAST DISORDERS MILD NPOSSIBLE YY.AA....DL B?B?DMBPlacebo Pbo B@<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0691 HLT_0189 PELVIC PAIN DM/BDL{01-713-1179ACDISCPILOT01ADAE 7131179VERBATIM_1024GASTROENTERITIS VIRAL INFECTIONS AND INFESTATIONS MODERATENREMOTE YY..A....DL B?B?DLBBPlacebo Pbo B@<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0385 HLT_0211 STOMACH FLU DM/BDL{01-713-1179ACDISCPILOT01ADAE 7131179VERBATIM_1801GASTROOESOPHAGEAL REFLUX DISEASE GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YY..A....DL B?B?..Placebo Pbo B@<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0304 HLT_0407 GASTROOESOPHAGEAL REFLUX DISEASE DM/BDL{01-713-1179ACDISCPILOT01ADAE 7131179VERBATIM_0207VAGINAL MYCOSIS INFECTIONS AND INFESTATIONS MILD NREMOTE YY..A....DL BkBkDLBtPlacebo Pbo B@<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0643 HLT_0508 VAGINAL YEAST INFECTION DM/BDL{01-713-1179ACDISCPILOT01ADAE 7131179VERBATIM_1707CERVICITIS INFECTIONS AND INFESTATIONS MILD NREMOTE YY..A....DL BkBkDLBtPlacebo Pbo B@<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0282 HLT_0651 CERVICITIS DM/BDL{01-713-1179ACDISCPILOT01ADAE 7131179VERBATIM_0207VAGINAL MYCOSIS INFECTIONS AND INFESTATIONS MILD NREMOTE YY.......DL BkBkDLBtPlacebo Pbo B@<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0643 HLT_0508 VAGINAL YEAST INFECTION DM/BDL{01-713-1179ACDISCPILOT01ADAE 7131179VERBATIM_1707CERVICITIS INFECTIONS AND INFESTATIONS MILD NREMOTE YY.......DL BkBkDLBtPlacebo Pbo B@<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0282 HLT_0651 CERVICITIS DM/BDL{01-713-1179ACDISCPILOT01ADAE 7131179VERBATIM_0230PELVIC PAIN REPRODUCTIVE SYSTEM AND BREAST DISORDERS MILD NPOSSIBLE YY.......DL B?B?DMBPlacebo Pbo B@<65 ACAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0691 HLT_0189 PELVIC PAIN DM/BDL{01-713-1209ACDISCPILOT01ADAE 7131209VERBATIM_0554ABDOMINAL PAIN GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YYAAA....DL4 A@A@..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0419 HLT_0217 ABDOMINAL PAIN DLBDL101-713-1209A CDISCPILOT01ADAE 7131209VERBATIM_1219APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADL7 ApAp..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLBDL101-713-1209A0CDISCPILOT01ADAE 7131209VERBATIM_0554ABDOMINAL PAIN GASTROINTESTINAL DISORDERS MODERATENPOSSIBLE YY.......DL4 A@A@..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0419 HLT_0217 ABDOMINAL PAIN DLBDL101-713-1209A@CDISCPILOT01ADAE 7131209VERBATIM_1049DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YY.AA....DL BB..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 LIGHTHEADEDNESS DLBDL101-713-1256ACDISCPILOT01ADAE 7131256VERBATIM_1298APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADK` B*B*DKaB+Placebo Pbo BG65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DKBDK701-713-1256A CDISCPILOT01ADAE 7131256VERBATIM_1298APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADK` B*B*DKaB+Placebo Pbo BG65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DKBDK701-713-1269ACDISCPILOT01ADAE 7131269VERBATIM_0232APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADM, ApAp..Placebo Pbo BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DMBDM&01-713-1269A CDISCPILOT01ADAE 7131269VERBATIM_0910COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NREMOTE YY.AA....DMw BRBR..Placebo Pbo BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DMBDM&01-713-1269A0CDISCPILOT01ADAE 7131269VERBATIM_0061SHOULDER PAIN MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MILD NPOSSIBLE YY.AA....DM B~B~..Placebo Pbo BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0288 HLT_0527 SHOULDER PAIN DMBDM&01-713-1269A@CDISCPILOT01ADAE 7131269VERBATIM_0389RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENREMOTE YY.AA...ADM BB..Placebo Pbo BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DMBDM&01-713-1269APCDISCPILOT01ADAE 7131269VERBATIM_0061SHOULDER PAIN MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MODERATENPOSSIBLE YY.......DM B~B~..Placebo Pbo BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0288 HLT_0527 SHOULDER PAIN DMBDM&01-713-1269A`CDISCPILOT01ADAE 7131269VERBATIM_0389RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NREMOTE YY......ADM BB..Placebo Pbo BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DMBDM&01-713-1448ACDISCPILOT01ADAE 7131448VERBATIM_1336APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYYAAA...ADMY B<B<DMB}Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DMBvDM01-713-1448A CDISCPILOT01ADAE 7131448VERBATIM_0775NAUSEA GASTROINTESTINAL DISORDERS MILD NPOSSIBLEYYY.AA....DMa BDBDDMB}Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0326 HLT_0742 NAUSEA DMBvDM01-713-1448A0CDISCPILOT01ADAE 7131448VERBATIM_1336APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY......ADMY B<B<DMB}Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DMBvDM01-713-1448A@CDISCPILOT01ADAE 7131448VERBATIM_0775NAUSEA GASTROINTESTINAL DISORDERS MILD NPOSSIBLEYYY.......DMa BDBDDMB}Xanomeline Low Dose Xan_Lo ABG65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0326 HLT_0742 NAUSEA DMBvDM01-714-1035ACDISCPILOT01ADAE 7141035VERBATIM_0319BUNDLE BRANCH BLOCK RIGHT CARDIAC DISORDERS MILD NREMOTE YYAAA....DM B(B(DMB1Placebo Pbo BX>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0597 HLT_0751 INCOMPLETE RIGHT BUNDLE BRANCH BLOCK DN,BDMv01-714-1035A CDISCPILOT01ADAE 7141035VERBATIM_0748ELECTROCARDIOGRAM T WAVE INVERSION INVESTIGATIONS MILD NREMOTE YY.AA....DM B(B(..Placebo Pbo BX>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0130 HLT_0289 T WAVE INVERSION DN,BDMv01-714-1035A0CDISCPILOT01ADAE 7141035VERBATIM_1420SUPRAVENTRICULAR EXTRASYSTOLES CARDIAC DISORDERS MILD NREMOTE YY..A....DM B1B1DMB>Placebo Pbo BX>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0279 HLT_0188 PREMATURE ATRIAL CONTRACTION DN,BDMv01-714-1035A@CDISCPILOT01ADAE 7141035VERBATIM_1153ELECTROCARDIOGRAM ST SEGMENT DEPRESSION INVESTIGATIONS MILD NREMOTE YY..A....DM B1B1..Placebo Pbo BX>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0220 HLT_0610 ST SEGMENT DEPRESSED DN,BDMv01-714-1035APCDISCPILOT01ADAE 7141035VERBATIM_0319BUNDLE BRANCH BLOCK RIGHT CARDIAC DISORDERS MILD NREMOTE YY.......DM B(B(DMB1Placebo Pbo BX>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0597 HLT_0751 INCOMPLETE RIGHT BUNDLE BRANCH BLOCK DN,BDMv01-714-1035A`CDISCPILOT01ADAE 7141035VERBATIM_1420SUPRAVENTRICULAR EXTRASYSTOLES CARDIAC DISORDERS MILD NREMOTE YY.......DM B1B1DMB>Placebo Pbo BX>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0279 HLT_0188 PREMATURE ATRIAL CONTRACTION DN,BDMv01-714-1035ApCDISCPILOT01ADAE 7141035VERBATIM_1176BRONCHITIS INFECTIONS AND INFESTATIONS MODERATENNONE YY.AA....DM B]B]DMBcPlacebo Pbo BX>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0523 HLT_0634 BRONCHITIS DN,BDMv01-714-1068ACDISCPILOT01ADAE 7141068VERBATIM_0019SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYYAAA...ADL~ APAPDLAXanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DLB>DLz01-714-1068A CDISCPILOT01ADAE 7141068VERBATIM_0019SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADL~ APAPDLAXanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DLB>DLz01-714-1068A0CDISCPILOT01ADAE 7141068VERBATIM_0343APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY.AA...ADL B,B,..Xanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE ERYTHEMA DLB>DLz01-714-1068A@CDISCPILOT01ADAE 7141068VERBATIM_1386APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY..A...ADL B,B,..Xanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLB>DLz01-714-1068APCDISCPILOT01ADAE 7141068VERBATIM_0343APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY......ADL B,B,..Xanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE ERYTHEMA DLB>DLz01-714-1068A`CDISCPILOT01ADAE 7141068VERBATIM_1386APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY......ADL B,B,..Xanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DLB>DLz01-714-1195ACDISCPILOT01ADAE 7141195VERBATIM_1274DIARRHOEA GASTROINTESTINAL DISORDERS MILD NREMOTE YYAAA....DL" BBDLdBSXanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 LOOSE STOOLS DLBDL01-714-1195A CDISCPILOT01ADAE 7141195VERBATIM_1325HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLE YY.AA....DL" BBDLdBSXanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 SWEATING DLBDL01-714-1195A0CDISCPILOT01ADAE 7141195VERBATIM_0907APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS SEVERE NPROBABLE YY.AA...ADL# BBDLdBSXanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DLBDL01-714-1195A@CDISCPILOT01ADAE 7141195VERBATIM_0352SOMNOLENCE NERVOUS SYSTEM DISORDERS MILD NNONE YY.AA....DL$ BB..Xanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0254 HLT_0160 DROWSINESS DLBDL01-714-1195APCDISCPILOT01ADAE 7141195VERBATIM_1606APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADL' BB..Xanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE PRURITUS DLBDL01-714-1195A`CDISCPILOT01ADAE 7141195VERBATIM_1274DIARRHOEA GASTROINTESTINAL DISORDERS MILD NREMOTE YY.......DL" BBDLdBSXanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 LOOSE STOOLS DLBDL01-714-1195ApCDISCPILOT01ADAE 7141195VERBATIM_1325HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLE YY.......DL" BBDLdBSXanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 SWEATING DLBDL01-714-1195ACDISCPILOT01ADAE 7141195VERBATIM_0907APPLICATION SITE ERYTHEMA GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS SEVERE NPROBABLE YY......ADL# BBDLdBSXanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0152 HLT_0617 APPLICATION SITE REDNESS DLBDL01-714-1195ACDISCPILOT01ADAE 7141195VERBATIM_1664DYSURIA RENAL AND URINARY DISORDERS MILD NREMOTE YY.AA....DLl B[B[DLxBgXanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0210 HLT_0637 URINATION DIFFICULTY DLBDL01-714-1288ACDISCPILOT01ADAE 7141288VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YYAAA....DL AADLAXanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DMBDL01-714-1288A CDISCPILOT01ADAE 7141288VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YY.AA....DL AADLAXanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DMBDL01-714-1288A0CDISCPILOT01ADAE 7141288VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY.AA...ADM B'B'..Xanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DMBDL01-714-1288A@CDISCPILOT01ADAE 7141288VERBATIM_0405NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MILD NNONE YY.AA....DM! B2B2DM$B5Xanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 HEAD COLD DMBDL01-714-1288APCDISCPILOT01ADAE 7141288VERBATIM_0910COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NNONE YY.AA....DM! B2B2DM$B5Xanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DMBDL01-714-1288A`CDISCPILOT01ADAE 7141288VERBATIM_0291BACK PAIN MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MILD NNONE YY.AA....DMB BSBSDMmB~Xanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0508 HLT_0115 LOW BACK PAIN DMBDL01-714-1288ApCDISCPILOT01ADAE 7141288VERBATIM_0672ARTHRALGIA MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MODERATENNONE YY..A....DMN B_B_..Xanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0610 HLT_0375 KNEE PAIN DMBDL01-714-1288ACDISCPILOT01ADAE 7141288VERBATIM_0291BACK PAIN MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MILD NNONE YY.......DMB BSBSDMmB~Xanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0508 HLT_0115 LOW BACK PAIN DMBDL01-714-1288ACDISCPILOT01ADAE 7141288VERBATIM_1595SINUS BRADYCARDIA CARDIAC DISORDERS MODERATENREMOTE YY.AA....DM BB..Xanomeline High DoseXan_Hi A BM65-80A AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 BRADYCARDIA SINUS DMBDL01-714-1375ACDISCPILOT01ADAE 7141375VERBATIM_0290SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENNONE YYAAA...ADK B!B!DKB(Placebo Pbo BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 IRRITATION SKIN DLBDK01-714-1375A CDISCPILOT01ADAE 7141375VERBATIM_1599EAR PAIN EAR AND LABYRINTH DISORDERS MILD NNONE YY.AA....DK B&B&DLB1Placebo Pbo BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0432 HLT_0631 EAR PAIN DLBDK01-714-1375A0CDISCPILOT01ADAE 7141375VERBATIM_0290SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENNONE YY......ADK B!B!DKB(Placebo Pbo BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 IRRITATION SKIN DLBDK01-714-1375A@CDISCPILOT01ADAE 7141375VERBATIM_1599EAR PAIN EAR AND LABYRINTH DISORDERS MILD NNONE YY.......DK B&B&DLB1Placebo Pbo BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0432 HLT_0631 EAR PAIN DLBDK01-714-1375APCDISCPILOT01ADAE 7141375VERBATIM_1586PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLE YY..A...ADL3 B]B]..Placebo Pbo BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITIS DLBDK01-714-1375A`CDISCPILOT01ADAE 7141375VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLE YY..A...ADLE BoBo..Placebo Pbo BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLBDK01-714-1375ApCDISCPILOT01ADAE 7141375VERBATIM_1586PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY......ADL3 B]B]..Placebo Pbo BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 PRURITIS DLBDK01-714-1375ACDISCPILOT01ADAE 7141375VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY......ADLE BoBo..Placebo Pbo BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLBDK01-714-1425ACDISCPILOT01ADAE 7141425VERBATIM_1758ATRIOVENTRICULAR BLOCK SECOND DEGREE CARDIAC DISORDERS MODERATENNONE NN.......DL ..Xanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0086 HLT_0415 AV BLOCK SECOND DEGREE DLAPDL01-715-1107ACDISCPILOT01ADAE 7151107VERBATIM_0387DERMATITIS CONTACT SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYYAAA...ADL BGBGDL+BUXanomeline Low Dose Xan_Lo ABA65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0331 HLT_0056 CONTACT DERMATITIS DLBGDK01-715-1107A CDISCPILOT01ADAE 7151107VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MILD NNONE YNY.AA....DL# BMBM..Xanomeline Low Dose Xan_Lo ABA65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DLBGDK01-715-1107A0CDISCPILOT01ADAE 7151107VERBATIM_0387DERMATITIS CONTACT SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADL BGBGDL+BUXanomeline Low Dose Xan_Lo ABA65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0331 HLT_0056 CONTACT DERMATITIS DLBGDK01-715-1207ACDISCPILOT01ADAE 7151207VERBATIM_0739NEPHROLITHIASIS RENAL AND URINARY DISORDERS MODERATENNONE YYAAA....DK B6B6DKB6Placebo Pbo BN65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0546 HLT_0439 KIDNEY STONES DL1BDKs01-715-1319ACDISCPILOT01ADAE 7151319VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MODERATENNONE NYAAA....DK BBDKBXanomeline High DoseXan_Hi A BA65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DKBDK01-715-1321ACDISCPILOT01ADAE 7151321VERBATIM_0775NAUSEA GASTROINTESTINAL DISORDERS MILD NREMOTE YYYAAA....DMT B B DMTB Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0326 HLT_0742 NAUSEA DMzBFDM501-715-1321A CDISCPILOT01ADAE 7151321VERBATIM_0775NAUSEA GASTROINTESTINAL DISORDERS MILD NREMOTE YYY.......DMT B B DMTB Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0326 HLT_0742 NAUSEA DMzBFDM501-715-1321A0CDISCPILOT01ADAE 7151321VERBATIM_1688APPLICATION SITE REACTION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY.AA...ADMz BFBF..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0668 HLT_0339 APPLICATION SITE REACTION DMzBFDM501-715-1321A@CDISCPILOT01ADAE 7151321VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MILD NNONE YNY.AA....DM{ BGBG..Xanomeline High DoseXan_Hi A BK65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DMzBFDM501-715-1405ACDISCPILOT01ADAE 7151405VERBATIM_0135PALPITATIONS CARDIAC DISORDERS MODERATENPROBABLEYNYAAA....DL[ A0A0DL[A0Xanomeline Low Dose Xan_Lo ABE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0593 HLT_0493 PALPITATIONS DLZA DLY01-715-1405A CDISCPILOT01ADAE 7151405VERBATIM_1343HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYNY.AA....DL[ A0A0DL[A0Xanomeline Low Dose Xan_Lo ABE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 SWEATING DLZA DLY01-715-1405A0CDISCPILOT01ADAE 7151405VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MODERATENPROBABLEYNY.AA....DL[ A0A0DL[A0Xanomeline Low Dose Xan_Lo ABE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DLZA DLY01-715-1405A@CDISCPILOT01ADAE 7151405VERBATIM_1713CONFUSIONAL STATE PSYCHIATRIC DISORDERS MODERATENPROBABLEYNY.AA....DL[ A0A0DL[A0Xanomeline Low Dose Xan_Lo ABE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0329 HLT_0642 CONFUSION DLZA DLY01-715-1405APCDISCPILOT01ADAE 7151405VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MODERATENNONE YNY..A....DL` AADL`AXanomeline Low Dose Xan_Lo ABE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DLZA DLY01-715-1405A`CDISCPILOT01ADAE 7151405VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MODERATENNONE YNY.......DL` AADL`AXanomeline Low Dose Xan_Lo ABE65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DLZA DLY01-716-1024ACDISCPILOT01ADAE 7161024VERBATIM_1552NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MODERATENNONE YYAAA....DK B+B+DK?BQPlacebo Pbo BW>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD SYMPTOMS DKBDJ01-716-1024A CDISCPILOT01ADAE 7161024VERBATIM_1552NASOPHARYNGITIS INFECTIONS AND INFESTATIONS MODERATENNONE YY.......DK B+B+DK?BQPlacebo Pbo BW>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0709 HLT_0036 COLD SYMPTOMS DKBDJ01-716-1024A0CDISCPILOT01ADAE 7161024VERBATIM_0087EMPHYSEMA RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NPROBABLE YY.AA....DK BB..Placebo Pbo BW>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0221 HLT_0698 EMPHYSEMA DKBDJ01-716-1026ACDISCPILOT01ADAE 7161026VERBATIM_1115HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YYAAA....DMv BB..Placebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 PERSPIRATION EXCESSIVE DN,BDMg01-716-1026A CDISCPILOT01ADAE 7161026VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY..A...ADMv BB..Placebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DN,BDMg01-716-1026A0CDISCPILOT01ADAE 7161026VERBATIM_1077ELECTROCARDIOGRAM T WAVE INVERSION INVESTIGATIONS MILD NREMOTE YY.AA....DMw BBDMByPlacebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0130 HLT_0289 T WAVE INVERTED DN,BDMg01-716-1026A@CDISCPILOT01ADAE 7161026VERBATIM_1034EAR INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YY.AA....DM BjBjDMBsPlacebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0760 HLT_0757 EAR INFECTION DN,BDMg01-716-1026APCDISCPILOT01ADAE 7161026VERBATIM_1711ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED INVESTIGATIONS MILD NREMOTE YY..A....DM ByBy..Placebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0030 HLT_0037 T WAVE FLATTENING OF DN,BDMg01-716-1026A`CDISCPILOT01ADAE 7161026VERBATIM_1077ELECTROCARDIOGRAM T WAVE INVERSION INVESTIGATIONS MILD NREMOTE YY.......DMw BBDMByPlacebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0130 HLT_0289 T WAVE INVERTED DN,BDMg01-716-1026ApCDISCPILOT01ADAE 7161026VERBATIM_1034EAR INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YY.......DM BBDMBPlacebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0760 HLT_0757 EAR INFECTION DN,BDMg01-716-1044ACDISCPILOT01ADAE 7161044VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YYAAA....DL+ BBDL0BPlacebo Pbo BJ65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DLBDL01-716-1044A CDISCPILOT01ADAE 7161044VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MILD NPOSSIBLE YY.......DL+ BBDL0BPlacebo Pbo BJ65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DLBDL01-716-1044A0CDISCPILOT01ADAE 7161044VERBATIM_1524CONFUSIONAL STATE PSYCHIATRIC DISORDERS MILD NPOSSIBLE YY.AA....DL BB..Placebo Pbo BJ65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0329 HLT_0642 CONFUSION DLBDL01-716-1063ACDISCPILOT01ADAE 7161063VERBATIM_0056HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYNY..A....DM CC..Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 PERSPIRATION EXCESSIVE DLBmDL01-716-1063A CDISCPILOT01ADAE 7161063VERBATIM_0885FATIGUE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYYAAA....DLT B6B6..Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0181 HLT_0043 TIREDNESS DLBmDL01-716-1063A0CDISCPILOT01ADAE 7161063VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY.AA...ADLW B9B9DLoBQXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLBmDL01-716-1063A@CDISCPILOT01ADAE 7161063VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLEYYY......ADLW B9B9DLoBQXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLBmDL01-716-1063APCDISCPILOT01ADAE 7161063VERBATIM_0749RESTLESSNESS PSYCHIATRIC DISORDERS MODERATENPROBABLEYYY.AA....DLo BQBQDLrBTXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0510 HLT_0427 RESTLESSNESS DLBmDL01-716-1063A`CDISCPILOT01ADAE 7161063VERBATIM_1091LETHARGY NERVOUS SYSTEM DISORDERS MODERATENPROBABLEYYY.AA....DLr BTBT..Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0448 HLT_0027 LETHARGY DLBmDL01-716-1063ApCDISCPILOT01ADAE 7161063VERBATIM_0749RESTLESSNESS PSYCHIATRIC DISORDERS MODERATENPROBABLEYYY.......DLo BQBQDLrBTXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0510 HLT_0427 RESTLESSNESS DLBmDL01-716-1071ACDISCPILOT01ADAE 7161071VERBATIM_1251HYPERSOMNIA NERVOUS SYSTEM DISORDERS MILD NPOSSIBLEYYYAAA....DL` B$B$..Xanomeline High DoseXan_Hi A BN65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0628 HLT_0231 SLEEP EXCESSIVE DLsB7DL=01-716-1071A CDISCPILOT01ADAE 7161071VERBATIM_1745FATIGUE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLEYYY.AA....DL` B$B$..Xanomeline High DoseXan_Hi A BN65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0181 HLT_0043 TIREDNESS DLsB7DL=01-716-1071A0CDISCPILOT01ADAE 7161071VERBATIM_1714SYNCOPE NERVOUS SYSTEM DISORDERS MODERATENPROBABLEYYY..A....DLr B6B6DLrB6Xanomeline High DoseXan_Hi A BN65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0310 HLT_0440 SYNCOPE DLsB7DL=01-716-1094ACDISCPILOT01ADAE 7161094VERBATIM_0096ATRIAL FLUTTER CARDIAC DISORDERS MODERATENPOSSIBLEYYYAAA....DK B B ..Xanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0627 HLT_0477 ATRIAL FLUTTER DKB%DK01-716-1094A CDISCPILOT01ADAE 7161094VERBATIM_1728BUNDLE BRANCH BLOCK RIGHT CARDIAC DISORDERS MODERATENPOSSIBLEYYY..A....DK B B ..Xanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0597 HLT_0751 INCOMPLETE RIGHT BUNDLE BRANCH BLOCK DKB%DK01-716-1094A0CDISCPILOT01ADAE 7161094VERBATIM_1723VENTRICULAR SEPTAL DEFECT CONGENITAL, FAMILIAL AND GENETIC DISORDERS MODERATENPOSSIBLEYYY.AA....DK B B ..Xanomeline Low Dose Xan_Lo ABR>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0747 HLT_0589 VENTRICULAR SEPTAL DEFECT DKB%DK01-716-1103ACDISCPILOT01ADAE 7161103VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLE YYAAA...ADM BpBp..Xanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DNBDMZ01-716-1103A CDISCPILOT01ADAE 7161103VERBATIM_1655BLISTER SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLE YY..A...ADM BpBpDMBwXanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0267 HLT_0752 BLISTERS DNBDMZ01-716-1103A0CDISCPILOT01ADAE 7161103VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLE YY..A...ADM BpBp..Xanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DNBDMZ01-716-1103A@CDISCPILOT01ADAE 7161103VERBATIM_1655BLISTER SKIN AND SUBCUTANEOUS TISSUE DISORDERS SEVERE NPROBABLE YY......ADM BBDMBXanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0267 HLT_0752 BLISTERS DNBDMZ01-716-1103APCDISCPILOT01ADAE 7161103VERBATIM_1655BLISTER SKIN AND SUBCUTANEOUS TISSUE DISORDERS SEVERE NPROBABLE YY......ADM BBDMBXanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0267 HLT_0752 BLISTERS DNBDMZ01-716-1108ACDISCPILOT01ADAE 7161108VERBATIM_1095ELECTROCARDIOGRAM ST SEGMENT DEPRESSION INVESTIGATIONS MILD NPOSSIBLE YYAAA....DL B<B<..Placebo Pbo BV>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0220 HLT_0610 ST SEGMENT DEPRESSED DL|BDK01-716-1108A CDISCPILOT01ADAE 7161108VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY.AA...ADL BOBO..Placebo Pbo BV>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DL|BDK01-716-1151ACDISCPILOT01ADAE 7161151VERBATIM_0742MALIGNANT FIBROUS HISTIOCYTOMA NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)MILD NNONE YYYAAA....DK BBDKB2Xanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)YNNNNNHLGT_0507 HLT_0245 MALIGNANT FIBROUS HISTIOCYTOMA DL!BdDK01-716-1151A CDISCPILOT01ADAE 7161151VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY.AA...ADK B+B+..Xanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DL!BdDK01-716-1151A0CDISCPILOT01ADAE 7161151VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY..A...ADK B+B+..Xanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DL!BdDK01-716-1151A@CDISCPILOT01ADAE 7161151VERBATIM_0742MALIGNANT FIBROUS HISTIOCYTOMA NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)MILD NNONE YYY.......DK BBDKB2Xanomeline Low Dose Xan_Lo ABS>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)YNNNNNHLGT_0507 HLT_0245 MALIGNANT FIBROUS HISTIOCYTOMA DL!BdDK01-716-1157ACDISCPILOT01ADAE 7161157VERBATIM_1539UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YYAAA....DL BBDLB"Xanomeline Low Dose Xan_Lo ABU>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DMiBDL01-716-1157A CDISCPILOT01ADAE 7161157VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY.AA...ADL BB..Xanomeline Low Dose Xan_Lo ABU>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DMiBDL01-716-1157A0CDISCPILOT01ADAE 7161157VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY..A...ADL BB..Xanomeline Low Dose Xan_Lo ABU>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DMiBDL01-716-1157A@CDISCPILOT01ADAE 7161157VERBATIM_1539UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MILD NNONE YY.......DL BBDLB"Xanomeline Low Dose Xan_Lo ABU>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DMiBDL01-716-1160ACDISCPILOT01ADAE 7161160VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YYAAA...ADL B#B#..Placebo Pbo BS>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLBDK01-716-1160A CDISCPILOT01ADAE 7161160VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY..A...ADL B#B#..Placebo Pbo BS>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLBDK01-716-1167ACDISCPILOT01ADAE 7161167VERBATIM_0658PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENNONE YYAAA...ADKr B)B)..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCH DLBDKJ01-716-1167A CDISCPILOT01ADAE 7161167VERBATIM_1412SWELLING GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENNONE YY.AA....DKr B)B)..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0484 HLT_0658 SWELLING DLBDKJ01-716-1167A0CDISCPILOT01ADAE 7161167VERBATIM_1655BLISTER SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLE YY..A...ADK B9B9..Xanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0267 HLT_0752 BLISTERS DLBDKJ01-716-1167A@CDISCPILOT01ADAE 7161167VERBATIM_1451HYPERSENSITIVITY IMMUNE SYSTEM DISORDERS MILD NNONE YY.AA....DK BBDLBXanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0765 HLT_0473 ALLERGY DLBDKJ01-716-1167APCDISCPILOT01ADAE 7161167VERBATIM_1451HYPERSENSITIVITY IMMUNE SYSTEM DISORDERS MILD NNONE YY.......DK BBDLBXanomeline Low Dose Xan_Lo ABD65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0765 HLT_0473 ALLERGY DLBDKJ01-716-1177ACDISCPILOT01ADAE 7161177VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE NN......ADM ..Placebo Pbo BH65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DNBDN01-716-1189ACDISCPILOT01ADAE 7161189VERBATIM_0460HALLUCINATION PSYCHIATRIC DISORDERS MODERATENNONE YYYAAA....DKy B/B/..Xanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0649 HLT_0026 HALLUCINATION DKBDKK01-716-1189A CDISCPILOT01ADAE 7161189VERBATIM_1218DELUSION PSYCHIATRIC DISORDERS MODERATENNONE YYY..A....DKy B/B/..Xanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0565 HLT_0198 DELUSIONS DKBDKK01-716-1189A0CDISCPILOT01ADAE 7161189VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLEYYY.AA...ADK BYBY..Xanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DKBDKK01-716-1189A@CDISCPILOT01ADAE 7161189VERBATIM_0154PROSTATE CANCER NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)SEVERE NNONE YYY.AA....DK BzBz..Xanomeline High DoseXan_Hi A BQ>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)YNNNNNHLGT_0190 HLT_0412 PROSTATE CANCER DKBDKK01-716-1229ACDISCPILOT01ADAE 7161229VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYYAAA...ADK AA..Xanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DKB(DK01-716-1229A CDISCPILOT01ADAE 7161229VERBATIM_1044BLOOD CHOLESTEROL INCREASED INVESTIGATIONS MILD NNONE YYY.AA....DK AA..Xanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0430 HLT_0210 HIGH CHOLESTEROL DKB(DK01-716-1298ACDISCPILOT01ADAE 7161298VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYYAAA...ADL AADLYBZXanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLQBRDL01-716-1298A CDISCPILOT01ADAE 7161298VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY..A...ADL AADLYBZXanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLQBRDL01-716-1298A0CDISCPILOT01ADAE 7161298VERBATIM_1655BLISTER SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY..A...ADL= B>B>DLYBZXanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0267 HLT_0752 BLISTERS DLQBRDL01-716-1298A@CDISCPILOT01ADAE 7161298VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADL AADLYBZXanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLQBRDL01-716-1298APCDISCPILOT01ADAE 7161298VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADL AADLYBZXanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLQBRDL01-716-1298A`CDISCPILOT01ADAE 7161298VERBATIM_1655BLISTER SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY......ADL= B>B>DLYBZXanomeline Low Dose Xan_Lo ABL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0267 HLT_0752 BLISTERS DLQBRDL01-716-1308ACDISCPILOT01ADAE 7161308VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YYAAA...ADL BB..Placebo Pbo BL65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLB)DL01-716-1311ACDISCPILOT01ADAE 7161311VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YYAAA...ADM AADNBXanomeline Low Dose Xan_Lo ABN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DNBDM01-716-1311A CDISCPILOT01ADAE 7161311VERBATIM_0554ABDOMINAL PAIN GASTROINTESTINAL DISORDERS MODERATENNONE YY.AA....DM BFBFDMBQXanomeline Low Dose Xan_Lo ABN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0419 HLT_0217 ABDOMINAL PAIN DNBDM01-716-1311A0CDISCPILOT01ADAE 7161311VERBATIM_1041ULCER GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENNONE YY.AA....DM BQBQ..Xanomeline Low Dose Xan_Lo ABN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0245 HLT_0040 ULCER DNBDM01-716-1311A@CDISCPILOT01ADAE 7161311VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY......ADM AADNBXanomeline Low Dose Xan_Lo ABN65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DNBDM01-716-1364ACDISCPILOT01ADAE 7161364VERBATIM_0658PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YYAAA...ADL B.B...Xanomeline High DoseXan_Hi A BT>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCH DMBDLW01-716-1364A CDISCPILOT01ADAE 7161364VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY..A...ADL B=B=..Xanomeline High DoseXan_Hi A BT>80 A0CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DMBDLW01-716-1373ACDISCPILOT01ADAE 7161373VERBATIM_0384COGNITIVE DISORDER NERVOUS SYSTEM DISORDERS MILD NNONE YYYAAA....DK AA..Xanomeline High DoseXan_Hi A BJ65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0506 HLT_0265 COGNITIVE IMPAIRMENT DKBLDK01-716-1373A CDISCPILOT01ADAE 7161373VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLEYYY.AA...ADK A A ..Xanomeline High DoseXan_Hi A BJ65-80A CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DKBLDK01-716-1418ACDISCPILOT01ADAE 7161418VERBATIM_1341URTICARIA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YYAAA...ADL AADLA0Xanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0705 HLT_0420 WELTS DLBDL01-716-1418A CDISCPILOT01ADAE 7161418VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY..A...ADL AA..Xanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DLBDL01-716-1418A0CDISCPILOT01ADAE 7161418VERBATIM_1341URTICARIA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY......ADL AADLA0Xanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0705 HLT_0420 WELTS DLBDL01-716-1418A@CDISCPILOT01ADAE 7161418VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY..A...ADL A0A0..Xanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLBDL01-716-1418APCDISCPILOT01ADAE 7161418VERBATIM_0301HEADACHE NERVOUS SYSTEM DISORDERS MODERATENPOSSIBLE YY.AA....DLTDB:B:DLBXanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DLBDL01-716-1418A`CDISCPILOT01ADAE 7161418VERBATIM_0911VISION BLURRED EYE DISORDERS MODERATENPOSSIBLE YY.AA....DLTDB:B:DLBXanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0598 HLT_0120 BLURRED VISION DLBDL01-716-1418ApCDISCPILOT01ADAE 7161418VERBATIM_0301HEADACHE NERVOUS SYSTEM DISORDERS MODERATENPOSSIBLE YY.......DLTDB:B:DLBXanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DLBDL01-716-1418ACDISCPILOT01ADAE 7161418VERBATIM_0911VISION BLURRED EYE DISORDERS MODERATENPOSSIBLE YY.......DLTDB:B:DLBXanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0598 HLT_0120 BLURRED VISION DLBDL01-716-1418ACDISCPILOT01ADAE 7161418VERBATIM_0301HEADACHE NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YY.......DL BBDLBXanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DLBDL01-716-1418ACDISCPILOT01ADAE 7161418VERBATIM_0301HEADACHE NERVOUS SYSTEM DISORDERS MILD NPOSSIBLE YY.......DL BBDLBXanomeline High DoseXan_Hi A BP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0344 HLT_0064 HEADACHE DLBDL01-716-1441ACDISCPILOT01ADAE 7161441VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YYAAA...ADM BnBn..Placebo Pbo BU>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DMBDM!01-716-1447ACDISCPILOT01ADAE 7161447VERBATIM_0056HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YYAAA....DM BB..Xanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 PERSPIRATION EXCESSIVE DMBDL01-716-1447A CDISCPILOT01ADAE 7161447VERBATIM_0300ERYTHEMA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLE YY..A...ADM BB..Xanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0192 HLT_0284 ERYTHEMA DMBDL01-716-1447A0CDISCPILOT01ADAE 7161447VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLE YY..A...ADM BB..Xanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DMBDL01-716-1447A@CDISCPILOT01ADAE 7161447VERBATIM_0366ELECTROCARDIOGRAM T WAVE INVERSION INVESTIGATIONS MILD NPOSSIBLE YY.AA....DMT BYBY..Xanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0130 HLT_0289 T WAVE INVERTED DMBDL01-716-1447APCDISCPILOT01ADAE 7161447VERBATIM_0517CHEST PAIN GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NREMOTE YY.AA....DMj BoBoDMnBsXanomeline High DoseXan_Hi A BH65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0195 HLT_0717 CHEST PAIN DMBDL01-717-1004ACDISCPILOT01ADAE 7171004VERBATIM_1678ENURESIS RENAL AND URINARY DISORDERS MODERATENPOSSIBLE NN.......DLD ..Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0623 HLT_0107 BED WETTING DMBDM01-717-1004A CDISCPILOT01ADAE 7171004VERBATIM_1666DIARRHOEA GASTROINTESTINAL DISORDERS MILD NPOSSIBLE NN.......DM DM4BXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 SOFT STOOLS DMBDM01-717-1004A0CDISCPILOT01ADAE 7171004VERBATIM_1357COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MODERATENREMOTE YYAAA....DM A A DM<B$Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DMBDM01-717-1004A@CDISCPILOT01ADAE 7171004VERBATIM_0214RHINORRHOEA RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NREMOTE YY..A....DM A A DM2BXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0460 HLT_0635 RUNNY NOSE DMBDM01-717-1004APCDISCPILOT01ADAE 7171004VERBATIM_0555FATIGUE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPOSSIBLE YY.AA....DM A A ..Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0181 HLT_0043 FATIGUE DMBDM01-717-1004A`CDISCPILOT01ADAE 7171004VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY.AA...ADM A A DM3BXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DMBDM01-717-1004ApCDISCPILOT01ADAE 7171004VERBATIM_1280ANXIETY PSYCHIATRIC DISORDERS MILD NPOSSIBLE YY.AA....DM A A ..Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0570 HLT_0559 ANXIETY DMBDM01-717-1004ACDISCPILOT01ADAE 7171004VERBATIM_0793IRRITABILITY PSYCHIATRIC DISORDERS MILD NPOSSIBLE YY..A....DM A A ..Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0461 HLT_0627 IRRITABILITY DMBDM01-717-1004ACDISCPILOT01ADAE 7171004VERBATIM_0214RHINORRHOEA RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NREMOTE YY.......DM A A DM2BXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0460 HLT_0635 RUNNY NOSE DMBDM01-717-1004ACDISCPILOT01ADAE 7171004VERBATIM_1666DIARRHOEA GASTROINTESTINAL DISORDERS MILD NPOSSIBLE NN.......DM DM4BXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 SOFT STOOLS DMBDM01-717-1004ACDISCPILOT01ADAE 7171004VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY......ADM A A DM3BXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DMBDM01-717-1004ACDISCPILOT01ADAE 7171004VERBATIM_1357COUGH RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MODERATENREMOTE YY.......DM A A DM<B$Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0280 HLT_0701 COUGH DMBDM01-717-1004ACDISCPILOT01ADAE 7171004VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY......ADMO B7B7DMUB=Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DMBDM01-717-1004ACDISCPILOT01ADAE 7171004VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY......ADMO B7B7DMUB=Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DMBDM01-717-1004ACDISCPILOT01ADAE 7171004VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MILD NPOSSIBLE YY.AA....DMm BUBU..Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DMBDM01-717-1004BCDISCPILOT01ADAE 7171004VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY......ADMz BbBb..Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DMBDM01-717-1004BCDISCPILOT01ADAE 7171004VERBATIM_1583BACK PAIN MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MODERATENNONE YY.AA....DM BB..Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0508 HLT_0115 BACK PAIN DMBDM01-717-1004BCDISCPILOT01ADAE 7171004VERBATIM_0942WOUND INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NPROBABLE YY.AA....DM BBDMBXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0540 HLT_0542 WOUND NOS DMBDM01-717-1004BCDISCPILOT01ADAE 7171004VERBATIM_0942WOUND INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NPROBABLE YY.......DM BBDMBXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0540 HLT_0542 WOUND NOS DMBDM01-717-1109ACDISCPILOT01ADAE 7171109VERBATIM_0156INCREASED APPETITE METABOLISM AND NUTRITION DISORDERS MILD NREMOTE YYAAA....DM( A0A0DMBXanomeline High DoseXan_Hi A BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0769 HLT_0566 INCREASED APPETITE DMBDM&01-717-1109A CDISCPILOT01ADAE 7171109VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY.AA...ADM9 BB..Xanomeline High DoseXan_Hi A BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DMBDM&01-717-1109A0CDISCPILOT01ADAE 7171109VERBATIM_0895HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY..A....DM9 BBDM;BXanomeline High DoseXan_Hi A BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 SWEATING INCREASED DMBDM&01-717-1109A@CDISCPILOT01ADAE 7171109VERBATIM_1524CONFUSIONAL STATE PSYCHIATRIC DISORDERS MILD NREMOTE YY.AA....DM> BB..Xanomeline High DoseXan_Hi A BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0329 HLT_0642 CONFUSION DMBDM&01-717-1109APCDISCPILOT01ADAE 7171109VERBATIM_0377INSOMNIA PSYCHIATRIC DISORDERS MILD NPOSSIBLE YY..A....DM@ BB..Xanomeline High DoseXan_Hi A BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0469 HLT_0297 INSOMNIA DMBDM&01-717-1109A`CDISCPILOT01ADAE 7171109VERBATIM_0990PRURITUS GENERALISED SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY..A...ADMJ B%B%..Xanomeline High DoseXan_Hi A BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0689 HLT_0123 GENERALIZED PRURITUS DMBDM&01-717-1109ApCDISCPILOT01ADAE 7171109VERBATIM_0760VENTRICULAR EXTRASYSTOLES CARDIAC DISORDERS MILD NNONE YY.AA....DMw BRBR..Xanomeline High DoseXan_Hi A BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0594 HLT_0050 PREMATURE VENTRICULAR CONTRACTIONS DMBDM&01-717-1109ACDISCPILOT01ADAE 7171109VERBATIM_0156INCREASED APPETITE METABOLISM AND NUTRITION DISORDERS MILD NREMOTE YY.......DM( A0A0DMBXanomeline High DoseXan_Hi A BT>80 A0CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0769 HLT_0566 INCREASED APPETITE DMBDM&01-717-1174ACDISCPILOT01ADAE 7171174VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YYAAA...ADK APAP..Xanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DLkBDK01-717-1174A CDISCPILOT01ADAE 7171174VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YY..A...ADK AA..Xanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLkBDK01-717-1174A0CDISCPILOT01ADAE 7171174VERBATIM_0377INSOMNIA PSYCHIATRIC DISORDERS MILD NPOSSIBLE YY.AA....DL BVBVDL BXXanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0469 HLT_0297 INSOMNIA DLkBDK01-717-1174A@CDISCPILOT01ADAE 7171174VERBATIM_0426RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS SEVERE NREMOTE YY..A...ADL B^B^DLB_Xanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DLkBDK01-717-1174APCDISCPILOT01ADAE 7171174VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLE YY......ADK APAP..Xanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DLkBDK01-717-1174A`CDISCPILOT01ADAE 7171174VERBATIM_0216PRURITUS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLE YY......ADK AA..Xanomeline High DoseXan_Hi A BI65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0695 HLT_0778 ITCHING DLkBDK01-717-1201ACDISCPILOT01ADAE 7171201VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YYAAA...ADL AA..Placebo Pbo BU>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DM?BADL01-717-1201A CDISCPILOT01ADAE 7171201VERBATIM_1197ALOPECIA SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NREMOTE YY..A....DM BB..Placebo Pbo BU>80 A0CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0234 HLT_0077 HAIR LOSS DM?BADL01-717-1344ACDISCPILOT01ADAE 7171344VERBATIM_1164NASAL CONGESTION RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS MILD NREMOTE YYAAA....DM+ BBDM0BPlacebo Pbo B@<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0549 HLT_0118 NOSE CONGESTION DMTB?DM01-717-1344A CDISCPILOT01ADAE 7171344VERBATIM_0555FATIGUE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY.AA....DM+ BBDM<B'Placebo Pbo B@<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0181 HLT_0043 FATIGUE DMTB?DM01-717-1344A0CDISCPILOT01ADAE 7171344VERBATIM_0555FATIGUE GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPOSSIBLE YY.......DM+ BBDM<B'Placebo Pbo B@<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0181 HLT_0043 FATIGUE DMTB?DM01-717-1344A@CDISCPILOT01ADAE 7171344VERBATIM_0775NAUSEA GASTROINTESTINAL DISORDERS MODERATENREMOTE YY.AA....DMF B1B1DMGB2Placebo Pbo B@<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0326 HLT_0742 NAUSEA DMTB?DM01-717-1344APCDISCPILOT01ADAE 7171344VERBATIM_0897VOMITING GASTROINTESTINAL DISORDERS MODERATENREMOTE YY..A....DMF B1B1DMGB2Placebo Pbo B@<65 ACAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 VOMITING DMTB?DM01-717-1357ACDISCPILOT01ADAE 7171357VERBATIM_0529DIZZINESS NERVOUS SYSTEM DISORDERS MODERATENNONE NN.......D0D:9..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DLBDL01-717-1357A CDISCPILOT01ADAE 7171357VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPROBABLE YYAAA...ADL- BB..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DLBDL01-717-1357A0CDISCPILOT01ADAE 7171357VERBATIM_0286OEDEMA PERIPHERAL GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPOSSIBLE YY.AA....DL3 BB..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0137 HLT_0661 ANKLE EDEMA DLBDL01-717-1357A@CDISCPILOT01ADAE 7171357VERBATIM_0707APPLICATION SITE PERSPIRATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY..A...ADL@ B*B*DLBXanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0403 HLT_0283 APPLICATION SITE PERSPIRATION DLBDL01-717-1357APCDISCPILOT01ADAE 7171357VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLE YY......ADL- BB..Xanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DLBDL01-717-1357A`CDISCPILOT01ADAE 7171357VERBATIM_0897VOMITING GASTROINTESTINAL DISORDERS MODERATENREMOTE YY.AA....DLZ BDBDDL[BEXanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 VOMITING DLBDL01-717-1357ApCDISCPILOT01ADAE 7171357VERBATIM_0775NAUSEA GASTROINTESTINAL DISORDERS MILD NREMOTE YY..A....DLi BSBSDLiBSXanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0326 HLT_0742 NAUSEA DLBDL01-717-1357ACDISCPILOT01ADAE 7171357VERBATIM_1533DIZZINESS NERVOUS SYSTEM DISORDERS MODERATENREMOTE YY.AA....DL| BfBfDL|BfXanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 DIZZINESS DLBDL01-717-1357ACDISCPILOT01ADAE 7171357VERBATIM_0707APPLICATION SITE PERSPIRATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY......ADL@ B*B*DLBXanomeline High DoseXan_Hi A BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0403 HLT_0283 APPLICATION SITE PERSPIRATION DLBDL01-717-1446ACDISCPILOT01ADAE 7171446VERBATIM_1480ANXIETY PSYCHIATRIC DISORDERS MILD NPOSSIBLE YYAAA....DL AADLBXanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0570 HLT_0559 ANXIETY AGGRAVATED DMIBDL01-717-1446A CDISCPILOT01ADAE 7171446VERBATIM_1480ANXIETY PSYCHIATRIC DISORDERS MILD NPOSSIBLE YY.......DL AADLBXanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0570 HLT_0559 ANXIETY AGGRAVATED DMIBDL01-717-1446A0CDISCPILOT01ADAE 7171446VERBATIM_1630SKIN IRRITATION SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLE YY.AA...ADL BB..Xanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0384 HLT_0583 SKIN IRRITATION DMIBDL01-717-1446A@CDISCPILOT01ADAE 7171446VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MILD NREMOTE YY.AA....DL B$B$DMIBXanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DMIBDL01-717-1446APCDISCPILOT01ADAE 7171446VERBATIM_1706RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NREMOTE YY..A...ADL B%B%DLB)Xanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DMIBDL01-717-1446A`CDISCPILOT01ADAE 7171446VERBATIM_1706RASH SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NREMOTE YY......ADL B%B%DLB)Xanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0198 HLT_0762 RASH DMIBDL01-717-1446ApCDISCPILOT01ADAE 7171446VERBATIM_1240PAIN GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY.AA....DM BBDMBXanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0478 HLT_0314 STINGING DMIBDL01-717-1446ACDISCPILOT01ADAE 7171446VERBATIM_1240PAIN GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY.......DM' BB..Xanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0478 HLT_0314 STINGING DMIBDL01-717-1446ACDISCPILOT01ADAE 7171446VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MILD NREMOTE YY.......DL B$B$DMIBXanomeline Low Dose Xan_Lo ABK65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DMIBDL01-718-1066ACDISCPILOT01ADAE 7181066VERBATIM_1714SYNCOPE NERVOUS SYSTEM DISORDERS SEVERE NPOSSIBLEYYYAAA....DLc AADLgAXanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0310 HLT_0440 SYNCOPE DLcADLZ01-718-1066A CDISCPILOT01ADAE 7181066VERBATIM_0499AGITATION PSYCHIATRIC DISORDERS MODERATENPOSSIBLEYNY.AA....DLe AA..Xanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0170 HLT_0140 AGITATION DLcADLZ01-718-1066A0CDISCPILOT01ADAE 7181066VERBATIM_1714SYNCOPE NERVOUS SYSTEM DISORDERS SEVERE NPOSSIBLEYNY.......DLq BB..Xanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0310 HLT_0440 SYNCOPE DLcADLZ01-718-1066A@CDISCPILOT01ADAE 7181066VERBATIM_1651INFLAMMATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENREMOTE YNY.AA....DLq BB..Xanomeline Low Dose Xan_Lo ABO65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0004 HLT_0582 INFLAMMATION LOCALIZED DLcADLZ01-718-1079ACDISCPILOT01ADAE 7181079VERBATIM_1524CONFUSIONAL STATE PSYCHIATRIC DISORDERS MODERATENPOSSIBLEYYYAAA....DKG BB..Xanomeline Low Dose Xan_Lo ABC65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0329 HLT_0642 CONFUSION DKaB+DK701-718-1079A CDISCPILOT01ADAE 7181079VERBATIM_1567APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY.AA...ADKG BB..Xanomeline Low Dose Xan_Lo ABC65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DKaB+DK701-718-1079A0CDISCPILOT01ADAE 7181079VERBATIM_1567APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS SEVERE NPROBABLEYYY......ADKG BB..Xanomeline Low Dose Xan_Lo ABC65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DKaB+DK701-718-1101ACDISCPILOT01ADAE 7181101VERBATIM_0897VOMITING GASTROINTESTINAL DISORDERS MILD NNONE YYAAA....DK BBDKBXanomeline High DoseXan_Hi A BR>80 A0AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0350 HLT_0016 VOMITING DLrBDK01-718-1101A CDISCPILOT01ADAE 7181101VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MILD NNONE YY.AA....DL B8B8DL"BUXanomeline High DoseXan_Hi A BR>80 A0AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DLrBDK01-718-1101A0CDISCPILOT01ADAE 7181101VERBATIM_0149HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY.AA....DL B9B9DLYBXanomeline High DoseXan_Hi A BR>80 A0AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 PERSPIRATION EXCESSIVE DLrBDK01-718-1101A@CDISCPILOT01ADAE 7181101VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MILD NNONE YY.......DL B8B8DL"BUXanomeline High DoseXan_Hi A BR>80 A0AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DLrBDK01-718-1101APCDISCPILOT01ADAE 7181101VERBATIM_0706MYOCARDIAL INFARCTION CARDIAC DISORDERS MILD NNONE YY..A....DLY BB..Xanomeline High DoseXan_Hi A BR>80 A0AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0688 HLT_0649 INFERIOR MYOCARDIAL INFARCTION DLrBDK01-718-1101A`CDISCPILOT01ADAE 7181101VERBATIM_0149HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MILD NPOSSIBLE YY.......DL B9B9DLYBXanomeline High DoseXan_Hi A BR>80 A0AFRICAN DESCENT (NEGRO, BLACK) A MYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 PERSPIRATION EXCESSIVE DLrBDK01-718-1139ACDISCPILOT01ADAE 7181139VERBATIM_0731SOMNOLENCE NERVOUS SYSTEM DISORDERS MODERATENPOSSIBLE YYAAA....DL8 BBDLcB;Placebo Pbo BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0254 HLT_0160 SLEEPINESS DLBDL)01-718-1139A CDISCPILOT01ADAE 7181139VERBATIM_0731SOMNOLENCE NERVOUS SYSTEM DISORDERS MODERATENPOSSIBLE YY.......DL8 BBDLcB;Placebo Pbo BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0254 HLT_0160 SLEEPINESS DLBDL)01-718-1139A0CDISCPILOT01ADAE 7181139VERBATIM_1126DIARRHOEA GASTROINTESTINAL DISORDERS MILD NNONE YY.AA....DL BBDLBPlacebo Pbo BM65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0588 HLT_0148 DIARRHEA DLBDL)01-718-1150ACDISCPILOT01ADAE 7181150VERBATIM_0125BRADYCARDIA CARDIAC DISORDERS MILD NPOSSIBLE YYAAA....DK BBDKB:Placebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0294 HLT_0640 BRADYCARDIA DLpBDK01-718-1150A CDISCPILOT01ADAE 7181150VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MODERATENNONE YY.AA....DK B/B/DKBCPlacebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DLpBDK01-718-1150A0CDISCPILOT01ADAE 7181150VERBATIM_0479APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADK B8B8DKB8Placebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DLpBDK01-718-1150A@CDISCPILOT01ADAE 7181150VERBATIM_0125BRADYCARDIA CARDIAC DISORDERS MILD NPOSSIBLE YY.......DK BBDKB:Placebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0294 HLT_0640 BRADYCARDIA DLpBDK01-718-1150APCDISCPILOT01ADAE 7181150VERBATIM_0579UPPER RESPIRATORY TRACT INFECTION INFECTIONS AND INFESTATIONS MODERATENNONE YY.......DK B/B/DKBCPlacebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0489 HLT_0520 UPPER RESPIRATORY INFECTION DLpBDK01-718-1150A`CDISCPILOT01ADAE 7181150VERBATIM_0125BRADYCARDIA CARDIAC DISORDERS MILD NPOSSIBLE YY.......DL BpBpDLZBPlacebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0294 HLT_0640 BRADYCARDIA DLpBDK01-718-1150ApCDISCPILOT01ADAE 7181150VERBATIM_1319FOOD CRAVING METABOLISM AND NUTRITION DISORDERS MILD NPOSSIBLE YY.AA....DL> BB..Placebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0376 HLT_0754 CARBOHYDRATE CRAVING DLpBDK01-718-1150ACDISCPILOT01ADAE 7181150VERBATIM_1031APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADLE BB..Placebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DLpBDK01-718-1150ACDISCPILOT01ADAE 7181150VERBATIM_0125BRADYCARDIA CARDIAC DISORDERS MILD NPOSSIBLE YY.......DL BpBpDLZBPlacebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0294 HLT_0640 BRADYCARDIA DLpBDK01-718-1150ACDISCPILOT01ADAE 7181150VERBATIM_0796SINUS BRADYCARDIA CARDIAC DISORDERS MILD NPOSSIBLE NY..A....DLr BB..Placebo Pbo BI65-80A CAUCASIAN AFYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0500 HLT_0644 SINUS BRADYCARDIA DLpBDK01-718-1170ACDISCPILOT01ADAE 7181170VERBATIM_1049DIZZINESS NERVOUS SYSTEM DISORDERS MODERATENPOSSIBLEYYYAAA....DL BBDLBXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0751 HLT_0619 LIGHTHEADEDNESS DLBDL01-718-1170A CDISCPILOT01ADAE 7181170VERBATIM_0889HYPERHIDROSIS SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPOSSIBLEYYY.AA....DL BBDLBXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0005 HLT_0587 DIAPHORESIS DLBDL01-718-1170A0CDISCPILOT01ADAE 7181170VERBATIM_1174BODY TEMPERATURE INCREASED INVESTIGATIONS MILD NPOSSIBLEYYY.AA....DL BBDLBXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0351 HLT_0734 TEMPERATURE ELEVATION DLBDL01-718-1170A@CDISCPILOT01ADAE 7181170VERBATIM_0342HYPERTENSION VASCULAR DISORDERS MILD NPOSSIBLEYYY.AA....DL BBDLBXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0476 HLT_0228 HYPERTENSION DLBDL01-718-1170APCDISCPILOT01ADAE 7181170VERBATIM_1714SYNCOPE NERVOUS SYSTEM DISORDERS SEVERE YAPROBABLEYYY..AAAA.DL BBDLBXanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNYNHLGT_0310 HLT_0440 SYNCOPE DLBDL01-718-1170A`CDISCPILOT01ADAE 7181170VERBATIM_0258AGITATION PSYCHIATRIC DISORDERS SEVERE NPOSSIBLEYNY.AA....DL BB..Xanomeline Low Dose Xan_Lo ABP65-80A CAUCASIAN AFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0170 HLT_0140 INCREASED AGITATION DLBDL01-718-1250ACDISCPILOT01ADAE 7181250VERBATIM_0272BALANCE DISORDER NERVOUS SYSTEM DISORDERS MODERATENPOSSIBLEYYYAAA....DL BBDLB8Xanomeline Low Dose Xan_Lo ABR>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0101 HLT_0541 UNSTEADINESS DM*BDL01-718-1250A CDISCPILOT01ADAE 7181250VERBATIM_0992FALL INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NREMOTE YYY.AA....DL BBDLBXanomeline Low Dose Xan_Lo ABR>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0446 HLT_0168 FALL DM*BDL01-718-1250A0CDISCPILOT01ADAE 7181250VERBATIM_1794CONTUSION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MODERATENREMOTE YYY..A....DL BBDLB+Xanomeline Low Dose Xan_Lo ABR>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0381 HLT_0713 BRUISING OF FACE DM*BDL01-718-1250A@CDISCPILOT01ADAE 7181250VERBATIM_0272BALANCE DISORDER NERVOUS SYSTEM DISORDERS MILD NPOSSIBLEYYY.......DL BBDLB8Xanomeline Low Dose Xan_Lo ABR>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0101 HLT_0541 UNSTEADINESS DM*BDL01-718-1250APCDISCPILOT01ADAE 7181250VERBATIM_1794CONTUSION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NREMOTE YYY.......DL BBDLB+Xanomeline Low Dose Xan_Lo ABR>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0381 HLT_0713 BRUISING OF FACE DM*BDL01-718-1250A`CDISCPILOT01ADAE 7181250VERBATIM_0272BALANCE DISORDER NERVOUS SYSTEM DISORDERS MILD NPOSSIBLEYYY.......DL BBDLB8Xanomeline Low Dose Xan_Lo ABR>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0101 HLT_0541 UNSTEADINESS DM*BDL01-718-1250ApCDISCPILOT01ADAE 7181250VERBATIM_1794CONTUSION INJURY, POISONING AND PROCEDURAL COMPLICATIONS MILD NREMOTE YYY.......DL BBDLB+Xanomeline Low Dose Xan_Lo ABR>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0381 HLT_0713 BRUISING OF FACE DM*BDL01-718-1250ACDISCPILOT01ADAE 7181250VERBATIM_0425COORDINATION ABNORMAL NERVOUS SYSTEM DISORDERS MILD NPOSSIBLEYYY..A....DL B8B8DLB8Xanomeline Low Dose Xan_Lo ABR>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0015 HLT_0315 INCOORDINATION DM*BDL01-718-1250ACDISCPILOT01ADAE 7181250VERBATIM_0414APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLEYYY.AA...ADM BdBdDM=BXanomeline Low Dose Xan_Lo ABR>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DM*BDL01-718-1250ACDISCPILOT01ADAE 7181250VERBATIM_0414APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY......ADM BdBdDM=BXanomeline Low Dose Xan_Lo ABR>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DM*BDL01-718-1250ACDISCPILOT01ADAE 7181250VERBATIM_0414APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLEYYY......ADM BdBdDM=BXanomeline Low Dose Xan_Lo ABR>80 A0HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APFYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DM*BDL01-718-1254ACDISCPILOT01ADAE 7181254VERBATIM_1282ARTHRALGIA MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MODERATENNONE YYAAA....DL` A@A@..Xanomeline Low Dose Xan_Lo ABN65-80A HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0610 HLT_0375 PAIN IN HIP DMBDL]01-718-1254A CDISCPILOT01ADAE 7181254VERBATIM_0209ARTHRALGIA MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MILD NNONE YY.......DLl BBDLlBXanomeline Low Dose Xan_Lo ABN65-80A HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0610 HLT_0375 KNEE PAIN DMBDL]01-718-1254A0CDISCPILOT01ADAE 7181254VERBATIM_0209ARTHRALGIA MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS MILD NNONE YY.......DLl BBDLlBXanomeline Low Dose Xan_Lo ABN65-80A HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0610 HLT_0375 KNEE PAIN DMBDL]01-718-1254A@CDISCPILOT01ADAE 7181254VERBATIM_1032APPLICATION SITE DISCOLOURATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY.AA...ADL B#B#..Xanomeline Low Dose Xan_Lo ABN65-80A HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0273 HLT_0121 APPLICATION SITE DISCOLORATION DMBDL]01-718-1254APCDISCPILOT01ADAE 7181254VERBATIM_0777APPLICATION SITE PRURITUS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY..A...ADL B#B#..Xanomeline Low Dose Xan_Lo ABN65-80A HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0338 HLT_0317 APPLICATION SITE ITCHING DMBDL]01-718-1254A`CDISCPILOT01ADAE 7181254VERBATIM_0118SOMNOLENCE NERVOUS SYSTEM DISORDERS MODERATENREMOTE YY.AA....DL B8B8DLBHXanomeline Low Dose Xan_Lo ABN65-80A HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0254 HLT_0160 SOMNOLENCE DMBDL]01-718-1254ApCDISCPILOT01ADAE 7181254VERBATIM_0118SOMNOLENCE NERVOUS SYSTEM DISORDERS MODERATENREMOTE YY.......DL B8B8DLBHXanomeline Low Dose Xan_Lo ABN65-80A HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0254 HLT_0160 SOMNOLENCE DMBDL]01-718-1254ACDISCPILOT01ADAE 7181254VERBATIM_1319FOOD CRAVING METABOLISM AND NUTRITION DISORDERS MODERATEN YY.AA....DL BrBr..Xanomeline Low Dose Xan_Lo ABN65-80A HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0376 HLT_0754 CARBOHYDRATE CRAVING DMBDL]01-718-1254ACDISCPILOT01ADAE 7181254VERBATIM_1056DYSPHAGIA GASTROINTESTINAL DISORDERS MODERATEN YY.AA....DL BrBr..Xanomeline Low Dose Xan_Lo ABN65-80A HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA) APMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0405 HLT_0563 SWALLOWING DIFFICULT DMBDL]01-718-1328ACDISCPILOT01ADAE 7181328VERBATIM_1195APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YYAAA...ADK B3B3DKB5Xanomeline High DoseXan_Hi A BV>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DL BMDK01-718-1328A CDISCPILOT01ADAE 7181328VERBATIM_0504APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADK B3B3DKB5Xanomeline High DoseXan_Hi A BV>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE BURNING DL BMDK01-718-1328A0CDISCPILOT01ADAE 7181328VERBATIM_1406APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADK B=B=DL BPXanomeline High DoseXan_Hi A BV>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DL BMDK01-718-1328A@CDISCPILOT01ADAE 7181328VERBATIM_1406APPLICATION SITE IRRITATION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY......ADK B=B=DL BPXanomeline High DoseXan_Hi A BV>80 A0CAUCASIAN AMYYYNMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0346 HLT_0061 APPLICATION SITE IRRITATION DL BMDK01-718-1355ACDISCPILOT01ADAE 7181355VERBATIM_0931SKIN ULCER SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLE YYAAA...ADK AADKBPlacebo Pbo BO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0017 HLT_0005 SKIN EROSION DLBDK01-718-1355A CDISCPILOT01ADAE 7181355VERBATIM_0931SKIN ULCER SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENPROBABLE YY......ADK AADKBPlacebo Pbo BO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0017 HLT_0005 SKIN EROSION DLBDK01-718-1355A0CDISCPILOT01ADAE 7181355VERBATIM_0331DERMATITIS ATOPIC SKIN AND SUBCUTANEOUS TISSUE DISORDERS MODERATENNONE NN......A. ....Placebo Pbo BO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0257 HLT_0480 ATOPIC DERMATITIS DLBDK01-718-1355A@CDISCPILOT01ADAE 7181355VERBATIM_1524CONFUSIONAL STATE PSYCHIATRIC DISORDERS MODERATENREMOTE YY.AA....DL B1B1..Placebo Pbo BO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0329 HLT_0642 CONFUSION DLBDK01-718-1355APCDISCPILOT01ADAE 7181355VERBATIM_0873APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY.AA...ADL B;B;DLB;Placebo Pbo BO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DLBDK01-718-1355A`CDISCPILOT01ADAE 7181355VERBATIM_0306APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADL" BJBJDL"BJPlacebo Pbo BO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DLBDK01-718-1355ApCDISCPILOT01ADAE 7181355VERBATIM_0622APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADL& BNBNDL&BNPlacebo Pbo BO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DLBDK01-718-1355ACDISCPILOT01ADAE 7181355VERBATIM_0404APPLICATION SITE DERMATITIS GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY......ADL* BRBRDL*BRPlacebo Pbo BO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0241 HLT_0343 APPLICATION SITE RASH DLBDK01-718-1355ACDISCPILOT01ADAE 7181355VERBATIM_0066SOMNOLENCE NERVOUS SYSTEM DISORDERS MODERATENNONE YY.AA....DL/ BWBW..Placebo Pbo BO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0254 HLT_0160 SLEEPINESS DLBDK01-718-1355ACDISCPILOT01ADAE 7181355VERBATIM_0592APPLICATION SITE REACTION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MILD NPROBABLE YY..A...ADLL BtBtDLBPlacebo Pbo BO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0668 HLT_0339 APPLICATION SITE REACTION DLBDK01-718-1355ACDISCPILOT01ADAE 7181355VERBATIM_0592APPLICATION SITE REACTION GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS MODERATENPROBABLE YY......ADLL BtBtDLBPlacebo Pbo BO65-80A CAUCASIAN AMYYYYMedDRA version 8.0 (partially masked by request of MSSO)NNNNNNHLGT_0668 HLT_0339 APPLICATION SITE REACTION DLBDK01-718-1355ACDISCPILOT01ADAE 7181355VERBATIM_0342HYPERTENSION VASCULAR DISORDERS MODERATENREMOTE YY.AA....DL BBDLBPl